Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.8645363823524203,-2.845685702810381,0.0,0.0,0.0,44/53,9.75%,COX5A;COX7B;COX5B;COX6C;NDUFB7;NDUFB8;NDUFS5;COX6A1;UQCRB;COX6B1;NDUFB4;NDUFA13;NDUFB2;UQCRQ;NDUFV3;NDUFB3;NDUFC1;UQCR11;NDUFA7;NDUFB9;NDUFA3;COX4I1;NDUFS6;NDUFB6;NDUFC2;NDUFA11;COX8A;NDUFA1;NDUFS4;NDUFA8;NDUFA2;COX7C;UQCRC2;NDUFV2;NDUFS8;UQCRFS1;NDUFS2;NDUFB10;NDUFB11;NDUFB5;NDUFS3;NDUFA9;UQCR10;SDHC
gsea,aerobic electron transport chain (GO:0019646),-0.8677870525455977,-2.82757381777228,0.0,0.0,0.0,44/52,9.75%,COX5A;COX7B;COX5B;COX6C;NDUFB7;NDUFB8;NDUFS5;COX6A1;UQCRB;COX6B1;NDUFB4;NDUFA13;NDUFB2;UQCRQ;NDUFV3;NDUFB3;NDUFC1;UQCR11;NDUFA7;NDUFB9;NDUFA3;COX4I1;NDUFS6;NDUFB6;NDUFC2;NDUFA11;COX8A;NDUFA1;NDUFS4;NDUFA8;NDUFA2;COX7C;UQCRC2;NDUFV2;NDUFS8;UQCRFS1;NDUFS2;NDUFB10;NDUFB11;NDUFB5;NDUFS3;NDUFA9;UQCR10;SDHC
gsea,mitochondrial respiratory chain complex assembly (GO:0033108),-0.8153493137963842,-2.7779198823480864,0.0,0.0,0.0,39/52,12.34%,UQCC2;NDUFB7;NDUFB8;NDUFS5;NDUFB4;NDUFA13;NDUFB2;NDUFV3;NDUFB3;NDUFC1;NDUFA7;NDUFB9;NDUFA3;NDUFS6;NDUFB6;DMAC1;NDUFC2;NDUFA11;COX16;NDUFA1;NDUFS4;NDUFA8;TMEM126A;SURF1;COA3;NDUFA2;NDUFV2;NDUFS8;UQCRFS1;NDUFS2;NDUFB10;NDUFB11;NDUFB5;NDUFS3;NDUFA9;TTC19;COA5;COX20;NDUFAF8
gsea,non-canonical Wnt signaling pathway (GO:0035567),-0.7257296512612066,-2.752128763429444,0.0,0.0,0.0,19/54,9.72%,CALM1;PSMB8;PSMB3;PSMA2;CDC42;PSMA7;PSMB10;GNG2;PSMA1;GNB1;RAC1;PSME1;PSMB1;PSMB4;PSMD8;RHOA;PSMB9;CTNNB1;ARRB2
gsea,NADH dehydrogenase complex assembly (GO:0010257),-0.868300373609917,-2.7120777511188687,0.0,0.0,0.0,30/37,9.08%,NDUFB7;NDUFB8;NDUFS5;NDUFB4;NDUFA13;NDUFB2;NDUFV3;NDUFB3;NDUFC1;NDUFA7;NDUFB9;NDUFA3;NDUFS6;NDUFB6;DMAC1;NDUFC2;NDUFA11;NDUFA1;NDUFS4;NDUFA8;TMEM126A;NDUFA2;NDUFV2;NDUFS8;NDUFS2;NDUFB10;NDUFB11;NDUFB5;NDUFS3;NDUFA9
gsea,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.868300373609917,-2.7120777511188687,0.0,0.0,0.0,30/37,9.08%,NDUFB7;NDUFB8;NDUFS5;NDUFB4;NDUFA13;NDUFB2;NDUFV3;NDUFB3;NDUFC1;NDUFA7;NDUFB9;NDUFA3;NDUFS6;NDUFB6;DMAC1;NDUFC2;NDUFA11;NDUFA1;NDUFS4;NDUFA8;TMEM126A;NDUFA2;NDUFV2;NDUFS8;NDUFS2;NDUFB10;NDUFB11;NDUFB5;NDUFS3;NDUFA9
gsea,cellular response to tumor necrosis factor (GO:0071356),-0.7389868561456742,-2.6988084242662476,0.0,0.0,0.0,17/44,9.10%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PYCARD;PSMA1;TXNDC17;PSME1;PSMB1;PSMB4;PSMD8;COMMD7;ASAH1;ILK;CIB1;PSMB9
gsea,regulation of establishment of planar polarity (GO:0090175),-0.7478159282099792,-2.692031540039585,0.0,0.0,0.0,15/42,9.72%,PSMB8;PSMB3;PSMA2;CDC42;PSMA7;PSMB10;PSMA1;RAC1;PSME1;PSMB1;PSMB4;PSMD8;RHOA;PSMB9;ARRB2
gsea,cellular response to interleukin-1 (GO:0071347),-0.709149096831762,-2.6889262123557915,0.0,0.0,0.0,13/49,4.26%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PYCARD;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8;UBE2V1
gsea,regulation of primary metabolic process (GO:0080090),-0.7408328899425699,-2.682981753704469,0.0,0.0,0.0,14/45,3.28%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;ID2;EDF1;OAZ1;PSMA1;PSME1;PSMB1;PSMB4;PSMD8;SIN3B
gsea,interleukin-1-mediated signaling pathway (GO:0070498),-0.7502542144822048,-2.680532261251515,0.0,0.0,0.0,12/41,4.26%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8;UBE2V1
gsea,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.8875543924338953,-2.640730831740167,0.0,0.0,0.0,28/31,9.08%,NDUFB7;NDUFB8;NDUFS5;NDUFB4;NDUFA13;NDUFB2;NDUFV3;NDUFB3;NDUFC1;NDUFA7;NDUFB9;NDUFA3;NDUFS6;NDUFB6;NDUFC2;NDUFA11;NDUFA1;NDUFS4;NDUFA8;NDUFA2;NDUFV2;NDUFS8;NDUFS2;NDUFB10;NDUFB11;NDUFB5;NDUFS3;NDUFA9
gsea,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.7737053265697746,-2.6299610417092323,0.0,0.0,0.0,12/36,5.41%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8;FBXO6
gsea,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.7497344905969916,-2.6269913783430123,0.0,0.0,0.0,15/40,9.72%,PSMB8;PSMB3;PSMA2;CDC42;PSMA7;PSMB10;PSMA1;RAC1;PSME1;PSMB1;PSMB4;PSMD8;RHOA;PSMB9;ARRB2
gsea,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.8254749813389344,-2.62667446406086,0.0,0.0,0.0,17/29,7.07%,PSMB8;CYBA;PSMB3;PSMA2;PSMA7;PSMB10;NCF4;PSMA1;PSME1;PSMB1;TAPBP;PSMB4;PSMD8;B2M;SEC22B;ITGAV;SNAP23
gsea,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.7694020750599139,-2.608432168004818,0.0,0.0,0.0,14/35,6.72%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PYCARD;PSMA1;TXNDC17;PSME1;PSMB1;PSMB4;PSMD8;COMMD7;ILK
gsea,muscle contraction (GO:0006936),-0.7195544253451839,-2.6047474759626157,0.0,0.0,0.0,4/33,1.34%,CALM1;MYL6;MYL12A;MYL12B
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.8088501130857686,-2.596086217880009,0.0,0.0,0.0,17/30,7.07%,PSMB8;CYBA;PSMB3;PSMA2;PSMA7;PSMB10;NCF4;PSMA1;PSME1;PSMB1;TAPBP;PSMB4;PSMD8;B2M;SEC22B;ITGAV;SNAP23
gsea,ephrin receptor signaling pathway (GO:0048013),-0.733948759228279,-2.594813768707353,0.0,0.0,0.0,10/34,6.80%,CDC42;ARPC2;ACTR3;ARPC5;ARPC4;ARPC3;ARPC1B;RAC1;ARPC1A;RHOA
gsea,regulation of mitotic cell cycle phase transition (GO:1901990),-0.7118124997104074,-2.5898444804311938,0.0,0.0,0.0,20/50,9.23%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;ID2;DYNLL1;PSMA1;PSME1;PSMB1;PPP2R1A;PSMB4;PSMD8;UBE2E1;DCTN3;CETN2;CDC26;DCTN2;PSMB9;UBE2D1
gsea,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.7858259696365455,-2.5631482026922883,0.0,0.0,0.0,12/32,3.25%,PSMB8;PSMB3;ELOB;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8
gsea,cellular response to hypoxia (GO:0071456),-0.7387507896211386,-2.504079779964414,0.0,0.0,0.0,15/36,9.10%,PSMB8;PSMB3;ELOB;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8;BAD;ACAA2;PSMB9
gsea,NIK/NF-kappaB signaling (GO:0038061),-0.8240201142577263,-2.502819285506212,0.0,0.0,0.0,10/26,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;PSMB4;PSMD8
gsea,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.7886475123065374,-2.4898459819548604,0.0,0.0,0.0,15/28,9.90%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;PSMB4;PSMD8;UBE2E1;CDC26;PSMB9;UBE2D1;PTTG1
gsea,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.7618410901485916,-2.4778011012487693,0.0,0.0,0.0,12/31,3.25%,PSMB8;PSMB3;ELOB;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8
gsea,cell-matrix adhesion (GO:0007160),-0.6877210501477896,-2.472084596089341,0.0,0.0,0.0,9/35,6.72%,THY1;FERMT3;RAC1;ITGB2;ITGB1BP1;PARVG;TIMM10B;ITGAV;ILK
gsea,neutrophil activation involved in immune response (GO:0002283),-0.5595747806519213,-2.470817956392625,0.0,0.0,0.0,53/141,14.79%,CYBA;PSMA2;ARPC5;FTH1;DEGS1;PYCARD;COTL1;GSTP1;CSTB;DYNLL1;GMFG;RAC1;SURF4;PSMB1;NDUFC2;SRP14;ITGB2;CNN2;GOLGA7;COMMD3;CTSB;CTSC;TMEM30A;ERP44;ACTR10;B2M;CAT;LAMTOR2;DERA;DBNL;CAP1;ITGAV;GGH;ASAH1;TRAPPC1;RHOA;MAN2B1;SNAP23;RAB5C;PNP;UNC13D;ACTR1B;PRDX6;RAB3A;TBC1D10C;CSNK2B;SNAP29;FUCA2;VAMP2;PSMD13;RAP1B;LAMTOR3;RAP1A
gsea,regulation of cellular amino acid metabolic process (GO:0006521),-0.8651809838493141,-2.4697716000218595,0.0,0.0,0.0,11/21,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;OAZ1;PSMA1;PSME1;PSMB1;PSMB4;PSMD8
gsea,regulation of cellular amine metabolic process (GO:0033238),-0.8651809838493141,-2.4697716000218595,0.0,0.0,0.0,11/21,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;OAZ1;PSMA1;PSME1;PSMB1;PSMB4;PSMD8
gsea,neutrophil degranulation (GO:0043312),-0.5618544224540915,-2.467415954809153,0.0,0.0,0.0,53/140,14.79%,CYBA;PSMA2;ARPC5;FTH1;DEGS1;PYCARD;COTL1;GSTP1;CSTB;DYNLL1;GMFG;RAC1;SURF4;PSMB1;NDUFC2;SRP14;ITGB2;CNN2;GOLGA7;COMMD3;CTSB;CTSC;TMEM30A;ERP44;ACTR10;B2M;CAT;LAMTOR2;DERA;DBNL;CAP1;ITGAV;GGH;ASAH1;TRAPPC1;RHOA;MAN2B1;SNAP23;RAB5C;PNP;UNC13D;ACTR1B;PRDX6;RAB3A;TBC1D10C;CSNK2B;SNAP29;FUCA2;VAMP2;PSMD13;RAP1B;LAMTOR3;RAP1A
gsea,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.8157603604915302,-2.4621140277857587,0.0,0.0,0.0,11/25,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8
gsea,integrin-mediated signaling pathway (GO:0007229),-0.7771550603848143,-2.4606879112348254,0.0,0.0,0.0,8/21,6.72%,CDC42;THY1;FERMT3;ITGB2;ITGB1BP1;LAT;ITGAV;ILK
gsea,neutrophil mediated immunity (GO:0002446),-0.5563605009047489,-2.459944281112705,0.0,0.0,0.0,53/143,14.79%,CYBA;PSMA2;ARPC5;FTH1;DEGS1;PYCARD;COTL1;GSTP1;CSTB;DYNLL1;GMFG;RAC1;SURF4;PSMB1;NDUFC2;SRP14;ITGB2;CNN2;GOLGA7;COMMD3;CTSB;CTSC;TMEM30A;ERP44;ACTR10;B2M;CAT;LAMTOR2;DERA;DBNL;CAP1;ITGAV;GGH;ASAH1;TRAPPC1;RHOA;MAN2B1;SNAP23;RAB5C;PNP;UNC13D;ACTR1B;PRDX6;RAB3A;TBC1D10C;CSNK2B;SNAP29;FUCA2;VAMP2;PSMD13;RAP1B;LAMTOR3;RAP1A
gsea,pre-replicative complex assembly (GO:0036388),-0.8386906497808,-2.4425918944698224,0.0,0.0,0.0,10/21,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;PSMB4;PSMD8
gsea,regulation of mRNA stability (GO:0043488),-0.7051912242230938,-2.442353353552028,0.0,0.0,0.0,12/40,6.12%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;YWHAZ;PSMA1;PSME1;PSMB1;PSMB4;PSMD8;DCP2
gsea,protein N-linked glycosylation (GO:0006487),-0.7492551036269116,-2.4388348445416916,0.0,0.0,0.0,11/25,9.16%,KRTCAP2;OST4;TMEM258;OSTC;DAD1;MGAT2;DPM1;MGAT3;ALG5;TMEM165;DPM2
gsea,substantia nigra development (GO:0021762),-0.8119280571168198,-2.4375136149275045,0.0,0.0,0.0,9/18,9.12%,CALM1;CDC42;CALM3;COX6B1;DYNLL1;CNP;RHOA;NDUFS3;YWHAH
gsea,mitochondrial translation (GO:0032543),-0.7300570093460819,-2.4346587356088394,0.0,0.0,0.0,21/41,11.21%,MRPS21;MRPL36;MRPS33;MRPS14;MRPL33;NDUFA7;MRPS36;MRPL52;MRPL34;MRPS15;MRPL32;MRPL21;MRPL27;MRPS16;MRPL23;MRPS18C;MRPL57;MRPS24;MRPS23;AURKAIP1;MRPL46
gsea,DNA-dependent DNA replication (GO:0006261),-0.7448028006344759,-2.430628199026528,0.0,0.0,0.0,11/31,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;SSBP1;PSMB4;PSMD8
gsea,lymphocyte differentiation (GO:0030098),0.7832153998973007,2.4157619918572206,0.0,0.0,0.0,13/18,16.42%,PTPRC;TOX;GPS2;LCK;TCF3;LFNG;LMBR1L;PTPN2;PTPN22;CEBPG;RHOH;JAK3;SOX4
gsea,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.7678121077910158,-2.4140777640609032,0.0,0.0,0.0,11/28,4.10%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;PSMB4;PSMD8;PDCD2
gsea,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.8631661927417547,-2.4137138770897266,0.0,0.0,0.0,11/20,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8
gsea,translational termination (GO:0006415),-0.7176703306154255,-2.408037985268307,0.0,0.0,0.0,20/41,11.21%,MRPS21;MRPL36;MRPS33;MRPS14;MRPL33;MRPS36;MRPL52;MRPL34;MRPS15;MRPL32;MRPL21;MRPL27;MRPS16;MRPL23;MRPS18C;MRPL57;MRPS24;MRPS23;AURKAIP1;MRPL46
gsea,mitochondrial translational termination (GO:0070126),-0.729614891703329,-2.4068501513552367,0.0,0.0,0.0,20/39,11.21%,MRPS21;MRPL36;MRPS33;MRPS14;MRPL33;MRPS36;MRPL52;MRPL34;MRPS15;MRPL32;MRPL21;MRPL27;MRPS16;MRPL23;MRPS18C;MRPL57;MRPS24;MRPS23;AURKAIP1;MRPL46
gsea,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.7771360556334614,-2.4022819596680636,0.0,0.0,0.0,11/27,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8
gsea,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.5154204407148492,2.3993199729920205,0.0,0.0,0.0,67/154,21.24%,FOXM1;EZH2;HMGB2;CDKN1B;ID3;FOXP1;TERF1;NCOR1;ARID5B;NIPBL;BHLHE40;SP3;NKAP;PCIF1;SUDS3;VGLL4;TGFB1;GSK3B;PFDN5;RPL13A;RCOR1;ARID4A;WAPL;MYB;CDK5;GSK3A;RING1;WWP2;KAT5;PHF12;FOXO1;PHC2;PBXIP1;CIR1;LEF1;NR1H2;CAPN3;RSF1;SAMD4B;RFX3;TSC22D4;SFMBT2;MECP2;KDM1A;DPF2;DAPK3;HIC2;DDX6;INPP5K;TBX21;HMGA2;DPF3;MPHOSPH8;ATOH8;ZBTB18;SMAD4;PEX14;SCMH1;LOXL3;LIMS1;HMBOX1;TRAF6;RBPJ;RELA;CTBP1;NR1D2;SAMD13
gsea,"regulation of transcription, DNA-templated (GO:0006355)",0.45594472711528083,2.3969295266273245,0.0,0.0,0.0,188/483,21.24%,FOXM1;RAD21;TCF7;EZH2;NR4A1;BTG1;HMGB2;SKAP1;BACH2;CDKN1B;NSD3;FOSB;ID3;HMGB1;NR4A3;HIF1A;FOXP1;STAT4;TOX;SATB1;NCOR1;VEZF1;ING2;NR2C2;KLF2;ARID5B;IRF2;DDX5;ELF2;HBP1;BRD9;PRKCQ;NIPBL;PIAS1;BHLHE40;TIAL1;NFATC3;GPBP1;SP3;IRF9;NKAP;MED18;SP140;BCL10;BRD4;MEF2D;SUDS3;KLF13;ETS1;PHF20L1;VGLL4;CDK11B;TGFB1;CDK17;PFDN5;RCOR1;ARID4A;SOX5;ATF2;MYB;WBP2;CDK5;TCF3;CCNL2;EP300;KMT2E;PHF6;TGFBR1;PRKAR1A;DYRK1B;UBP1;RING1;SAP30L;WWP2;KAT5;CAMK4;DNM2;PHF12;USF2;PHF1;DMTF1;RLF;FOXO1;PHC2;PBXIP1;SERTAD3;CBFB;CIR1;LEF1;NR1H2;WAC;CAPN3;DBX1;GPBP1L1;STAT3;MAPRE3;RSF1;MAPK14;RFX3;RXRB;DVL1;RNF111;NSD1;POU6F1;TSC22D4;SMARCD1;SFMBT2;MECP2;EGR1;CARF;MAP3K2;CCNL1;KDM1A;RFXANK;OGT;ZFHX2;USP21;CEBPG;KLF14;MED31;DPF2;CDC5L;FBXL19;LHX2;RHOG;DAPK3;HIC2;PHF14;INPP5K;TBX21;IRF3;ARID4B;HMGA2;CELSR2;RHOH;MED27;TOX2;MLF2;CCNT1;BCL6B;SMARCD2;PGBD1;MAP2K7;SP110;DPF3;MPHOSPH8;FOXJ3;ATOH8;POLR3C;SLC39A8;ZBTB18;CSRNP2;SOX4;GRHL1;RFX2;MEIS3;INSR;NR6A1;NFIA;ZFP69;SMAD4;CXXC1;PEX14;MZF1;RNF4;PQBP1;EPC2;SCMH1;CREM;LOXL3;ZBTB37;LIMS1;SS18L1;HMBOX1;TBX6;SETD5;TRAF6;MAX;RBPJ;ZIK1;RELA;MED26;LCOR;ZEB2;CTBP1;NR1D2;CCNT2;SAMD13
gsea,mitochondrial translational elongation (GO:0070125),-0.7386218775551714,-2.3893636174180117,0.0,0.0,0.0,20/37,11.21%,MRPS21;MRPL36;MRPS33;MRPS14;MRPL33;MRPS36;MRPL52;MRPL34;MRPS15;MRPL32;MRPL21;MRPL27;MRPS16;MRPL23;MRPS18C;MRPL57;MRPS24;MRPS23;AURKAIP1;MRPL46
gsea,regulation of stem cell differentiation (GO:2000736),-0.7346090216809725,-2.3890937933063525,0.0,0.0,0.0,10/32,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;PSMB4;PSMD8
gsea,regulation of cellular ketone metabolic process (GO:0010565),-0.8275831668908444,-2.3859112304951497,0.0,0.0,0.0,11/22,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;OAZ1;PSMA1;PSME1;PSMB1;PSMB4;PSMD8
gsea,regulation of mRNA catabolic process (GO:0061013),-0.6842416946496342,-2.3779307810442245,0.0,0.0,0.0,18/39,17.07%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;YWHAZ;PSMA1;PSME1;PSMB1;PSMB4;PSMD8;DCP2;PSMB9;ELAVL1;PSMD13;YTHDF2;PSMF1;PSMD10
gsea,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.5636768202561998,-2.3661299362436283,0.0,0.0,0.0,43/93,22.67%,TMED9;CAPZB;DYNLL1;SEC13;IER3IP1;TFG;CTSC;COPE;PDCD6;ACTR10;CNIH1;TMED5;SEC22B;DCTN3;SAR1A;SAR1B;TRAPPC1;BET1;TRAPPC4;DCTN6;ARF4;ERGIC3;BCAP31;DCTN2;TMED7;TRAPPC3;CAPZA1;YKT6;RAB1A;DCTN5;YIF1B;SPAST;VAMP4;TBC1D20;COPB1;VAPB;RAB1B;GOPC;TMED3;SCFD1;VTI1B;VAPA;DYNC1LI1
gsea,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.765171374774348,-2.3652343221082845,0.0,0.0,0.0,10/27,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;PSMB4;PSMD8
gsea,protein targeting to mitochondrion (GO:0006626),-0.7760854416839664,-2.3645471770424593,0.0,0.0,0.0,13/20,10.79%,ROMO1;NDUFA13;TOMM7;TSPO;TOMM22;TOMM34;DNAJC19;TIMM10B;PAM16;DNLZ;BCAP31;TOMM40L;FIS1
gsea,"negative regulation of transcription, DNA-templated (GO:0045892)",0.4739330697349163,2.352359368006809,0.0,0.0,0.0,98/247,21.24%,FOXM1;EZH2;HMGB2;CDKN1B;FOSB;ID3;HMGB1;NR4A3;FOXP1;GPS2;SATB1;NCOR1;NR2C2;KLF2;ARID5B;IRF2;DDX5;NIPBL;BHLHE40;SP3;NKAP;SUDS3;MAP2K5;VGLL4;TGFB1;PFDN5;RCOR1;ARID4A;MIER1;RTF1;MYB;CDK5;CGGBP1;TCF3;MAF1;PAF1;EP300;PHF6;UBC;RING1;WWP2;TCF25;KAT5;PHF12;FOXO1;PHC2;PBXIP1;CBFB;CIR1;LEF1;NR1H2;CAPN3;STAT3;DLG1;RSF1;NOP53;RFX3;NSD1;POU6F1;TSC22D4;SFMBT2;MECP2;KDM1A;DPF2;RNF2;HIC2;INPP5K;TBX21;HMGA2;BCL6B;CBX8;DPF3;MPHOSPH8;PDE2A;ATOH8;PER3;ZBTB18;NR6A1;ZFP69;SMAD4;PEX14;MZF1;SCMH1;CREM;LOXL3;LIMS1;HMBOX1;TBX6;VPS72;TRAF6;MAX;RBPJ;RELA;LCOR;ZEB2;CTBP1;NR1D2;SAMD13
gsea,positive regulation of lamellipodium organization (GO:1902745),-0.8164918367299727,-2.3504817868962506,0.0,0.0,0.0,7/15,4.01%,CDC42;ARPC2;ACTR3;RAC1;TWF2;RAC2;AKIRIN1
gsea,Fc receptor signaling pathway (GO:0038093),-0.6733393637223948,-2.3464604342478217,0.0,0.0,0.0,15/42,9.10%,CALM1;PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;RAC1;PSME1;PSMB1;PSMB4;PSMD8;LAT;GRB2;PSMB9
gsea,negative regulation of cell cycle (GO:0045786),0.7537573311572183,2.3402690411233777,0.0,0.0,0.0,11/21,11.57%,NR4A1;BTG1;CDKN1B;HECA;TGFB1;PTEN;RNF167;ANGEL2;APC;PPP1R13B;SLC9A3R1
gsea,regulation of cell cycle phase transition (GO:1901987),-0.7495925044825661,-2.332342019126362,0.0,0.0,0.0,14/27,9.23%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;PSMB4;PSMD8;UBE2E1;CDC26;PSMB9;UBE2D1
gsea,phosphorylation (GO:0016310),0.5118274519564313,2.332294857509467,0.0,0.0,0.0,56/139,17.26%,FYN;LCK;TLK1;PANK2;HCST;STK38;STK4;SIK1;PKN2;STK11;CDK11B;TGFB1;GRK6;CLK3;GSK3B;CDK17;STK17B;PAK2;VRK2;CDK5;MAPK1;GSK3A;SRPK2;TGFBR1;DYRK1B;CAMK4;MAP4K2;MARK2;MAML1;AKT3;PRKCD;STAT3;TESK2;PRKAG1;SHPK;MARK3;JAK1;CDK10;PNKP;CSNK1D;DGKZ;DAPK3;CSNK2A1;GNPTG;CSNK1G2;STK19;SIK3;GLYCTK;CCNT1;ADAM10;MORC3;CAMK2B;JAK3;INSR;PRKCH;FASTK
gsea,intracellular protein transmembrane transport (GO:0065002),-0.7685715958831082,-2.328487797133623,0.0,0.0,0.0,8/18,8.87%,SEC61B;SEC61G;ROMO1;PEX16;DNAJC19;PAM16;DNLZ;TOMM40L
gsea,negative regulation of nucleic acid-templated transcription (GO:1903507),0.5092500321843211,2.3251575769221353,0.0,0.00010928017403503065,0.001,58/133,21.24%,FOXM1;EZH2;HMGB2;CDKN1B;ID3;FOXP1;NCOR1;ARID5B;NIPBL;BHLHE40;SP3;NKAP;SUDS3;VGLL4;TGFB1;PFDN5;RCOR1;ARID4A;MYB;CDK5;RING1;WWP2;KAT5;PHF12;FOXO1;PHC2;PBXIP1;CIR1;LEF1;NR1H2;CAPN3;RSF1;RFX3;TSC22D4;SFMBT2;MECP2;KDM1A;DPF2;HIC2;INPP5K;TBX21;HMGA2;DPF3;MPHOSPH8;ATOH8;ZBTB18;SMAD4;PEX14;SCMH1;LOXL3;LIMS1;HMBOX1;TRAF6;RBPJ;RELA;CTBP1;NR1D2;SAMD13
gsea,peptidyl-serine modification (GO:0018209),0.5877899470915675,2.318014415929276,0.0,0.00019124030456130366,0.002,27/60,12.61%,TLK1;PRKCQ;STK38;STK4;PKN2;GSK3B;PAK2;VRK2;TNKS;CDK5;MAPK1;SRPK2;TGFBR1;DYRK1B;CAMK4;RPS6KB2;MARK2;AKT3;GALNT2;PRKCD;MAPK14;AKT2;MARK3;CSNK1D;CSNK2A1;CSNK1G2;SMG1
gsea,negative regulation of transcription by RNA polymerase II (GO:0000122),0.48806096367409657,2.317838843402142,0.0,0.0001699913818322699,0.002,69/175,21.09%,FOXM1;EZH2;FOSB;ID3;HMGB1;NR4A3;FOXP1;GPS2;SATB1;NCOR1;NR2C2;KLF2;ARID5B;IRF2;DDX5;NIPBL;BHLHE40;NFATC3;NKAP;SUDS3;MAP2K5;MIER1;RTF1;MYB;CGGBP1;TCF3;PAF1;EP300;PHF6;UBC;WWP2;TCF25;KAT5;PHF12;CBFB;CIR1;NR1H2;STAT3;DLG1;NOP53;NSD1;POU6F1;MECP2;KDM1A;DPF2;RNF2;TBX21;HMGA2;BCL6B;CBX8;PDE2A;PER3;ZBTB18;NR6A1;ZFP69;SMAD4;MZF1;CREM;HMBOX1;TBX6;VPS72;TRAF6;MAX;RBPJ;RELA;LCOR;ZEB2;CTBP1;NR1D2
gsea,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.6813083673775946,-2.3080958259237363,0.0,0.0,0.0,12/30,8.04%,CDC42;ARPC2;ACTR3;ARPC5;ARPC4;ARPC3;CD3G;ARPC1B;RAC1;ARPC1A;GRB2;WAS
gsea,Fc-gamma receptor signaling pathway (GO:0038094),-0.6813083673775946,-2.3080958259237363,0.0,0.0,0.0,12/30,8.04%,CDC42;ARPC2;ACTR3;ARPC5;ARPC4;ARPC3;CD3G;ARPC1B;RAC1;ARPC1A;GRB2;WAS
gsea,protein-DNA complex assembly (GO:0065004),-0.7091250069189665,-2.3012539454862675,0.0,2.1587497705557386e-05,0.001,14/31,9.10%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8;GTF2H5;CETN2;PSMB9
gsea,cellular response to chemical stress (GO:0062197),-0.708126229554835,-2.2969322014210474,0.0,2.122160791393777e-05,0.001,10/24,8.89%,CYBA;GSTP1;NCF4;PRDX2;CHCHD2;PRDX5;CAT;MGAT3;NUDT2;PRDX6
gsea,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.5947340789432868,-2.29420839384559,0.0,4.173582889741095e-05,0.002,18/53,17.41%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;PSMB4;PSMD8;ILK;PSMB9;PSMD13;GSKIP;TRPM4;PSMF1;PSMD10;AMER1
gsea,peptidyl-serine phosphorylation (GO:0018105),0.5903383048375624,2.2934173628251733,0.0,0.0001529922436490429,0.002,26/59,12.61%,TLK1;PRKCQ;STK38;STK4;PKN2;GSK3B;PAK2;VRK2;TNKS;CDK5;MAPK1;SRPK2;TGFBR1;DYRK1B;CAMK4;RPS6KB2;MARK2;AKT3;PRKCD;MAPK14;AKT2;MARK3;CSNK1D;CSNK2A1;CSNK1G2;SMG1
gsea,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.5673734100301369,-2.2876698214820523,0.0,4.1051634981059944e-05,0.002,20/64,18.60%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8;PSMB9;PSMD13;ZNRF3;MAD2L2;PSMF1;PSMD10;AMER1;AMFR;ANKRD6
gsea,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.692260788586315,-2.2842184964975183,0.0,4.038951183620414e-05,0.002,8/23,4.83%,CDC42;ARPC2;ACTR3;RAC1;TWF2;RAC2;AKIRIN1;MIEN1
gsea,regulation of nucleic acid-templated transcription (GO:1903506),0.5105352504582145,2.283284008647946,0.0,0.00013908385786276628,0.002,44/107,18.51%,TCF7;EZH2;BTG1;NSD3;HIF1A;ING2;NR2C2;IRF2;PRKCQ;BHLHE40;GPBP1;SP3;CDK11B;PFDN5;ATF2;MYB;TCF3;EP300;TGFBR1;SAP30L;DNM2;PHF12;PHF1;DMTF1;SERTAD3;GPBP1L1;STAT3;RFX3;DVL1;NSD1;DAPK3;TBX21;HMGA2;CELSR2;RHOH;MLF2;SLC39A8;SOX4;INSR;NFIA;CXXC1;MZF1;PQBP1;CREM
gsea,ubiquitin-dependent ERAD pathway (GO:0030433),-0.6410090929597582,-2.2819830727287105,0.0,3.974840847372471e-05,0.002,15/31,18.45%,SEC61B;UBE2G2;FBXO6;UBE2J2;TRIM13;SGTA;UBXN4;OS9;UBXN8;DERL1;FBXO17;EDEM2;JKAMP;DNAJB9;AMFR
gsea,Fc-epsilon receptor signaling pathway (GO:0038095),-0.6444331403515687,-2.2659134224955513,0.0,5.869100938698415e-05,0.003,15/43,9.10%,CALM1;PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;RAC1;PSME1;PSMB1;PSMB4;PSMD8;LAT;GRB2;PSMB9
gsea,positive regulation of cellular catabolic process (GO:0031331),0.5998008712721081,2.264266967246371,0.0,0.0002549870727484049,0.004,18/47,10.56%,HMGB1;HIF1A;ZC3HAV1;GTPBP1;PTPN1;STK11;VGLL4;GSK3B;ITCH;GSK3A;TMEM59;KAT5;FOXO1;TNFRSF1B;PRKCD;PTTG1IP;AKT2;TRIM68
gsea,regulation of transcription by RNA polymerase II (GO:0006357),0.43244895601660627,2.2603000490598273,0.0,0.0002353726825369891,0.004,214/490,27.98%,FOXM1;RAD21;TCF7;EZH2;NR4A1;HMGB2;SKAP1;BACH2;FOSB;ID3;HMGB1;NR4A3;HIF1A;FOXP1;STAT4;PPP1R12A;TOX;GPS2;SATB1;NCOR1;VEZF1;NR2C2;KLF2;ARID5B;IRF2;DDX5;ELF2;HBP1;TNRC6C;MLLT10;BRD9;NIPBL;PIAS1;BHLHE40;TIAL1;TNRC6B;NFATC3;SP3;IRF9;NKAP;MED18;SP140;BRD4;MEF2D;SUDS3;KLF13;ETS1;MAP2K5;PHF20L1;TGFB1;IL18;NLRC5;ATAD2B;RCOR1;ARID4A;PPM1D;SOX5;ATF2;MIER1;RTF1;MYB;IER2;WBP2;TNKS;CGGBP1;TCF3;PTEN;CCNL2;PAF1;EP300;PHF6;PRKAR1A;UBC;UBP1;METTL23;WWP2;TCF25;KAT5;PHF12;USF2;THAP3;DMTF1;RLF;FOXO1;MAML1;CBFB;CIR1;LEF1;NR1H2;DBX1;STAT3;DLG1;MRTFA;RSF1;MAPK14;NOP53;PTPRN;RFX3;RXRB;DVL1;RNF111;NSD1;POU6F1;SMARCD1;MECP2;EGR1;CARF;CCNL1;AKAP8L;KDM1A;RFXANK;OGT;ZFHX2;CEBPG;KLF14;MED31;DPF2;CDC5L;RNF2;KANSL3;CAPRIN2;FBXL19;LHX2;HIC2;PHF14;TBX21;IRF3;ARID4B;HMGA2;MED19;MED27;CRTC3;TOX2;CCNT1;BCL6B;SMARCD2;PGBD1;SP110;CBX8;DPF3;FOXJ3;PDE2A;ATOH8;PER3;ZBTB18;CSRNP2;SOX4;GRHL1;RFX2;ASXL2;MEIS3;NR6A1;NFIA;ZFP69;SMAD4;MZF1;RNF4;SS18;PPIL4;EPC2;CREM;AGRN;ZBTB37;ELL3;SS18L1;HMBOX1;TBX6;VPS72;TRAF6;MAX;RBPJ;ZIK1;RELA;MED26;LCOR;ZEB2;CTBP1;CRTC2;NR1D2;CCNT2;ZKSCAN7;MAPK3;ESR1;FZD5;FOXJ1;SP100;NEDD4L;MYSM1;DPF1;PROX2;ZXDB;MRGBP;FIZ1;DVL3;TAF7;SP9;NACC2;NR4A2;MESP2;DDX17;ZFP30;PKD1;NPAS4;SOX12;RREB1;CEBPA;KDM4C;CNOT2;PURB;MEF2A;RPS14;CRK;POGZ;PKN1
gsea,establishment of protein localization to mitochondrion (GO:0072655),-0.7701261490973296,-2.2569814499600076,0.0,0.00011557614156206108,0.006,12/18,10.79%,ROMO1;TOMM7;TSPO;TOMM22;TOMM34;DNAJC19;TIMM10B;PAM16;DNLZ;BCAP31;TOMM40L;FIS1
gsea,regulation of cell cycle (GO:0051726),0.5258528150622213,2.256556794840265,0.0,0.0002185603480700613,0.004,31/83,14.60%,FOXM1;NR4A1;CDKN1B;PTPRC;SON;HBP1;SIK1;UHRF2;STK11;CDK11B;TGFB1;CDK5;EP300;RNF167;SRPK2;TGFBR1;CYLD;RPS15A;STAT3;APC;NOP53;AKT2;XIAP;PPP1R13B;CDK10;EVI2B;DAPK3;CSNK2A1;FBXL17;HMGA2;ADAM10
gsea,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.6653075028742551,-2.2556394728827507,0.0,0.00011382498790202985,0.006,17/41,9.10%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;DYNLL1;PSMA1;PSME1;PSMB1;PPP2R1A;RBX1;PSMB4;PSMD8;DCTN3;CETN2;DCTN2;PSMB9
gsea,cellular component assembly (GO:0022607),-0.5138125643385294,-2.255283007491098,0.0,0.00011212610748558164,0.006,24/86,14.60%,ELOB;CDC42;YWHAZ;CD3G;VASP;IL2RB;RAC1;TAPBP;PPP2R1A;RAC2;STX7;PARVG;PDCD10;VMP1;ILK;RHOA;RTN4;WAS;CAPZA1;VAMP2;CORO1B;YTHDF2;BSN;RSPH1
gsea,MAPK cascade (GO:0000165),-0.5205961764711131,-2.2490458788898073,0.0,0.00011047719414020546,0.006,28/96,17.07%,CALM1;PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;IL2RB;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8;GOLGA7;IL2RG;LAMTOR2;LAT;ITGAV;GRB2;LYPLA1;LGALS9;PSMB9;ABHD17A;RASAL3;PSMD13;LAMTOR3;PSMF1;PSMD10
gsea,membrane organization (GO:0061024),-0.5176142479844579,-2.246601531056233,0.0,0.0001088760753845503,0.006,46/95,28.38%,ARPC2;ACTR3;ARPC5;ARPC4;ARPC3;CD3G;MTCH1;CHMP2A;ARPC1A;CHMP4B;CHMP5;SAR1A;SAR1B;CHMP2B;SNAP23;GRB2;PLEKHA3;SCARB2;CD3D;ARRB2;RABIF;MITD1;PDCD6IP;UBXN2A;SNAP29;VAMP2;CHMP1B;AP2S1;SH3GLB1;MOSPD3;SPAST;VAMP4;VAPB;AP2M1;VTI1B;VAPA;BIN1;CHMP1A;EPN1;RABEP1;NAPA;CLTA;TOR1AIP2;SNX3;WASL;VPS4A
gsea,translational elongation (GO:0006414),-0.6735383585100689,-2.239242037138024,0.0,0.00010732070287905672,0.006,20/40,11.21%,MRPS21;MRPL36;MRPS33;MRPS14;MRPL33;MRPS36;MRPL52;MRPL34;MRPS15;MRPL32;MRPL21;MRPL27;MRPS16;MRPL23;MRPS18C;MRPL57;MRPS24;MRPS23;AURKAIP1;MRPL46
gsea,cytokine-mediated signaling pathway (GO:0019221),-0.49429757055469675,-2.2349348266098485,0.0,0.00014107885824476938,0.006,43/142,17.08%,PSMB8;PSMB3;PSMA2;CDC42;PSMA7;PSMB10;YWHAZ;PYCARD;TALDO1;IL2RB;PSMA1;TXNDC17;ARF1;PSME1;PSMB1;RBX1;PSMB4;PSMD8;ITGB2;CNN2;UBE2V1;IL2RG;B2M;SLA2;PITPNA;COMMD7;IFI35;ILK;UGCG;IL12RB1;CSK;GRB2;IL27RA;PSMB9;CAPZA1;CSNK2B;CRLF2;PSMD13;PRKACA;RAP1B;PSMF1;PSMD10;IL1RAP
gsea,response to lipid (GO:0033993),0.6109706241052263,2.2345605364884897,0.0,0.0002039896581987239,0.004,11/37,8.82%,HMGB2;FOXP1;IFNAR1;OTUD5;TGFB1;PELI1;FOXO1;STAT3;TAB2;PTPN22;RXRB
gsea,post-translational protein modification (GO:0043687),-0.5034096296066982,-2.23192755893063,0.0,0.00015650935836529104,0.007,43/107,21.94%,PSMB8;PSMB3;ELOB;PSMA2;PSMA7;PSMB10;PSMA1;NEDD8;PSME1;PSMB1;RBX1;PSMB4;PSMD8;FBXO22;FBXO6;NUCB1;UBE2F;PNPLA2;COPS8;RAB3A;PSMB9;KBTBD13;APLP2;COMMD1;RAB1A;SUMF1;FUCA2;FBXO4;WSB2;PSMD13;APOA2;KCTD6;FBXO17;DNAJC3;PSMF1;PSMD10;KBTBD8;FBXO9;RAB8A;RAB1B;ASB6;OBSL1;FGF23
gsea,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.6433955300969354,-2.2308600278453605,0.0,0.0001502489840306794,0.007,11/37,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;KLRD1;PSMB4;PSMD8
gsea,cellular response to lectin (GO:1990858),-0.6433955300969354,-2.2308600278453605,0.0,0.0001502489840306794,0.007,11/37,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;KLRD1;PSMB4;PSMD8
gsea,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.6433955300969354,-2.2308600278453605,0.0,0.0001502489840306794,0.007,11/37,3.25%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;KLRD1;PSMB4;PSMD8
gsea,negative regulation of Wnt signaling pathway (GO:0030178),-0.53942925494372,-2.223930094736123,0.0,0.00014827202371448626,0.007,24/70,23.42%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8;PSMB9;PSMD13;ZNRF3;MAD2L2;PSMF1;PSMD10;AMER1;AMFR;ANKRD6;SDHAF2;FZD6;CTNNBIP1;PSMD4
gsea,Golgi organization (GO:0007030),-0.5912732375078875,-2.219473515817765,0.0,0.00016260712557432836,0.007,20/44,24.04%,CDC42;TMED9;YWHAZ;SURF4;TMED5;PDCD10;SEC22B;VMP1;BET1;TMED7;UBXN2A;RAB1A;BLZF1;VAMP4;TBC1D20;TMED3;OBSL1;VTI1B;VCPIP1;GORASP1
gsea,positive regulation of Wnt signaling pathway (GO:0030177),-0.5643269900468851,-2.2188380991378143,0.0,0.00016052241883619594,0.007,24/59,24.15%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;PSMB4;PSMD8;ILK;PSMB9;PSMD13;GSKIP;TRPM4;PSMF1;PSMD10;AMER1;PPM1N;RNF146;PRDM15;PSMD4;DISC1;JRK
gsea,mitochondrion organization (GO:0007005),-0.5640919622132708,-2.2114262864136824,0.0,0.00019018858738060684,0.009,23/53,20.55%,COX7A2;TOMM7;SSBP1;TSPO;CHCHD2;TOMM22;TOMM34;DNAJC19;TIMM10B;SLC25A4;FMC1;HIGD2A;TFB2M;MPV17;RAB5IF;BCAP31;SLIRP;FIS1;MIEF2;TMEM11;GBA;MTFR1L;BNIP3L
gsea,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.642569979427864,-2.2003311105005205,0.0,0.00020346216587487832,0.009,12/31,8.04%,CDC42;ARPC2;ACTR3;ARPC5;ARPC4;ARPC3;CD3G;ARPC1B;RAC1;ARPC1A;GRB2;WAS
gsea,mitochondrial transport (GO:0006839),-0.6933631654340263,-2.1871336430820443,0.0,0.00023186571609672753,0.01,12/21,10.79%,TOMM7;TMEM14C;TSPO;TOMM22;TOMM34;DNAJC19;TIMM10B;SLC25A4;BAD;MAIP1;BCAP31;FIS1
gsea,regulation of gene expression (GO:0010468),0.4413597464977281,2.1867587703519082,0.0,0.0004302906852629332,0.009,105/258,22.91%,TCF7;EZH2;BTG1;NSD3;IFNGR1;HIF1A;PTPRC;CD28;FOXP1;SON;PCBP2;ING2;NR2C2;IRF2;CLK1;TNRC6C;YTHDC1;PRKCQ;BHLHE40;TNRC6B;GPBP1;KRAS;SP3;NKAP;TRA2B;ETS1;CDK11B;TGFB1;CLK3;AFF4;GSK3B;PFDN5;ATF2;MYB;MAPK1;CGGBP1;TCF3;GSK3A;EP300;SRPK2;TGFBR1;ZC3H7A;SAP30L;WWP2;CLK4;DNM2;PHF12;PHF1;DMTF1;MBNL1;SERTAD3;LEF1;MATR3;NDFIP1;GPBP1L1;STAT3;MAPK14;PTPN22;RFX3;DVL1;PRKAG1;NSD1;ZUP1;SFMBT2;MECP2;EGR1;PABPN1;RFXANK;CNTF;TRIM68;DAPK3;MAPK11;MBNL2;TBX21;HMGA2;CELSR2;RHOH;MLF2;ADAM10;BCL6B;CRKL;PDE2A;ATOH8;SLC39A8;SOX4;INSR;NFIA;FASTK;CXXC1;MZF1;PQBP1;PCBP3;CREM;BRAF;LIMS1;RBPJ;RC3H1;RELA;MED26;NR1D2;PRX;ACTR8;MAPK3;ANK3;ESR1
gsea,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.4850701142863712,-2.1834699949631156,0.0,0.00025957649680097056,0.012,46/134,18.84%,PSMB8;SEC61B;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8;UBE2G2;UBE2E1;FBXO6;UBE2J2;TRIM13;SGTA;CDC26;PSMB9;UBE2D1;CTNNB1;ARRB2;PTTG1;UBXN4;UBXN2A;OS9;TRIM2;UBXN8;UBE2W;FBXO4;UBE2A;PSMD13;BFAR;DERL1;FBXO17;NHLRC1;PCNP;PSMF1;JKAMP;PSMD10;DNAJB9;UBE2D3;AMFR;KCTD5;FBXO9
gsea,organelle organization (GO:0006996),-0.46998546109972894,-2.1800133902695302,0.0,0.0002564490691286697,0.012,52/134,28.38%,CDC42;THY1;TMED9;CAPZB;PLAAT3;SURF4;SSBP1;CHCHD2;CNN2;STX7;TMED5;PEX16;CHMP2A;VMP1;CHMP4B;CHMP5;SAR1A;SAR1B;CHMP2B;BSCL2;REEP5;TFB2M;TMED7;PDCD6IP;UBXN2A;RAB1A;CHMP1B;BLZF1;MIEF2;PKD2;YTHDF2;TBC1D20;TMEM11;VAPB;FITM2;GBA;TMED3;PEX19;OBSL1;VAPA;BIN1;CHMP1A;YTHDF3;HPS6;GORASP1;TWNK;SLC25A36;ARAP3;ATL1;TOR1AIP2;WASL;VPS4A
gsea,DNA metabolic process (GO:0006259),0.537325294919062,2.1799940819995243,0.0,0.0004049794684827607,0.009,19/63,13.40%,RAD21;HMGB2;HMGB1;TERF1;RAD51B;TOP2B;UBE2B;UHRF2;POLD4;XRCC3;SRPK2;UBC;PARG;KAT5;NOP53;ATRIP;NABP2;PNKP;PARP4
gsea,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.6036192218135973,-2.1783496385524668,0.0,0.0002620621814488594,0.013,14/34,12.41%,CAPZB;DYNLL1;ARF1;SEC13;ACTR10;DCTN3;AP1S1;SAR1B;DCTN6;ACTR1B;DCTN2;CAPZA1;DCTN5;AP2S1
gsea,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.6036192218135973,-2.1783496385524668,0.0,0.0002620621814488594,0.013,14/34,12.41%,CAPZB;DYNLL1;ARF1;SEC13;ACTR10;DCTN3;AP1S1;SAR1B;DCTN6;ACTR1B;DCTN2;CAPZA1;DCTN5;AP2S1
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.6036192218135973,-2.1783496385524668,0.0,0.0002620621814488594,0.013,14/34,12.41%,CAPZB;DYNLL1;ARF1;SEC13;ACTR10;DCTN3;AP1S1;SAR1B;DCTN6;ACTR1B;DCTN2;CAPZA1;DCTN5;AP2S1
gsea,protein insertion into ER membrane (GO:0045048),-0.6964584478040267,-2.17415199603593,0.0,0.00028783330274076516,0.014,10/20,13.82%,SEC61B;SEC61G;EMC6;WDR83OS;TRAM1;UBE2J2;SGTA;VAMP2;EMC2;CYB5A
gsea,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.6884474832933347,-2.171503274346702,0.0,0.00028456246975507466,0.014,5/19,7.82%,CDC42;RAC1;ITGB1BP1;ILK;CIB1
gsea,protein targeting (GO:0006605),-0.5507946183477597,-2.1645987922750565,0.0,0.00033763816636107733,0.014,24/55,18.58%,NACA;SEC61G;TOMM7;CDC37;RPL11;SRP14;TSPO;SPCS2;GOLGA7;SPCS1;PEX16;TOMM22;TOMM34;DNAJC19;TIMM10B;BCAP31;FIS1;YIF1B;ATG3;ZDHHC7;ARL6;ZDHHC4;AP1S3;ZDHHC20
gsea,substrate adhesion-dependent cell spreading (GO:0034446),-0.7441621845534714,-2.1559820353123333,0.0,0.0003895344030425022,0.018,6/15,6.80%,FERMT3;RAC1;PARVG;ITGAV;ILK;RHOA
gsea,cellular protein-containing complex assembly (GO:0034622),-0.5393249668106719,-2.1558569616915455,0.0,0.00038525380520687026,0.018,25/56,23.42%,CYBA;POMP;COX7A2;SRP19;TBCA;RPL38;CHMP2A;FKBP1A;CHMP4B;HIGD2A;RTN4;RAB5IF;CSNK2B;VAMP2;AP2S1;BBS12;PSMD13;VAMP4;ARL6;AP2M1;DNAAF3;BBS10;BIN1;GTF2B;PSMD4
gsea,regulation of actin filament polymerization (GO:0030833),-0.6710795583880379,-2.151619052108949,0.0,0.000381066263845926,0.018,7/23,5.57%,PYCARD;COTL1;VASP;HCLS1;TWF2;MTPN;DBNL
gsea,response to molecule of bacterial origin (GO:0002237),0.6658027513229845,2.1463540049613856,0.0,0.0005099741454968096,0.012,7/24,8.27%,HMGB2;FOXP1;IFNAR1;OTUD5;PELI1;TAB2;PTPN22
gsea,negative regulation of cell migration (GO:0030336),-0.6032109594275783,-2.1455576490352044,0.0,0.00045774780081031367,0.024,6/30,12.96%,ARHGDIB;THY1;RAC1;ITGB1BP1;STK26;RNF20
gsea,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4774204500085134,2.137145276441585,0.0,0.0007247001014954664,0.018,45/112,18.51%,TCF7;EZH2;BTG1;NSD3;HIF1A;ING2;NR2C2;IRF2;PRKCQ;BHLHE40;GPBP1;SP3;PCIF1;CDK11B;PFDN5;ATF2;MYB;TCF3;EP300;TGFBR1;SAP30L;DNM2;PHF12;PHF1;DMTF1;SERTAD3;GPBP1L1;STAT3;RFX3;DVL1;NSD1;DAPK3;TBX21;HMGA2;CELSR2;RHOH;MLF2;SLC39A8;SOX4;INSR;NFIA;CXXC1;MZF1;PQBP1;CREM
gsea,positive regulation of nucleic acid-templated transcription (GO:1903508),0.46558438702999644,2.1357461206442916,0.0,0.0007267131573329539,0.019,51/140,17.62%,FOXM1;HMGB2;SKAP1;NSD3;HIF1A;ING2;KLF2;ELF2;SP3;BCL10;BRD4;ETS1;TGFB1;MYB;WBP2;TCF3;EP300;KMT2E;TGFBR1;DYRK1B;KAT5;CAMK4;DNM2;RLF;FOXO1;SERTAD3;LEF1;NR1H2;WAC;CAPN3;STAT3;MAPRE3;RSF1;RFX3;RXRB;RNF111;NSD1;EGR1;MAP3K2;USP21;LHX2;RHOG;INPP5K;TBX21;HMGA2;MAP2K7;ATOH8;SOX4;SMAD4;CXXC1;RNF4
gsea,response to metal ion (GO:0010038),-0.6661088000293658,-2.134290165363699,0.0,0.0005061579249260477,0.025,6/23,4.88%,CALM1;CALM3;PPP1CA;PDCD6;MTF1;ANXA11
gsea,cellular response to oxidative stress (GO:0034599),-0.5975932246716197,-2.129892199433594,0.0,0.0005008299467689314,0.025,12/35,8.89%,CYBA;GSTP1;ROMO1;NCF4;PRDX2;CHCHD2;PRDX5;CAT;MGAT3;NUDT2;MPV17;PRDX6
gsea,protein insertion into membrane (GO:0051205),-0.7382731679477775,-2.1260724492083525,0.0,0.0005216978612176368,0.026,9/15,13.82%,SEC61B;SEC61G;WDR83OS;TRAM1;UBE2J2;MAIP1;SGTA;VAMP2;CYB5A
gsea,protein homooligomerization (GO:0051260),-0.5938310554371169,-2.111439746865191,0.0,0.0006712153925769183,0.037,14/29,15.55%,PYCARD;G3BP2;SSBP1;B2M;CHMP2A;ACOT13;EHD1;PDCD6IP;ELAVL1;RNF135;PKD2;SPAST;USP16;TRPM4
gsea,regulation of insulin receptor signaling pathway (GO:0046626),0.692222138228773,2.1113403815762255,0.0,0.000983521566315276,0.024,11/18,16.78%,PRKCQ;PTPN1;PIP4K2A;GSK3A;PTPN2;PRKCD;ERFE;SORL1;OGT;INPP5K;SLC27A4
gsea,actin filament organization (GO:0007015),-0.5782860925574642,-2.1104820217945077,0.0,0.0006643662559179701,0.037,12/34,18.27%,CDC42;ARPC4;RAC1;RAC2;RHOA;RND1;WAS;TMOD3;DBN1;CORO1B;MAD2L2;MYO19
gsea,protein-containing complex assembly (GO:0065003),-0.47499299149068436,-2.1071767963030776,0.0,0.0007082443691681857,0.04,44/98,29.16%,ELOB;FERMT3;CD3G;IL2RB;SEC13;TAPBP;PPP2R1A;RBX1;TFG;ITGB1BP1;CTSC;PDCD6;CNIH1;SEC22B;DBNL;SAR1B;TRAPPC1;BET1;TRAPPC4;WAS;BAD;CTNNB1;TRAPPC3;CAPZA1;RAB1A;CSNK2B;VAMP2;TBC1D20;IL1RAP;AMER1;SLC9A3R2;RAB1B;AP2M1;SCFD1;CASP8;TCF7L1;GORASP1;NCKAP1L;NAPA;TRAPPC2;WASL;PARD6B;SEC24C;TRADD
gsea,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.7393237769771547,2.0928691678946594,0.0,0.0013560676141619711,0.034,7/16,9.72%,HIF1A;DDX5;NFATC3;ETS1;TGFB1;STAT3;EGR1
gsea,positive regulation of cytoskeleton organization (GO:0051495),-0.6813260926534479,-2.091396979499717,0.0,0.0009515768988609697,0.055,5/19,2.76%,CDC42;PYCARD;WDR1;VASP;HCLS1
gsea,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.6579459695326011,2.0893310320851515,0.0,0.0013968857028825658,0.035,6/21,10.21%,FOXM1;CDKN1B;CNOT6L;EP300;KAT5;CNOT4
gsea,fatty acid beta-oxidation (GO:0006635),-0.6583655012248926,-2.083051456869497,0.0,0.0010413295922918374,0.062,10/20,22.44%,ACADS;ETFA;ECI2;ACAA2;ACAT1;SCP2;ACOT8;ACADVL;ECHS1;CROT
gsea,positive regulation of endothelial cell proliferation (GO:0001938),0.6888381353697446,2.0777166612972233,0.0,0.001848656277425935,0.045,7/17,6.80%,NR4A1;HMGB2;HMGB1;HIF1A;PPP1R16B;TGFBR1;AKT3
gsea,selective autophagy (GO:0061912),-0.6753780285223944,-2.0769320856251796,0.0,0.0011047719414020545,0.068,8/20,11.66%,UFM1;DYNLL1;UBE2V1;UFC1;MAP1LC3B;TEX264;BECN1;UBA5
gsea,antigen receptor-mediated signaling pathway (GO:0050851),-0.5465431432974516,-2.076722112528457,0.0,0.0011062020668925426,0.069,20/57,9.36%,PSMB8;PSMB3;PSMA2;THY1;PSMA7;PSMB10;CD3G;PSMA1;PSME1;PSMB1;LIME1;PSMB4;PSMD8;SPG21;SLA2;LAT;CSK;WAS;PSMB9;CD3D
gsea,protein-containing complex subunit organization (GO:0043933),-0.5763478744678061,-2.073222873425591,0.0,0.0011437222342078961,0.073,10/35,18.50%,ELOB;CD3G;IL2RB;TAPBP;PPP2R1A;WAS;CAPZA1;VAMP2;IL1RAP;SLC9A3R2
gsea,endoplasmic reticulum organization (GO:0007029),-0.5985870484027862,-2.0639472283577733,0.0,0.0012878484345486808,0.081,11/29,14.14%,SEC61B;SEC61G;WDR83OS;TRAM1;REEP5;RTN4;UBE2J2;SGTA;VAMP2;CYB5A;MOSPD3
gsea,regulation of actin cytoskeleton organization (GO:0032956),-0.5932065775181792,-2.0596028875398313,0.0,0.001346571083293825,0.084,7/29,7.47%,ARHGDIB;RAC1;TWF2;RAC2;RHOA;PHPT1;RND1
gsea,positive regulation of intracellular protein transport (GO:0090316),-0.5055086135804213,-2.056387268078471,0.0,0.0013807928438956518,0.087,24/62,17.53%,YWHAZ;OAZ1;TOMM7;UBL5;HCLS1;ITGB2;UBE2L3;ITGB1BP1;RAC2;TMEM30A;PDCD10;SAR1A;SAR1B;CIB1;UBE2J2;BAD;LEPROT;YWHAH;FIS1;VAMP2;MIEF2;SH3GLB1;ZFAND1;UBE2D3
gsea,positive regulation of transcription by RNA polymerase II (GO:0045944),0.41542875973649707,2.0496262352107597,0.0,0.002753860385682772,0.068,111/242,26.59%,FOXM1;NR4A1;HMGB2;SKAP1;HMGB1;NR4A3;HIF1A;PPP1R12A;GPS2;VEZF1;NR2C2;KLF2;IRF2;MLLT10;NFATC3;SP3;BRD4;MEF2D;ETS1;MAP2K5;TGFB1;IL18;NLRC5;ATAD2B;ATF2;MYB;IER2;WBP2;TNKS;TCF3;EP300;UBC;UBP1;METTL23;KAT5;USF2;THAP3;RLF;FOXO1;MAML1;LEF1;NR1H2;STAT3;MRTFA;RSF1;PTPRN;RFX3;RXRB;DVL1;RNF111;SMARCD1;EGR1;AKAP8L;KDM1A;RFXANK;OGT;CEBPG;KLF14;DPF2;CDC5L;KANSL3;CAPRIN2;IRF3;HMGA2;MED19;CRTC3;TOX2;CCNT1;SMARCD2;DPF3;FOXJ3;ATOH8;ZBTB18;CSRNP2;SOX4;GRHL1;ASXL2;MEIS3;NFIA;SMAD4;MZF1;RNF4;SS18;AGRN;ELL3;SS18L1;TRAF6;MAX;RBPJ;RELA;ZEB2;CRTC2;NR1D2;CCNT2;MAPK3;ESR1;FZD5;FOXJ1;MYSM1;DPF1;FIZ1;DVL3;TAF7;TERT;NR4A2;DDX17;PKD1;NPAS4;SOX12;RREB1;CEBPA
gsea,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.5959609559135983,2.044709715780002,0.0,0.002942158531712364,0.075,13/30,6.51%,RBM39;SON;DDX5;CIRBP;SF1;YTHDC1;RBM5;PUF60;TRA2A;TRA2B;FAM172A;SRPK2;MBNL1
gsea,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.6935184135901162,-2.0428472367289134,0.0,0.0015998734410674197,0.101,4/15,7.82%,CDC42;RAC1;ILK;CIB1
gsea,"positive regulation of transcription, DNA-templated (GO:0045893)",0.40226532994879255,2.0415123935094326,0.0,0.0031448405638969928,0.081,134/314,26.59%,FOXM1;NR4A1;HMGB2;SKAP1;NSD3;HMGB1;NR4A3;HIF1A;PPP1R12A;GPS2;VEZF1;ING2;NR2C2;KLF2;IRF2;ELF2;MLLT10;NFATC3;SP3;BCL10;BRD4;MEF2D;ETS1;MAP2K5;TGFB1;IL18;NLRC5;ATAD2B;ATF2;MYB;IER2;WBP2;TNKS;TCF3;EP300;KMT2E;TGFBR1;DYRK1B;UBC;UBP1;METTL23;KAT5;CAMK4;DNM2;USF2;THAP3;RLF;FOXO1;MAML1;SERTAD3;LEF1;NR1H2;WAC;CAPN3;STAT3;MRTFA;MAPRE3;RSF1;PTPRN;RFX3;RXRB;DVL1;RNF111;NSD1;SMARCD1;EGR1;MAP3K2;AKAP8L;KDM1A;RFXANK;OGT;USP21;CEBPG;KLF14;DPF2;SERTAD1;CDC5L;KANSL3;CAPRIN2;LHX2;RHOG;INPP5K;TBX21;IRF3;HMGA2;MED19;CRTC3;TOX2;CCNT1;SMARCD2;MAP2K7;DPF3;FOXJ3;ATOH8;ZBTB18;CSRNP2;SOX4;GRHL1;ASXL2;MEIS3;NFIA;SMAD4;CXXC1;MZF1;RNF4;SS18;AGRN;ELL3;SS18L1;TRAF6;MAX;RBPJ;RELA;ZEB2;CRTC2;NR1D2;CCNT2;MAPK3;ESR1;FZD5;FOXJ1;SP100;MYSM1;DPF1;FIZ1;DVL3;TAF7;NR4A2;DDX17;PKD1;NPAS4;SOX12;RREB1;CEBPA
gsea,peptidyl-threonine phosphorylation (GO:0018107),0.6133526312079669,2.038337998610523,0.0,0.0031418050035071313,0.085,11/24,12.31%,GSK3B;TNKS;CDK5;MAPK1;GSK3A;TGFBR1;DYRK1B;MARK2;PRKCD;CDK10;CSNK2A1
gsea,regulation of cell cycle process (GO:0010564),-0.601106823016317,-2.0381025063881077,0.0,0.0016770911061528434,0.106,8/26,14.41%,CALM1;CDC42;CALM3;CETN2;CTNNB1;BECN1;SH3GLB1;YTHDF2
gsea,regulation of cytokinesis (GO:0032465),-0.6441042771292282,-2.035394808507505,0.0,0.0017756698112716656,0.111,8/21,14.25%,CALM1;CDC42;CALM3;RHOA;CETN2;BECN1;SH3GLB1;SPAST
gsea,protein phosphorylation (GO:0006468),0.4308403650166444,2.0311699924510394,0.0,0.0032444906842814276,0.091,83/164,31.64%,FYN;LCK;TLK1;HCST;PRKCQ;STK38;STK4;SIK1;PKN2;STK11;CDK11B;TGFB1;GRK6;CLK3;GSK3B;CDK17;STK17B;PAK2;VRK2;TNKS;CDK5;MAPK1;GSK3A;SRPK2;TGFBR1;DYRK1B;CAMK4;RPS6KB2;MAP4K2;MARK2;MAML1;AKT3;PRKCD;TESK2;MAPK14;PRKAG1;ABI1;AKT2;MARK3;JAK1;CDK10;CSNK1D;DAPK3;CSNK2A1;CSNK1G2;SMG1;STK19;SIK3;GLYCTK;CCNT1;ADAM10;MORC3;CAMK2B;JAK3;INSR;PRKCH;FASTK;IGF1R;BRAF;PRKX;CTBP1;MAPK3;SBK1;NRBP1;BRSK2;STK25;TAOK3;PDK3;PKD1;ACVR1B;PTK2;PKN1;GRK3;CSNK1G3;RPS6KB1;PKN3;TBK1;MKNK2;SRC;IRAK1;FAM20C;MARK4;ACVR2A
gsea,B cell activation (GO:0042113),0.7090705763975149,2.0271882438471116,0.0,0.0033913280675537845,0.097,7/15,10.72%,PTPRC;GPS2;TCF3;FCRL1;PTPN2;CD22;CEBPG
gsea,cell morphogenesis involved in differentiation (GO:0000904),-0.6389399706243812,-2.025468976901596,0.0,0.0019175921385296921,0.122,6/20,6.80%,FERMT3;RAC1;PARVG;ITGAV;ILK;RHOA
gsea,cellular protein metabolic process (GO:0044267),-0.5241890928296372,-2.023390301164492,0.004132231404958678,0.0019340084997996679,0.125,52/146,14.98%,SEC11C;RPS6;RPL28;MRPS21;RPL35;MRPL36;MRPS33;MRPS14;RPL27;RPL32;MRPS36;NEDD8;UBL5;RPL37;RPL11;SPCS2;RPS19;UBE2L3;MRPL52;RPL38;UBE2G2;MRPL34;MRPS15;MRPL32;FBXO22;SPCS1;RPL6;RPL12;RPL24;NUCB1;SEC11A;CCDC59;MRPL27;TMEM208;MAN2B1;PNPLA2;RPL36A;RPL26;RPS13;MRPS16;MRPL23;MRPS18C;RPL39;RPS11;APLP2;RPS7;FUCA2;ATG3;GALNT11;RPS10;APOA2;GGCX
gsea,COPII-coated vesicle budding (GO:0090114),-0.5663703713416623,-2.021734860607044,0.0018656716417910447,0.0019390539974460839,0.126,21/37,26.36%,SEC13;TFG;CTSC;PDCD6;CNIH1;SEC22B;SAR1A;SAR1B;TRAPPC1;BET1;TRAPPC4;TRAPPC3;RAB1A;TBC1D20;VAPB;RAB1B;SCFD1;VAPA;GORASP1;NAPA;TRAPPC2
gsea,regulation of myeloid cell differentiation (GO:0045637),0.7230460339819516,2.018720188604246,0.0,0.003923510764548036,0.109,9/15,10.21%,NR4A3;TNRC6C;PRKCQ;TNRC6B;PAF1;EP300;KMT2E;CBFB;CNOT4
gsea,ERAD pathway (GO:0036503),-0.5527089927932389,-2.0182549913390186,0.0,0.0020099096547963693,0.128,14/35,18.45%,SEC61B;UBE2G2;FBXO6;UBE2J2;TRIM13;SGTA;UBXN4;OS9;UBXN8;DERL1;FBXO17;JKAMP;DNAJB9;AMFR
gsea,vesicle coating (GO:0006901),-0.576517577055395,-2.016981364315446,0.001876172607879925,0.00197977649897975,0.13,18/34,26.36%,SEC13;TFG;CTSC;PDCD6;CNIH1;SEC22B;SAR1B;TRAPPC1;BET1;TRAPPC4;TRAPPC3;RAB1A;TBC1D20;RAB1B;SCFD1;GORASP1;NAPA;TRAPPC2
gsea,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.576517577055395,-2.016981364315446,0.001876172607879925,0.00197977649897975,0.13,18/34,26.36%,SEC13;TFG;CTSC;PDCD6;CNIH1;SEC22B;SAR1B;TRAPPC1;BET1;TRAPPC4;TRAPPC3;RAB1A;TBC1D20;RAB1B;SCFD1;GORASP1;NAPA;TRAPPC2
gsea,COPII vesicle coating (GO:0048208),-0.576517577055395,-2.016981364315446,0.001876172607879925,0.00197977649897975,0.13,18/34,26.36%,SEC13;TFG;CTSC;PDCD6;CNIH1;SEC22B;SAR1B;TRAPPC1;BET1;TRAPPC4;TRAPPC3;RAB1A;TBC1D20;RAB1B;SCFD1;GORASP1;NAPA;TRAPPC2
gsea,cell projection organization (GO:0030030),-0.6891812296076993,-2.0157029823787607,0.0,0.0019629987320392435,0.13,5/15,11.27%,CDC42;RAC1;RAC2;PARVG;P2RY12
gsea,cellular response to organonitrogen compound (GO:0071417),-0.5872743402506999,-2.009538040586607,0.0,0.0021253707825068095,0.14,12/28,14.79%,LAMTOR4;RRAGA;LAMTOR2;LAMTOR5;CTNNB1;P2RY12;RRAGC;RAP1B;PKD2;LAMTOR3;CPEB3;RAP1A
gsea,double-strand break repair via nonhomologous end joining (GO:0006303),0.6755500230795695,2.006641112932825,0.0021321961620469083,0.004637577385611613,0.129,6/18,7.23%,HMGB2;HMGB1;KAT5;BABAM1;BABAM2;NSMCE2
gsea,protein polyubiquitination (GO:0000209),-0.43169899898761593,-1.9995203294542623,0.0,0.002295470589357602,0.147,44/140,18.84%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8;UBE2L3;UBE2G2;UBE2V1;FBXO22;UBE2E1;FBXO6;ANAPC13;UBE2J2;CDC26;PSMB9;UBE2D1;CTNNB1;UBE2R2;RUSC1;RNF14;TRIM2;UBE2W;FBXO4;UBE2A;RNF20;PSMD13;RNF135;TRIM32;UBE2Q2;BFAR;FBXO17;NHLRC1;PSMF1;PSMD10;RNF6;UBE2D3;AMFR;FBXO9
gsea,negative regulation of stress-activated MAPK cascade (GO:0032873),0.7061698357905472,1.9947262018122434,0.0,0.005215644669853735,0.145,8/15,8.27%,FOXM1;GPS2;NCOR1;ITCH;FOXO1;CYLD;DLG1;PTPN22
gsea,cellular response to DNA damage stimulus (GO:0006974),0.47221308844357585,1.9942332101519513,0.0,0.005084742215394661,0.146,28/75,13.42%,MCL1;FOXP1;RAD51B;HMCES;NIPBL;UBE2B;STK11;XRCC3;ATF2;SUSD6;PHF1;FOXO1;TNFRSF1B;BABAM2;WAC;MAPK14;APC;NOP53;ATRIP;NABP2;XIAP;RNF169;PNKP;OTUB1;CDKN2AIP;IRF3;PARP4;UBA7
gsea,regulation of protein serine/threonine kinase activity (GO:0071900),-0.5511484046259519,-1.9927593612457584,0.0,0.0023592815674238917,0.15,10/37,7.82%,CALM1;THY1;PYCARD;CALM3;LIME1;CDC37;PDCD10;SNF8;RHOA;CIB1
gsea,negative regulation of cytokine production (GO:0001818),0.5137084876972273,1.9925260825063973,0.0,0.004983175935997398,0.147,21/52,15.94%,TIGIT;TAX1BP1;HMGB1;PTPRC;PCBP2;OTUD5;ATP2B1;MAP2K5;NLRC5;NPTN;ITCH;KAT5;LEF1;CYLD;PTPN22;TBX21;IRF3;UBA7;RNF216;F2;JAK3
gsea,G1/S transition of mitotic cell cycle (GO:0000082),0.6997240346007029,1.987418416466161,0.0,0.005099741454968097,0.151,5/15,6.28%,CDKN1B;BRD4;CDK17;CDK5;GPR132
gsea,mitotic cytokinetic process (GO:1902410),-0.6721295441254381,-1.9859524541292464,0.0,0.002575990095061512,0.163,9/16,15.11%,CHMP2A;CHMP4B;CHMP5;CHMP2B;RHOA;MITD1;PDCD6IP;CHMP1B;KLHDC8B
gsea,cell chemotaxis (GO:0060326),0.6745023559222724,1.9839939903062829,0.0,0.0052720300176359374,0.158,9/17,16.82%,NR4A1;HMGB2;PRKCQ;BIN2;LEF1;PRKCD;RHOG;CCR10;ACKR4
gsea,regulation of canonical Wnt signaling pathway (GO:0060828),-0.44499550373022645,-1.975491308008114,0.0,0.0029520464342071154,0.187,34/103,24.15%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PPP1CA;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8;ILK;PSMB9;CTNNB1;PSMD13;GSKIP;TRPM4;ZNRF3;MAD2L2;PSMF1;PSMD10;CCNY;AMER1;AMFR;ANKRD6;OTULIN;PPM1N;RNF146;SDHAF2;FZD6;PRDM15;PSMD4;JRK
gsea,"DNA-templated transcription, elongation (GO:0006354)",-0.6056209047235862,-1.972116392105226,0.003875968992248062,0.003039310765674362,0.195,8/23,8.60%,ELOB;WDR61;POLR2K;POLR2G;TCEA1;GTF2H5;POLR2J;POLR2D
gsea,regulation of mitotic cell cycle (GO:0007346),-0.5088009540943299,-1.97105834859735,0.0,0.0030350294774197243,0.196,23/56,17.66%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;PSMB4;PSMD8;UBE2E1;DYNLT3;CDC26;PSMB9;UBE2D1;SRA1;RNF20;PSMD13;CDK5RAP3;PSMF1;TMEM8B;PSMD10;BTG3
gsea,chromosome organization (GO:0051276),0.5965189196630251,1.9691012421967282,0.0,0.006019036954087346,0.178,6/24,6.41%,EZH2;HMGB2;SATB1;TOP2B;UBC;PHF1
gsea,protein targeting to membrane (GO:0006612),-0.5342210841513482,-1.9670926092823193,0.0,0.0032494323927269955,0.214,20/39,23.04%,NACA;SRP19;SRP14;GOLGA7;PEX16;CHMP4B;TRAM1;SGTA;SSR1;FIS1;YIF1B;ATG3;ZDHHC7;ARL6;ZDHHC4;ZDHHC20;PEX19;PXMP4;ATAD1;ZDHHC18
gsea,response to calcium ion (GO:0051592),-0.6175608715991564,-1.9652100332686804,0.0020491803278688526,0.003263281739773943,0.217,4/21,4.88%,CALM1;CALM3;PDCD6;ANXA11
gsea,T cell receptor signaling pathway (GO:0050852),-0.5256469349186036,-1.9633680408612004,0.0,0.003316042030364604,0.219,17/53,9.36%,PSMB8;PSMB3;PSMA2;THY1;PSMA7;PSMB10;CD3G;PSMA1;PSME1;PSMB1;PSMB4;PSMD8;LAT;CSK;WAS;PSMB9;CD3D
gsea,protein deubiquitination (GO:0016579),-0.4626354165058057,-1.9630829240512406,0.0,0.0032903362781912353,0.219,24/92,17.07%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;TAF10;NEDD8;PSME1;PSMB1;PSMB4;PSMD8;RHOA;PSMB9;UBE2D1;ENY2;ARRB2;BECN1;TAF9B;PSMD13;TFPT;USP16;PSMF1;PSMD10
gsea,regulation of actin filament-based process (GO:0032970),-0.6012898644196263,-1.9592294762764837,0.002044989775051125,0.00339986483095063,0.228,7/23,7.47%,ABRACL;RAC1;TWF2;CNN2;RAC2;RHOA;RND1
gsea,peptidyl-threonine modification (GO:0018210),0.5701315595559285,1.952943751803258,0.0019569471624266144,0.007198481207589583,0.212,12/27,12.31%,GSK3B;TNKS;CDK5;MAPK1;GSK3A;TGFBR1;DYRK1B;MARK2;GALNT2;PRKCD;CDK10;CSNK2A1
gsea,positive regulation of cellular process (GO:0048522),-0.41639617643121474,-1.9527186120309987,0.0,0.003660646366650777,0.243,35/134,17.07%,CYBA;CDC42;RPS6;COPS9;GNAI2;S100A13;PYCARD;RPS6KA1;ROMO1;IL2RB;RAC1;HCLS1;MTPN;RPS19;ITGB1BP1;CST7;IL2RG;PDCD10;POFUT2;ITGAV;CIB1;TRIM13;SSR1;MCTS1;FKBP1B;TAF9B;CAPNS1;CRLF2;UBE2A;TRIM32;RNF10;APOA2;TRPM4;TGFBR2;PSMD10
gsea,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.609862566729844,-1.951985039383627,0.0038240917782026767,0.0036518850285234576,0.244,8/22,8.60%,ELOB;WDR61;POLR2K;POLR2G;TCEA1;GTF2H5;POLR2J;POLR2D
gsea,positive regulation of epithelial cell proliferation (GO:0050679),0.5856262951717197,1.9493707533969082,0.0019342359767891683,0.00734362769515406,0.221,8/24,8.38%,NR4A1;HMGB2;NR4A3;HIF1A;PPP1R16B;TGFBR1;AKT3;PTPRN
gsea,cytoskeleton organization (GO:0007010),-0.5400632483436737,-1.947799423451315,0.004514672686230248,0.0037844668909983157,0.254,7/39,7.47%,THY1;CAPZB;RAC1;CNN2;RAC2;RHOA;RND1
gsea,positive regulation of cell growth (GO:0030307),-0.5820637424372646,-1.9462431738261612,0.004132231404958678,0.00378425612763838,0.257,10/26,17.07%,CDC42;RPS6KA1;TWF2;MTPN;DBNL;CIB1;TAF9B;DBN1;TRIM32;PSMD10
gsea,regulation of cellular component size (GO:0032535),-0.6518894756554562,-1.943569215598397,0.0,0.0038118723726302,0.258,5/17,5.77%,PPP1CA;LAMTOR4;RAC1;MTPN;LAMTOR5
gsea,negative regulation of signal transduction (GO:0009968),0.4633085963841673,1.9382703561066068,0.0,0.008209339903119376,0.237,21/79,14.25%,EZH2;PTPRC;GPS2;PRKCQ;PTPN1;VGLL4;UBASH3B;PIP4K2A;GSK3A;PTEN;ARRDC1;WWP2;PTPN2;PRKCD;NTN1;SLC9A3R1;CSNK2A1;INPP5K;SIAH2;LRP1;RNF43
gsea,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.6283042078813057,-1.9311672272078728,0.0,0.004547977825438458,0.29,4/17,9.25%,CALM1;GNG2;GNB1;CTNNB1
gsea,positive regulation of supramolecular fiber organization (GO:1902905),-0.5932189238955998,-1.9303188060578749,0.0,0.004578755535241508,0.295,4/23,2.02%,PYCARD;WDR1;VASP;RAC1
gsea,regulation of cell division (GO:0051302),-0.6085389501952322,-1.9287430378592596,0.0,0.004609087191279296,0.3,6/21,12.93%,CALM1;CALM3;CIB1;CETN2;BECN1;SH3GLB1
gsea,positive regulation of transport (GO:0051050),-0.5924829109708029,-1.9251080144574448,0.002070393374741201,0.00477409841344485,0.308,4/22,4.36%,CYBA;PYCARD;IL2RB;IL2RG
gsea,regulation of RNA splicing (GO:0043484),0.5970810217661334,1.9223753845243503,0.0,0.009725935489117727,0.275,15/23,21.76%,RBM39;SON;CLK1;SF1;YTHDC1;TRA2B;CLK3;SRPK2;CLK4;MBNL1;MBNL2;FASTK;PQBP1;TIA1;PRX
gsea,ubiquitin-dependent protein catabolic process (GO:0006511),-0.41649335624207273,-1.9219736279026525,0.0,0.004865205197183905,0.316,55/159,24.83%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;NEDD8;PSME1;PSMB1;RBX1;PSMB4;PSMD8;NDFIP2;UBE2L3;UBE2G2;FBXO22;UBE2E1;NTAN1;TRIM13;CDC26;PSMB9;UBE2D1;CTNNB1;ARRB2;PTTG1;UBE2R2;UBXN2A;RNF14;OS9;TRIM2;UBE2W;PPP1R11;UBE2A;RNF20;PSMD13;TRIM32;BFAR;KCTD6;NHLRC1;PCNP;ZNRF3;MVB12A;PSMF1;PSMD10;RNF6;UBE2D3;AMFR;KCTD5;VPS28;RNF146;PSMD4;RMND5B;RNF187;RNF11;ANAPC16
gsea,protein modification by small protein removal (GO:0070646),-0.45246637209460067,-1.9212752961811852,0.0,0.004892859940951794,0.319,24/94,17.07%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;TAF10;NEDD8;PSME1;PSMB1;PSMB4;PSMD8;RHOA;COPS8;PSMB9;UBE2D1;ARRB2;BECN1;TAF9B;PSMD13;TFPT;USP16;PSMF1;PSMD10
gsea,proteasomal protein catabolic process (GO:0010498),-0.4547044210676276,-1.9184518097159173,0.0,0.004955394895847525,0.322,28/92,18.66%,PSMB8;PSMB3;PSMA2;PSMA7;PSMB10;PSMA1;PSME1;PSMB1;RBX1;PSMB4;PSMD8;TRIM13;PSMB9;CTNNB1;ARRB2;UBXN2A;TRIM2;UBE2W;UBE2A;PSMD13;BFAR;DERL1;NHLRC1;PCNP;PSMF1;PSMD10;UBE2D3;KCTD5
gsea,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.6069208214703655,-1.913585097638997,0.006048387096774193,0.0051483917604918114,0.335,4/19,7.82%,CDC42;RAC1;ILK;CIB1
gsea,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.5549682798838228,-1.9096575322605784,0.0,0.005347403077480778,0.349,13/29,13.40%,PYCARD;NDUFA13;PDCD5;MTCH1;PDCD6;PDCD2;ARL6IP5;LGALS9;BAD;CFLAR;BCAP31;FIS1;BEX3
gsea,intraciliary transport involved in cilium assembly (GO:0035735),-0.6423139407584901,-1.9093124762589133,0.0020242914979757085,0.005353699430978231,0.349,4/15,10.10%,DYNLRB1;DYNLL1;IFT20;IFT52
gsea,activation of GTPase activity (GO:0090630),0.5509084846389248,1.90842804798863,0.0018281535648994515,0.01120757133708105,0.315,16/32,23.34%,RABGAP1L;ARHGAP45;TBC1D10A;RALGAPA1;TBC1D15;SIPA1L3;RHOG;RAP1GAP2;SLC27A4;TBC1D22A;GMIP;RAP1GAP;PIP5K1A;FOXJ1;ARHGAP29;APC2
gsea,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.5429609329517813,-1.907562483518228,0.0,0.005394212954069483,0.351,10/32,16.74%,CDC42;CAPZB;IFT20;RAC1;TWF2;WAS;TBC1D10C;ATG3;TBC1D20;TBC1D16
gsea,cell junction organization (GO:0034330),-0.5779465024730536,-1.9002880309362546,0.0041841004184100415,0.005851533561739044,0.378,6/23,10.75%,CDC42;VASP;VMP1;ILK;RHOA;CAPZA1
gsea,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.5865000043005171,-1.899516440622918,0.0,0.005845836034076547,0.379,10/24,12.93%,YWHAZ;TOMM7;UBL5;UBE2L3;RAC2;UBE2J2;BAD;LEPROT;YWHAH;SH3GLB1
gsea,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.5951931415548025,-1.8991068632548367,0.0022371364653243847,0.0058234086092427756,0.38,3/18,2.06%,GNG2;GNB1;GNAS
gsea,histone modification (GO:0016570),0.5171976261402392,1.8944324923098328,0.0,0.01262186010104604,0.347,12/37,10.62%,EZH2;NSD3;UBE2B;SUDS3;PHF20L1;RCOR1;MIER1;EP300;KAT5;PRKCD;NSD1;USP21
gsea,supramolecular fiber organization (GO:0097435),-0.4356501623623465,-1.8826587893333493,0.0,0.007011619254765039,0.423,21/79,25.91%,CDC42;PPIB;RAC1;ITM2B;RAC2;B2M;DNAJB6;FKBP1A;RHOA;RND1;CIB1;TMOD3;DBN1;CORO1B;SPAST;MAD2L2;MYO19;KATNAL1;EFEMP2;RAC3;APH1B
gsea,chromatin organization (GO:0006325),0.5329620231438835,1.881096139189032,0.0019267822736030828,0.014279276073910671,0.392,15/33,27.20%,EZH2;HMGB2;SATB1;MYB;PHF1;RSF1;SMARCD1;HMGA2;SMARCD2;SETD5;PADI4;ESR1;MYSM1;KDM4C;HDAC11
gsea,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.6441315558410553,-1.8797035947313636,0.0020408163265306124,0.007114438647810317,0.429,9/16,17.53%,TOMM7;PDCD5;UBL5;UBE2L3;RAC2;UBE2J2;LEPROT;SH3GLB1;UBE2D3
gsea,cell junction assembly (GO:0034329),-0.5526540630325162,-1.8765323019754945,0.002178649237472767,0.0072653291620098275,0.44,8/26,14.11%,CDC42;VASP;VMP1;DBNL;ILK;RHOA;CAPZA1;TLN1
gsea,regulation of cell adhesion (GO:0030155),-0.5199531226829728,-1.8749067320601824,0.0,0.007307861804978034,0.443,8/35,14.41%,ARHGDIB;PPP2R1A;ITGB1BP1;RAC2;ITGAV;RND1;CD164;YTHDF2
gsea,protein dephosphorylation (GO:0006470),0.47011079514091675,1.864774775674387,0.0,0.01647992537567408,0.443,21/57,21.74%,PPP2R2D;PTPRC;PPP1R12A;PPP1CC;PTPN1;PPP2R5E;STK11;PPP3CC;PPM1D;UBASH3B;PTEN;PPM1H;PTPRA;PTPN2;PTPN22;DUSP8;PPM1B;MTMR6;PTPN4;PPP2R5C;EYA1
gsea,modulation of chemical synaptic transmission (GO:0050804),0.6061810347832586,1.864155340953088,0.0018726591760299626,0.016292046371562972,0.447,8/20,14.14%,BTBD9;CDK5;PTEN;AKAP9;BEGAIN;EIF4EBP2;DGKZ;GRIK5
gsea,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.6010225034478864,1.8531827788330704,0.002044989775051125,0.017960651936715765,0.487,8/20,12.86%,DDX5;YTHDC1;RBM5;PUF60;TRA2B;FAM172A;MBNL1;MBNL2
gsea,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.6398887754535322,-1.850494921025356,0.0018726591760299626,0.009431213283311046,0.505,7/16,12.23%,LSM5;WDR61;LSM4;LSM6;DCP2;POLR2G;NT5C3B
gsea,negative regulation of MAPK cascade (GO:0043409),0.5368597127944091,1.8463435808411943,0.006048387096774193,0.018858635747759575,0.516,13/28,12.87%,FOXM1;PTPRC;STK38;PTPN1;PTEN;FOXO1;PTPN2;PRKCD;DLG1;RANBP9;SORL1;SLC9A3R1;INPP5K
gsea,ceramide metabolic process (GO:0006672),-0.5873370014281687,-1.8436939234852274,0.0056925996204933585,0.01004083264248035,0.525,9/20,20.69%,DEGS1;PPP2R1A;ASAH1;CERS2;ORMDL1;ORMDL2;PLA2G15;GBA;CERS4
gsea,negative regulation of mitotic cell cycle (GO:0045930),0.6328734836337262,1.8387209059791176,0.0036496350364963502,0.01979719632818615,0.538,7/17,11.57%,BTG1;CDKN1B;HECA;TGFB1;ANGEL2;NABP2;SLC9A3R1
gsea,regulation of RNA metabolic process (GO:0051252),0.6031273758930895,1.8370251251948428,0.003883495145631068,0.019664003080774043,0.541,14/20,21.76%,SON;PCBP2;CLK1;TRA2B;CLK3;CLK4;MBNL1;TNFRSF1B;MBNL2;FASTK;PQBP1;PCBP3;RC3H1;PRX
gsea,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.6372654286011248,-1.8357460257048592,0.004,0.01068276697354884,0.543,6/15,11.33%,CYBA;GSTP1;ROMO1;ITGB2;GRB2;DHRS4
gsea,central nervous system development (GO:0007417),-0.4342340357554889,-1.8346900888844733,0.0,0.010726373859939691,0.547,17/66,28.54%,COX7B;GSTP1;UFM1;IER3IP1;EOMES;NDUFS4;MTF1;UFC1;VAX2;CDK5RAP3;PKD2;PTS;TGFBR2;SEMA6B;UBE3A;JRKL;UGP2
gsea,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.4028251946275768,-1.8343245191523156,0.0,0.010706032564633327,0.547,46/124,32.03%,CYBA;CDC42;ARPC2;ACTR3;ARPC5;ARPC4;ARPC3;ARPC1B;NCF4;RAC1;POLR2K;ARPC1A;POLR2G;ITGAV;RHOA;GRB2;POLR2J;POLR2D;ATP6V1F;ATP6V1A;ATP6V1G2;ATP6V1H;AP2S1;ATP6V0D1;BRK1;AP2M1;STAP1;FGF23;POLR2I;NCKAP1L;SHC4;APH1B;VAV1;ERBB3;WASL;PXN;PSEN1;EPHA1;SDCBP;ATP6V1E1;NTRK1;TYRO3;FER;HPN;INSRR;AAMP
gsea,negative regulation of protein phosphorylation (GO:0001933),-0.4674837726196584,-1.8335347189655233,0.002150537634408602,0.0107095711887696,0.549,11/47,16.16%,CALM1;THY1;CALM3;GSTP1;RTRAF;ITGB1BP1;FKBP8;CIB1;CDK5RAP3;GSKIP;DNAJC3
gsea,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.5598492129346024,-1.8305882792879076,0.0078125,0.010971306021406902,0.562,7/24,6.80%,CYBA;CDC42;NCF4;RAC1;PDCD6;ITGAV;RHOA
gsea,protein transport (GO:0015031),-0.3924445332338177,-1.8267358644797358,0.0,0.011424211052850314,0.575,64/157,27.37%,TMED9;UNC119;CD3G;ARF1;SEC13;GOLGA7;ARF5;PDCD6;STX7;ARL6IP5;TMED5;CHMP2A;SVBP;VMP1;VPS29;SAR1A;SAR1B;CHMP2B;RAB5C;ERP29;ARF4;ARL5A;ARHGAP1;RAB3A;TMED7;ATP6V1F;YWHAH;EHD1;UNC119B;TBC1D10C;ARL4A;ATP6V1A;RAB1A;ATP6V1G2;VAMP2;ATP6V1H;FAM91A1;CHMP1B;BLZF1;VPS26B;VAMP4;ATP6V0D1;TBC1D16;ARL6;SNX4;SNX8;RAB28;RAB12;RAB8A;RAB1B;TMED3;SCFD1;VPS26A;SNX15;RUNDC1;RD3;CHMP1A;TOM1;SYNRG;SNX17;STXBP2;NAPA;LAMP2;RAB8B
gsea,mesenchymal cell differentiation (GO:0048762),0.5966444868300844,1.823750136419037,0.0035587188612099642,0.021889659475939988,0.572,11/19,20.05%,HIF1A;DDX5;TGFB1;GSK3B;TGFBR1;LEF1;FBXL17;HMGA2;LOXL3;LIMS1;RBPJ
gsea,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.5061156494633011,-1.822646354899698,0.0,0.011856066949746,0.59,16/36,20.68%,TMED9;SURF4;TAPBP;ARF5;COPE;SEC22B;ARF4;RER1;ERGIC3;TMED7;RAB1A;COPB1;RAB1B;TMED3;SCFD1;KIF5A
gsea,nuclear membrane reassembly (GO:0031468),-0.5777764379739739,-1.8196916424364613,0.005780346820809248,0.012128995183253723,0.602,9/21,14.25%,SEC13;PPP2R1A;CHMP2A;CHMP4B;CHMP2B;SUMO1;UBXN2A;PPP2R2A;SPAST
gsea,positive regulation of cell adhesion (GO:0045785),-0.5595469590095814,-1.8170280815641753,0.002127659574468085,0.012444402640752411,0.612,4/21,11.27%,RAC1;ITGAV;CIB1;P2RY12
gsea,protein glycosylation (GO:0006486),-0.5044582466719157,-1.8163539142945575,0.0,0.01246004200900887,0.613,9/34,9.74%,KRTCAP2;TMEM258;DAD1;MGAT2;DPM1;MGAT3;ALG5;TMEM165;C1GALT1C1
gsea,cellular response to oxygen-containing compound (GO:1901701),-0.4177294356514597,-1.8102396826468385,0.0,0.01329763849628955,0.638,29/80,24.74%,PYCARD;GSTP1;ROMO1;NDUFA13;GNG2;LAMTOR4;GNB1;RRAGA;TWF2;PRDX5;LAMTOR2;LAMTOR5;CHMP5;RHOA;MPV17;P2RY12;RRAGC;RAP1B;PKD2;TICAM1;LAMTOR3;CPEB3;RAP1A;ZFAND1;SNW1;STAP1;FAM210B;MAPK9;MYD88
gsea,cellular macromolecule biosynthetic process (GO:0034645),-0.5173939510060458,-1.8050967098858783,0.021825396825396824,0.013810310807610355,0.656,40/109,15.86%,RPS6;RPL28;MRPS21;RPL35;MRPL36;MRPS33;MRPS14;RPL27;RPL32;MRPS36;RPL37;RPL11;RPS19;MRPL52;RPL38;MRPL34;MRPS15;MRPL32;RPL6;RPL12;RPL24;POLR2K;MRPL27;POLR2G;RPL36A;RPL26;RPS13;MRPS16;MRPL23;MED20;POLR2J;POLR2D;MRPS18C;RPL39;RPS11;RPS7;RRAGC;ORC4;RPS10;EXT2
gsea,positive regulation of TOR signaling (GO:0032008),-0.5574629291820764,-1.8020423804605523,0.004434589800443459,0.014167823345353252,0.666,7/22,14.27%,LAMTOR4;SEC13;RRAGA;LAMTOR2;LAMTOR5;RRAGC;LAMTOR3
gsea,positive regulation of MAP kinase activity (GO:0043406),0.6121327083944086,1.797061377499243,0.0017699115044247787,0.02787056815908508,0.662,2/18,2.93%,EZH2;TGFB1
gsea,peptidyl-tyrosine phosphorylation (GO:0018108),0.572603264248375,1.7930348328763595,0.0,0.028530220250849298,0.676,7/21,17.89%,FYN;LCK;ITK;ABI1;JAK3;INSR;IGF1R
gsea,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.6025176571709678,-1.7925865402487433,0.010438413361169102,0.015625005291947873,0.7,2/16,1.15%,PYCARD;GSTP1
gsea,plasma membrane organization (GO:0007009),-0.6029381327468628,-1.7896804595950342,0.008368200836820083,0.01594554168756965,0.707,4/16,8.95%,DEGS1;ANXA6;UGCG;RAB3A
gsea,fatty acid oxidation (GO:0019395),-0.5591404827910276,-1.7892137655346247,0.011406844106463879,0.015910869507732277,0.708,9/21,27.47%,ACADS;ECI2;ACAA2;ACAT1;SCP2;ACADVL;ECHS1;CROT;HSD17B4
gsea,negative regulation of type I interferon production (GO:0032480),0.5667877018508158,1.7869356953387978,0.004158004158004158,0.02952750302426528,0.699,10/19,14.63%,TAX1BP1;PCBP2;OTUD5;NLRC5;ITCH;CYLD;IRF3;UBA7;RNF216;PPM1B
gsea,regulation of heart contraction (GO:0008016),-0.570526206028159,-1.785352612783806,0.010683760683760684,0.016364327330473223,0.719,7/19,22.05%,CALM1;CALM3;SRI;FKBP1B;PRKACA;ATP1B3;GJA5
gsea,translation (GO:0006412),-0.5892057331247207,-1.7848293885273234,0.016597510373443983,0.016349347539754568,0.72,38/87,11.30%,TMA7;RPS6;RPL28;MRPS21;RPL35;MRPL36;MRPS33;MRPS14;RPL27;RPL32;NDUFA7;RWDD1;MRPS36;RPL37;RPL11;RPS19;MRPL52;RPL38;MRPL34;MRPS15;MRPL32;RPL6;RPL12;RPL24;ZC3H15;MRPL27;RPL36A;AIMP1;RPL26;RPS13;MRPS16;MRPL23;MRPS18C;RPL39;MRPL57;MRPS24;RPS11;RPS7
gsea,protein processing (GO:0016485),-0.5212548706978568,-1.7842539306134748,0.006237006237006237,0.016334539930538426,0.721,6/27,8.35%,SEC11C;SPCS2;SPCS1;SEC11A;TMEM208;SRGN
gsea,peptide metabolic process (GO:0006518),-0.526063967189853,-1.7826372385046318,0.0,0.016498769389273655,0.725,11/26,28.55%,SEC11C;GSTP1;SPCS2;SPCS1;SEC11A;MGAT3;GLRX2;GGT1;APEH;RHD;PSEN1
gsea,ribonucleoprotein complex biogenesis (GO:0022613),-0.672844844133914,-1.7800881988668764,0.013513513513513514,0.016739387283342268,0.732,9/18,13.89%,RPS6;MRPL36;RBIS;RPL11;RPS19;RPL38;RPL26;RPS7;RIOK1
gsea,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.41704621814957665,-1.7728661005417947,0.0,0.01784029838631702,0.752,24/78,29.16%,S100A13;PYCARD;GSTP1;LITAF;LIME1;TFG;NDFIP2;UBE2V1;FKBP1A;LAMTOR5;RHOA;LGALS9;TRIM13;CFLAR;TMEM9B;TRIM32;TICAM1;PPM1N;CASP8;VAPA;MYD88;GOLT1B;TRIM62;TRADD
gsea,cellular response to peptide hormone stimulus (GO:0071375),0.5090787879277974,1.7725112805601309,0.00199203187250996,0.03279771223226357,0.734,11/32,16.97%,NR4A1;NR4A3;RAB10;GSK3A;PRKAR1A;FOXO1;PRKCD;AKT2;INPP5K;GCK;INSR
gsea,regulation of proteasomal protein catabolic process (GO:0061136),-0.5849439603244421,-1.7708225767148762,0.006109979633401222,0.01800736887259079,0.758,6/17,16.46%,PSME1;COMMD1;TMF1;PRKACA;LAMP3;PSMF1
gsea,negative regulation of apoptotic signaling pathway (GO:2001234),-0.513919185775939,-1.7699537572133663,0.0,0.01802568118468626,0.759,11/27,17.07%,GSTP1;NDUFA13;TMBIM6;GHITM;ITGAV;NDUFS3;CFLAR;ACAA2;TMEM14A;TRIAP1;PSMD10
gsea,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.6019861506070834,-1.7691276525112511,0.008213552361396304,0.01809943779851055,0.761,4/15,8.66%,UNC119;RAC1;ITGAV;LRPAP1
gsea,negative regulation of defense response (GO:0031348),0.5761539166916704,1.7680739093788371,0.0076045627376425855,0.033591191741539864,0.745,8/20,14.63%,PCBP2;GPS2;RNF26;ITCH;PTPN2;PRKCD;FNDC4;PPM1B
gsea,mitotic DNA damage checkpoint signaling (GO:0044773),0.613629090079307,1.7630454949021286,0.007532956685499058,0.034726601511028445,0.761,7/15,13.32%,ATF2;BABAM1;BABAM2;SDE2;WAC;NOP53;HMGA2
gsea,regulation of epithelial to mesenchymal transition (GO:0010717),0.5374806562143692,1.7604416447096354,0.003861003861003861,0.034902976262985046,0.768,10/24,19.56%,EZH2;TGFB1;PTEN;TGFBR1;LEF1;SMAD4;LDLRAD4;IL17RD;ELL3;MCRIP1
gsea,mitotic nuclear membrane reassembly (GO:0007084),-0.5622303599549524,-1.758170383536946,0.011450381679389313,0.019530992017541153,0.783,8/20,14.25%,SEC13;PPP2R1A;CHMP2A;CHMP4B;CHMP2B;SUMO1;PPP2R2A;SPAST
gsea,mitotic nuclear membrane organization (GO:0101024),-0.5622303599549524,-1.758170383536946,0.011450381679389313,0.019530992017541153,0.783,8/20,14.25%,SEC13;PPP2R1A;CHMP2A;CHMP4B;CHMP2B;SUMO1;PPP2R2A;SPAST
gsea,positive regulation of growth (GO:0045927),-0.5963436537058637,-1.7561690174012554,0.014553014553014554,0.019718468669235795,0.786,7/16,17.07%,CDC42;RPS6KA1;MTPN;CIB1;TAF9B;TRIM32;PSMD10
gsea,response to lipopolysaccharide (GO:0032496),0.4658562108388998,1.7543156530622241,0.00408997955010225,0.036067921440261864,0.781,18/42,20.18%,HMGB2;HMGB1;FOXP1;IFNAR1;OTUD5;BCL10;PAF1;PELI1;TNFRSF1B;TAB2;MAPK14;PTPN22;PABPN1;SHPK;GGT7;NFKBIL1;TRAF6;RELA
gsea,anterograde trans-synaptic signaling (GO:0098916),-0.4482540758875586,-1.7511320550363696,0.002257336343115124,0.02061840677594921,0.807,14/43,29.68%,CALM1;UNC119;RPS6KA1;CNP;PRKACA;BSN;KCNK3;SNCB;GPR176;KIF5A;SYNJ2BP;CACNB4;SDCBP;HTR6
gsea,gene expression (GO:0010467),-0.47208606942912784,-1.751078354641453,0.018329938900203666,0.020520491873018916,0.807,44/127,14.66%,RBM3;RPS6;RPL28;MRPS21;RPL35;MRPL36;MRPS33;MRPS14;RPL27;RPL32;MRPS36;RPL37;SEC13;RPL11;RPS19;MRPL52;RPL38;MRPL34;MRPS15;MRPL32;RPL6;RPL12;RPL24;POLR2K;MRPL27;POLR2G;SRSF11;RPL36A;RPL26;RPS13;MRPS16;MRPL23;MED20;POLR2J;POLR2D;MRPS18C;RPL39;HNRNPL;RPS11;THOC7;RPS7;RRAGC;CLP1;RPS10
gsea,organonitrogen compound biosynthetic process (GO:1901566),-0.44022475246203085,-1.7500894268594662,0.002028397565922921,0.02057172469523998,0.81,23/52,31.90%,DEGS1;GSTP1;AKR1A1;ESD;CERS2;MOCS2;ASL;CSNK2B;NFS1;APOA2;VAPB;LPIN3;CERS4;PHOSPHO1;VAPA;ELOVL1;SPNS2;RHD;MOCOS;MOCS3;ABHD3;MOCS1;PEMT
gsea,cellular respiration (GO:0045333),-0.5711241663622458,-1.7482682359904702,0.0074211502782931356,0.020763016910834976,0.814,12/20,19.78%,UQCRB;SDHB;NDUFS4;SURF1;UQCRC2;NDUFS8;UQCRFS1;ETFA;UQCR10;SDHC;BLOC1S1;MTFR1L
gsea,protein autophosphorylation (GO:0046777),0.46899790987101964,1.7378924556475455,0.007782101167315175,0.04095677604571919,0.822,25/46,30.67%,STK4;SIK1;STK11;ITK;GSK3B;STK17B;PAK2;VRK2;CAMK4;MARK2;MARK3;DAPK3;SMG1;CAMK2B;INSR;IGF1R;PRKX;MAPK3;STK25;TAOK3;ACVR1B;PTK2;MKNK2;SRC;IRAK1
gsea,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5283883656461769,-1.7368440180795366,0.004201680672268907,0.02280374651245773,0.841,14/26,16.59%,PYCARD;RPS6KA1;NDUFA13;PDCD5;PDCD6;ARL6IP5;DNAJB6;LAMTOR5;BAD;BCAP31;FIS1;BEX3;LAMP3;TRIAP1
gsea,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.6139907721000051,-1.7358909945075014,0.009560229445506692,0.022895083280865435,0.844,6/15,12.23%,LSM5;WDR61;LSM4;LSM6;DCP2;NT5C3B
gsea,positive regulation of protein polymerization (GO:0032273),-0.5423262676454457,-1.7349939571277924,0.008492569002123142,0.022853661255192816,0.845,3/22,2.02%,PYCARD;VASP;RAC1
gsea,positive regulation of translation (GO:0045727),-0.49092793142999525,-1.7346278035898905,0.0099601593625498,0.02280611760221351,0.847,18/34,24.72%,UQCC2;RBM3;EIF3E;COA3;POLR2G;NGRN;RPL26;POLR2D;ELAVL1;UHMK1;RPUSD4;CPEB3;YTHDF2;USP16;JMJD4;KHDRBS1;YTHDF3;RPS9
gsea,positive regulation of developmental growth (GO:0048639),-0.5932105450635241,-1.7345914315565136,0.010638297872340425,0.022687335739701983,0.847,4/16,12.25%,PPIB;TWF2;DBNL;DBN1
gsea,positive regulation of defense response (GO:0031349),-0.560394866714549,-1.734380064406687,0.010845986984815618,0.022621684253669217,0.848,5/18,8.71%,CYBA;IFI35;GPSM3;NMI;DDT
gsea,response to amino acid starvation (GO:1990928),-0.4907057186498399,-1.7335039171971145,0.016494845360824743,0.02250524312083467,0.848,13/33,15.73%,LAMTOR4;SEC13;RRAGA;LAMTOR2;LAMTOR5;ATP6V1F;ATP6V1A;RRAGC;ATP6V1G2;ATP6V1H;SH3GLB1;LAMTOR3;ATP6V0D1
gsea,cellular response to amino acid starvation (GO:0034198),-0.4907057186498399,-1.7335039171971145,0.016494845360824743,0.02250524312083467,0.848,13/33,15.73%,LAMTOR4;SEC13;RRAGA;LAMTOR2;LAMTOR5;ATP6V1F;ATP6V1A;RRAGC;ATP6V1G2;ATP6V1H;SH3GLB1;LAMTOR3;ATP6V0D1
gsea,positive regulation of autophagy (GO:0010508),0.5325909983444986,1.7306554041157196,0.007936507936507936,0.04276379971674054,0.833,9/24,10.56%,HMGB1;STK11;GSK3B;GSK3A;TMEM59;KAT5;FOXO1;WAC;TRIM68
gsea,negative regulation of protein binding (GO:0032091),-0.5546014370128451,-1.7299713639395766,0.00408997955010225,0.023016457885311987,0.855,7/19,10.03%,PPP1CA;TMBIM6;ITGB1BP1;B2M;LRPAP1;ARRB2;MITD1
gsea,regulation of neuron differentiation (GO:0045664),-0.5638462093860704,-1.729252713378021,0.010752688172043012,0.023033092983383338,0.855,5/19,13.59%,ID2;RHOA;YWHAH;CDK5RAP3;TRIM32
gsea,regulation of type I interferon production (GO:0032479),0.49081113466207316,1.7258208672526845,0.00847457627118644,0.043894203237403985,0.846,15/32,20.18%,TAX1BP1;PCBP2;OTUD5;NLRC5;RNF26;ITCH;EP300;CYLD;PTPN22;IRF3;UBA7;RNF216;POLR3C;PQBP1;RELA
gsea,protein ubiquitination (GO:0016567),-0.35581937566459837,-1.7232200991036464,0.0,0.023991778005572294,0.866,84/206,34.45%,PSMB8;PSMB3;ELOB;PSMA2;PSMA7;PSMB10;PSMA1;NEDD8;PSME1;PSMB1;RRAGA;RBX1;PSMB4;PSMD8;UBE2L3;UBE2G2;WDR61;UBE2V1;FBXO22;UBE2E1;FBXO6;UBE2J2;TRIM13;PSMB9;UBE2D1;CTNNB1;ARRB2;UBE2R2;RUSC1;COMMD1;RNF14;OS9;TRIM2;UBE2W;FBXO4;UBE2A;RNF20;ATG3;PSMD13;RNF135;TRIM32;UBE2Q2;BFAR;RNF10;DERL1;FBXO17;NHLRC1;PCNP;ZNRF3;PSMF1;PSMD10;RNF6;UBE2D3;KBTBD8;AMFR;FBXO9;OTULIN;TSPAN17;TRIM47;RNF146;TRIM11;VCPIP1;UBE3A;PSMD4;RNF187;RNF11;RNFT1;ANAPC16;KLHL7;TRIM62;RNF114;TRIM7;KLHL2;FBXO7;MSL2;FBXL5;CUL2;ASB5;CAND2;PEX12;KLHL8;FBXL2;CHFR;TRIM27
gsea,regulation of stress fiber assembly (GO:0051492),-0.5540165919262762,-1.722619211716405,0.01098901098901099,0.02395930197608154,0.866,5/20,8.04%,CDC42;RAC1;ITGB1BP1;RHOA;WAS
gsea,regulation of endothelial cell proliferation (GO:0001936),0.5715035040402937,1.7225981775805956,0.0038314176245210726,0.04429603554401196,0.851,8/17,15.97%,NR4A1;HMGB2;HIF1A;PPP1R16B;TGFBR1;AKT3;KRIT1;ATOH8
gsea,regulation of neuron projection development (GO:0010975),0.439915197966074,1.7173416395546939,0.0037313432835820895,0.045544614070907395,0.862,15/49,16.56%,TOX;GSK3B;NPTN;PAK2;RETREG3;CDK5;GSK3A;PTEN;EP300;MARK2;MYLIP;SERPINI1;CAMK2B;MAG;NTNG2
gsea,nucleotide-excision repair (GO:0006289),-0.4932844497054293,-1.7169973082604983,0.015873015873015872,0.0251103614561273,0.876,15/30,31.47%,RBX1;POLR2K;POLR2G;TCEA1;COPS8;GTF2H5;CETN2;POLR2J;POLR2D;COMMD1;CCNH;POLR2I;SLC30A9;COPS6;HUS1B
gsea,transcription-coupled nucleotide-excision repair (GO:0006283),-0.5438533472138234,-1.7167235152376845,0.013861386138613862,0.025053955794833858,0.876,8/21,8.60%,RBX1;POLR2K;POLR2G;TCEA1;COPS8;GTF2H5;POLR2J;POLR2D
gsea,actomyosin structure organization (GO:0031032),-0.5430797835033025,-1.715879002732175,0.006696428571428571,0.02512827480447089,0.879,12/20,35.20%,WDR1;PDCD10;RHOA;TMOD3;EPB41L4A;ZYX;EPB41L5;F11R;EPB41L1;ITGB5;MYH14;CDC42BPB
gsea,regulation of protein targeting to mitochondrion (GO:1903214),-0.576513647261968,-1.7149963897134315,0.012170385395537525,0.025257372315502145,0.882,8/17,17.53%,TOMM7;UBL5;UBE2L3;RAC2;UBE2J2;LEPROT;SH3GLB1;UBE2D3
gsea,regulation of kinase activity (GO:0043549),0.5439032546226125,1.7142791452991024,0.0038910505836575876,0.045955624702155695,0.87,10/23,24.50%,CDKN1B;ANKRD54;NLRC5;SOD1;SLC9A3R1;INSR;IGF1R;NPRL2;DSTYK;EPHB6
gsea,cellular response to interleukin-12 (GO:0071349),-0.575704402301294,-1.7120685398835416,0.012448132780082987,0.025790287209841296,0.885,8/18,13.58%,CDC42;TALDO1;ARF1;CNN2;PITPNA;IL12RB1;CAPZA1;RAP1B
gsea,regulation of cytokine production (GO:0001817),0.5082844685241936,1.7035366861699137,0.005597014925373134,0.04939137656908653,0.892,12/31,14.66%,PTPRC;CD28;FOXP1;ATP2B1;ITK;NPTN;RNF26;SOD1;TNFRSF1B;MAPK14;IRF3;BCL6B
gsea,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.5888022732860381,-1.7032443267601851,0.017130620985010708,0.027496785614069867,0.894,7/15,22.41%,CDC42;WDR1;RHOA;PDCD6IP;LIN7C;LIN7B;SYNJ2BP
gsea,endomembrane system organization (GO:0010256),-0.42356556302813675,-1.7019433241097546,0.004106776180698152,0.027655051672313566,0.9,22/61,28.38%,CDC42;TMED9;SURF4;TMED5;VMP1;CHMP2B;REEP5;SRGN;TMED7;UBXN2A;RAB1A;BLZF1;PLEKHJ1;TBC1D20;VAPB;TMED3;OBSL1;VAPA;GORASP1;ATL1;TOR1AIP2;VPS4A
gsea,cortical cytoskeleton organization (GO:0030865),-0.5773062978998118,-1.7007532442645756,0.021739130434782608,0.027848080615026086,0.9,5/16,7.47%,RAC1;RAC2;FMNL1;RHOA;RND1
gsea,amide biosynthetic process (GO:0043604),-0.569633707646763,-1.700455275327773,0.015841584158415842,0.027774391519132805,0.9,6/17,20.69%,DEGS1;ASAH1;CERS2;ASL;GBA;CERS4
gsea,autophagosome maturation (GO:0097352),-0.5558176650100279,-1.6978462312328753,0.009900990099009901,0.028150716744823067,0.902,4/18,11.22%,CALM1;VMP1;MAP1LC3B;SNAP29
gsea,interleukin-12-mediated signaling pathway (GO:0035722),-0.5766911324594983,-1.6971482241377542,0.012448132780082987,0.028183609028294507,0.902,8/17,13.58%,CDC42;TALDO1;ARF1;CNN2;PITPNA;IL12RB1;CAPZA1;RAP1B
gsea,Ras protein signal transduction (GO:0007265),-0.45549285024403974,-1.6935624871184145,0.00808080808080808,0.02891046801727765,0.908,17/43,18.47%,ARHGDIB;GNB1;RAC1;G3BP2;RAC2;RASSF1;LAT;DBNL;RHOA;GRB2;WAS;ARHGAP1;RAP1B;RIT1;RAP1A;RRAS;BRK1
gsea,organonitrogen compound catabolic process (GO:1901565),0.577994062295862,1.691956940619291,0.01303538175046555,0.053637280714605634,0.91,7/15,19.07%,USE1;CPQ;LNPEP;CAPN3;MPST;CLN8;TPP1
gsea,positive regulation of lymphocyte proliferation (GO:0050671),0.5865057327024201,1.6908234633171888,0.0057251908396946565,0.053403162149089835,0.911,3/16,2.99%,PTPRC;CD28;IL18
gsea,positive regulation of cytokine production (GO:0001819),0.4070985844054648,1.6894560093913893,0.0,0.05320851673765642,0.915,35/72,31.15%,TIGIT;HMGB1;HIF1A;PTPRC;CD28;FOXP1;PRKCQ;PDE4D;BCL10;TGFB1;IL18;ITK;EP300;SOD1;STAT3;MAPK14;PTPN22;EGR1;SORL1;CEBPG;CD2;MAPK11;IRF3;POLR3C;PQBP1;TRAF6;RELA;TLR1;FZD5;SCAMP5;TIRAP;TBK1;APPL1;IRAK1;DHX36
gsea,hemopoiesis (GO:0030097),0.5174204800988105,1.6893592381754967,0.013011152416356878,0.05250219741561874,0.915,10/26,19.22%,PTPRC;TOX;LCK;TGFB1;SELPLG;RTKN2;SBDS;ARIH2;RASGRP4;PRKX
gsea,cytoskeleton-dependent cytokinesis (GO:0061640),-0.5344406434509577,-1.688797982215457,0.012048192771084338,0.02989033444100898,0.914,9/20,14.25%,UNC119;DCTN3;CHMP4B;RHOA;MITD1;TTC19;PDCD6IP;ARL3;SPAST
gsea,fatty acid catabolic process (GO:0009062),-0.47442827895119966,-1.686381314278673,0.015151515151515152,0.03029668480806423,0.915,14/30,29.51%,ACADS;NUDT7;ECI2;ACAA2;ACAT1;SCP2;ACOT8;PLA2G15;ACADVL;ECHS1;LPIN3;CROT;HSD17B4;ABHD3
gsea,positive regulation of apoptotic process (GO:0043065),0.3902266118149202,1.6862944728167724,0.001890359168241966,0.053047935593032725,0.917,43/91,34.09%,BTG1;HMGB1;GNA13;ARHGEF1;RBM5;STK4;SIK1;BCL10;SUDS3;AKAP13;STK17B;CDK5;SRPK2;TGFBR1;DIABLO;SOD1;UBC;DNM2;TRAF7;FOXO1;ING3;APC;BMF;DAPK3;HMGA2;TNFRSF12A;SOX4;SLC27A4;TRIO;USP27X;BACE1;UBE2Z;TRAF6;CRADD;NCSTN;PSENEN;FGD1;MOAP1;FGD4;RASGRF2;ING4;FLCN;GPLD1
gsea,negative regulation of response to external stimulus (GO:0032102),0.5048529030483997,1.680503321098825,0.0150093808630394,0.054909544980889374,0.923,13/27,21.01%,PCBP2;GPS2;RNF26;ITCH;PTEN;PTPN2;PRKCD;CD109;FNDC4;PPM1B;NFKBIL1;CASK;SHARPIN
gsea,positive regulation of mRNA catabolic process (GO:0061014),0.5808437272250684,1.6789254863517484,0.012,0.054911810693494316,0.924,4/15,2.02%,ZC3HAV1;TNRC6C;TNRC6B;GTPBP1
gsea,positive regulation of signal transduction (GO:0009967),0.4128209500747857,1.6786885523063533,0.0017452006980802793,0.05429184752959036,0.924,30/63,25.16%,HIF1A;PTPRC;GPS2;KLF2;NPTN;ZRANB1;PTEN;EP300;TGFBR1;TRAF7;MAML1;TSPAN14;STAT3;ERFE;SORL1;CSNK2A1;CDKN2AIP;ATP6V0C;MBD5;ASXL2;TTC23;LOXL3;LIMS1;RBPJ;CRADD;DSTYK;ATP6AP2;SMO;NLGN3;TERT
gsea,regulation of cytokine-mediated signaling pathway (GO:0001959),0.500256742575073,1.6783818473108134,0.02100840336134454,0.05370832974416401,0.924,12/27,15.19%,TAX1BP1;IFNGR1;PTPRC;PIAS1;PTPN1;VRK2;RNF31;PTPN2;CBFB;CYLD;JAK1;RBCK1
gsea,regulation of autophagosome assembly (GO:2000785),-0.5740574052597724,-1.676733117520327,0.02490421455938697,0.032530543271439935,0.928,6/15,20.27%,IFT20;SEC22B;CHMP4B;SH3GLB1;RAB1B;SCFD1
gsea,regulation of TOR signaling (GO:0032006),-0.47647355393519725,-1.6759425241339059,0.012958963282937365,0.03257141735207713,0.93,11/30,23.10%,LAMTOR4;SEC13;RRAGA;PDCD6;LAMTOR2;LAMTOR5;RRAGC;LAMTOR3;FBXO9;GBA;GNA12
gsea,regulation of cation channel activity (GO:2001257),-0.540972143738994,-1.6755055435826787,0.015730337078651686,0.0325075733967612,0.931,5/19,13.45%,CALM1;FKBP1A;FKBP1B;VAMP2;PRKACA
gsea,positive regulation of intracellular signal transduction (GO:1902533),-0.3490846958124275,-1.6746906043338934,0.0,0.032559716470242854,0.932,66/151,40.77%,S100A13;LAMTOR4;LITAF;RAC1;RPL37;SEC13;RRAGA;HCLS1;TFG;NDFIP2;ITGB1BP1;RAC2;UBE2V1;LAMTOR2;FKBP1A;LAMTOR5;IFI35;ITGAV;NMI;ILK;RHOA;GRB2;RTN4;LGALS9;BAD;TRIM13;CFLAR;BCAP31;BECN1;FIS1;P2RY12;RRAGC;TMEM9B;CDK5RAP3;TRIM32;TICAM1;LAMTOR3;CASP8;VAPA;FGF23;MYD88;NR3C2;VAV1;AGER;ERBB3;NRG4;STYXL1;GOLT1B;TRIM62;GPR62;NRG2;TRADD;NTRK1;HTR6;LAPTM5;RPS3;TRIM27;HGF;FGF20;UNC5B;IRAK4;RPL23;SEMA4D;IKBKB;TREM2;JMJD8
gsea,negative regulation of cell cycle process (GO:0010948),0.5672604292337257,1.673907037288989,0.016260162601626018,0.054878516488137206,0.928,8/16,21.96%,EZH2;TERF1;WAPL;RING1;RNF2;CHMP4C;MAX;TOM1L2
gsea,positive regulation of GTPase activity (GO:0043547),0.42520116022997606,1.6715896726690647,0.007168458781362007,0.05520470125002965,0.93,26/57,24.59%,EZH2;RABGAP1L;RAPGEF6;ARHGAP45;GSK3B;TBC1D10A;RALGAPA1;TBC1D15;SIPA1L3;RALBP1;RIC1;RHOG;RAP1GAP2;RAB11FIP2;SLC27A4;AGRN;TBC1D22A;LIMS1;GMIP;RAP1GAP;PIP5K1A;DOCK10;FOXJ1;ARHGAP29;APC2;DVL3
gsea,inositol phosphate metabolic process (GO:0043647),-0.5418196459944189,-1.6713951836095366,0.018789144050104383,0.03304562890781305,0.934,7/18,14.02%,CALM1;NUDT3;INPP1;MINPP1;IMPA1;IMPA2;ITPK1
gsea,polyol metabolic process (GO:0019751),-0.5418196459944189,-1.6713951836095366,0.018789144050104383,0.03304562890781305,0.934,7/18,14.02%,CALM1;NUDT3;INPP1;MINPP1;IMPA1;IMPA2;ITPK1
gsea,negative regulation of cellular catabolic process (GO:0031330),0.5415908409738723,1.6711119190792332,0.017475728155339806,0.05475766695160365,0.93,8/20,10.99%,MCL1;GSK3A;STAT3;TAB2;PTPN22;SORL1;BMF;RIC1
gsea,cellular divalent inorganic cation homeostasis (GO:0072503),0.5339733052118264,1.670696509767692,0.009523809523809525,0.05430268448018217,0.93,7/20,16.07%,TPT1;LCK;ATP2B1;NPTN;STIM1;SLC10A7;SLC39A8
gsea,regulation of glycolytic process (GO:0006110),0.5520945330354236,1.6704934234670197,0.0039447731755424065,0.053698388727682594,0.93,8/20,16.97%,HIF1A;NCOR1;NUP50;EP300;PRKAG1;OGT;GCK;INSR
gsea,regulation of GTPase activity (GO:0043087),0.44829048224605256,1.6704419262615333,0.0018450184501845018,0.05306218791925342,0.93,22/45,28.05%,EZH2;KLRK1;ARHGAP15;RAPGEF6;GSK3B;SOD1;TBC1D15;RALBP1;PLXNA3;RIC1;OCRL;RAB11FIP2;AGRN;LIMS1;GMIP;RAP1GAP;DOCK10;DVL3;PTK2;FGD1;CRK;FICD
gsea,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.5651438765054158,1.6687076887841725,0.02004008016032064,0.05317862926837214,0.93,8/17,20.82%,CDKN1B;CNOT6L;EP300;SDE2;WAC;CNOT4;SOX4;CRADD
gsea,peptide biosynthetic process (GO:0043043),-0.5627119692730316,-1.6668620131029097,0.04771784232365145,0.03398814138754611,0.937,31/79,11.30%,RPS6;RPL28;MRPS21;RPL35;MRPL36;MRPS33;MRPS14;RPL27;RPL32;MRPS36;RPL37;RPL11;RPS19;MRPL52;RPL38;MRPL34;MRPS15;MRPL32;RPL6;RPL12;RPL24;MRPL27;RPL36A;RPL26;RPS13;MRPS16;MRPL23;MRPS18C;RPL39;RPS11;RPS7
gsea,Wnt signaling pathway (GO:0016055),0.46398323091358745,1.6668027928144702,0.017241379310344827,0.053310511566755786,0.934,17/34,28.19%,TCF7;GSK3B;ZRANB1;PTEN;UBC;LEF1;APC;DVL1;FRAT1;CSNK1G2;CELSR2;FZD5;DVL3;WNT16;NR4A2;KLHL12;CSNK1G3
gsea,protein localization to organelle (GO:0033365),-0.40563048455389916,-1.6653252515038715,0.007936507936507936,0.03419694070924513,0.937,19/59,23.30%,SEC61B;SEC61G;IFT20;RPL11;TMEM30A;WDR83OS;TRAM1;UBE2J2;SGTA;EHD1;VAMP2;ARL3;CYB5A;LAMP3;ARL6;TSPAN17;OBSL1;VAPA;RAB35
gsea,tRNA processing (GO:0008033),-0.566764597283163,-1.664350861896951,0.012320328542094456,0.03428541944153529,0.937,10/16,23.40%,RTRAF;RTCB;RPP21;POP7;URM1;DTWD2;CLP1;ZBTB8OS;TRIT1;PTCD1
gsea,regulation of cellular component movement (GO:0051270),0.5257286600729578,1.6586345704024024,0.01727447216890595,0.05610315570047844,0.948,8/21,13.13%,MYCBP2;RAF1;PKN2;ETS1;TGFBR1;ARHGAP18;DAPK3;YTHDF1
gsea,cellular response to interferon-gamma (GO:0071346),0.5359457940736243,1.6584607388128325,0.013565891472868217,0.05554863730164378,0.948,10/20,15.24%,IFNGR1;IRF2;IRF9;RPL13A;PRKCD;JAK1;TRIM68;DAPK3;IRF3;CAMK2B
gsea,response to endoplasmic reticulum stress (GO:0034976),-0.4761692582722057,-1.656439017869023,0.01882845188284519,0.03611927183368313,0.943,11/32,17.28%,UFM1;ERP44;UFC1;SELENOK;BCAP31;TMCO1;OS9;UBA5;CDK5RAP3;DERL1;DNAJB9
gsea,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.5661318748744998,-1.6519422795570142,0.018292682926829267,0.03715979337187339,0.949,3/16,9.78%,CDC42;GRB2;ZGPAT
gsea,positive regulation of macromolecule metabolic process (GO:0010604),0.3780770797422715,1.6506848691859524,0.003663003663003663,0.05819860119040316,0.953,42/101,31.15%,IFNGR1;HIF1A;CD28;KLF2;TNRC6C;TNRC6B;KRAS;PTPN1;ETS1;MAP2K5;TGFB1;GSK3B;ATF2;ITCH;MAPK1;GSK3A;SRPK2;TGFBR1;LEF1;STAT3;MAPK14;PTPN22;PRKAG1;EGR1;CNTF;MAPK11;HMGA2;MPHOSPH8;PDE2A;INSR;BRAF;LIMS1;RBPJ;MED26;MAPK3;ANK3;SMO;WNT16;CD3E;SLC24A3;AGO3;DHX36
gsea,mitotic metaphase plate congression (GO:0007080),-0.5483552434306602,-1.6500868479852169,0.01764705882352941,0.03747877434987504,0.95,8/18,12.36%,CHMP2A;CHMP4B;CHMP5;CHMP2B;DCTN2;BECN1;PDCD6IP;CHMP1B
gsea,double-strand break repair (GO:0006302),0.4496411151705396,1.6499691131682463,0.01282051282051282,0.05786757761202719,0.954,18/43,22.10%,RAD21;HMGB2;HMGB1;RAD51B;RNF138;XRCC3;KAT5;BABAM1;BABAM2;NSMCE2;UBXN1;NABP2;AP5S1;RMI1;XRCC4;IFFO1;EYA1;ACTR8
gsea,extrinsic apoptotic signaling pathway (GO:0097191),0.4897420930277432,1.6499519251681574,0.011857707509881422,0.057217380110768455,0.954,14/27,31.06%,MCL1;GABARAP;TGFB1;GSK3B;GSK3A;DIABLO;TNFRSF1B;CRADD;CD27;DEDD2;SORT1;ACVR1B;APPL1;MOAP1
gsea,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.5758308132254264,-1.6470813849867474,0.024640657084188913,0.0381495023611821,0.952,8/15,20.13%,CALM1;CALM3;FKBP1A;FKBP1B;CSNK2B;PPP1R11;MAGI2;PTPA
gsea,regulation of apoptotic process (GO:0042981),-0.3398965028963182,-1.6461776363855238,0.0,0.0382351673017867,0.954,80/188,41.24%,RPS6;YWHAZ;PYCARD;GSTP1;RPS6KA1;UFM1;PRDX2;IL2RB;PDCD5;MTCH1;TMBIM6;TMBIM4;IKZF3;IER3IP1;CTSB;NAA38;PDCD2;ARL6IP5;PRDX5;MIEN1;CAT;PDCD10;BAG1;HIGD2A;SAP18;RTN4;CIB1;ARF4;BAD;CFLAR;STK26;CTNNB1;HTATIP2;TAF9B;TRIM2;SRA1;GLO1;CASP6;MAP3K10;BFAR;TFPT;TMEM14A;DNAJC3;TRIAP1;PSMD10;DUSP9;CASP2;ARHGEF6;PTPA;BNIP3L;CASP8;BIN1;ARHGEF4;CASP9;MYD88;NCKAP1L;APH1B;VAV1;FZD9;BCL2L2;PSEN1;TRADD;RYBP;MCF2L;NTRK1;HPN;BCL2L14;EGLN2;RPS3;PRDM9;HGF;HS1BP3;WFS1;SEMA4D;OPN3;IKBKB;NOL3;SQSTM1;LTK;PIP5KL1
gsea,calcium ion transmembrane transport (GO:0070588),-0.48406528166798335,-1.6447606697792343,0.0041753653444676405,0.03844089503708903,0.956,10/27,17.37%,SMDT1;FKBP1A;ITGAV;MAIP1;TMEM165;TMCO1;MCUR1;PKD2;TRPM4;SLC8B1
gsea,Rho protein signal transduction (GO:0007266),-0.5222935092394171,-1.6437957379667778,0.017130620985010708,0.03854094208268774,0.957,5/19,8.45%,ARHGDIB;CDC42;RHOA;WAS;ARHGAP1
gsea,platelet degranulation (GO:0002576),-0.4842657812095591,-1.6436429484703974,0.015086206896551725,0.038416923199438575,0.957,13/28,26.82%,CALM1;FERMT3;WDR1;TEX264;SRGN;APLP2;TLN1;TMX3;APOOL;VTI1B;RAB27B;STXBP2;LAMP2
gsea,protein stabilization (GO:0050821),-0.4090253643162579,-1.6413777931634235,0.004056795131845842,0.03891188514993678,0.957,20/55,23.50%,PPIB;CDC37;RPL11;GOLGA7;PDCL3;PDCD10;BAG1;SUMO1;RTN4;DNLZ;GLMP;TAF9B;RPS7;SUGT1;APOA2;CCNH;ATP1B3;PEX19;MFSD1;SWSAP1
gsea,pattern recognition receptor signaling pathway (GO:0002221),0.5247836017790349,1.6382742136974955,0.015473887814313346,0.062055353937870115,0.962,7/17,25.81%,HMGB1;BCL10;UBC;TAB2;TRAF6;TLR1;IRAK2
gsea,regulation of Ras protein signal transduction (GO:0046578),0.4835433870714271,1.6330445448574837,0.009578544061302681,0.06384484013815829,0.966,15/29,17.56%,FOXM1;RAF1;KBTBD6;GABARAP;AKAP13;ARF6;DENND1A;ARHGAP17;OGT;RALGPS1;MAPKAP1;STK19;CRKL;LZTR1;RASGRP4
gsea,peptidyl-tyrosine modification (GO:0018212),0.5672810222946032,1.6325624362178495,0.016666666666666666,0.0634003183599974,0.967,5/16,16.97%,FYN;LCK;ABI1;JAK3;INSR
gsea,peroxisome organization (GO:0007031),-0.5615576000417433,-1.632016411245356,0.021568627450980392,0.04150196433893408,0.962,6/15,20.53%,PLAAT3;PEX16;FIS1;ACOT8;PEX19;PEX11G
gsea,enzyme linked receptor protein signaling pathway (GO:0007167),0.4678779934159616,1.6313906629894406,0.02018348623853211,0.06315454014716944,0.967,16/33,31.64%,FYN;LCK;CD8A;ABI1;JAK3;INSR;RASGRP4;IGF1R;TRIO;YES1;EPHB6;ACVR1B;PTK2;CD3E;SRC;ACVR2A
gsea,spindle assembly (GO:0051225),0.5371790195664767,1.628940640707905,0.023622047244094488,0.0636219872791605,0.967,7/17,17.20%,NCOR1;TNKS;RAB11A;MAPRE1;MAPRE3;CSNK1D;KIFC2
gsea,"transcription, DNA-templated (GO:0006351)",-0.38994847232901175,-1.6269333068311738,0.010080645161290322,0.0427962413741177,0.967,26/69,29.89%,ELOB;TAF10;WDR61;POLR2K;POLR2G;TCEA1;TFB2M;GTF2H5;MED20;POLR2J;POLR2D;ARRB2;CRCP;TAF13;TAF9B;GTF3C6;RRAGC;DRAP1;CCNH;GCM2;POLR2I;GTF2B;TWNK;DEAF1;NAT14;THRA
gsea,regulation of cell differentiation (GO:0045595),-0.4121609023391176,-1.625698965373179,0.006787330316742082,0.04297185152244965,0.968,11/49,13.45%,UQCC2;ID2;RPS6KA1;PPP2R1A;PDCD2;OCIAD1;PLEKHB2;YWHAH;RUNX3;CDK5RAP3;PRKACA
gsea,regulation of epithelial cell proliferation (GO:0050678),0.5607891907707059,1.6253499461886782,0.028985507246376812,0.06459493571329591,0.971,3/16,2.93%,NR4A1;NR4A3;TGFB1
gsea,macroautophagy (GO:0016236),-0.3938015964183885,-1.6249713429841233,0.006185567010309278,0.042991455749771354,0.969,33/67,40.86%,TOMM6;DYNLL1;TOMM7;CHMP2A;TOMM22;SNF8;VTA1;CHMP4B;MAP1LC3B;CHMP2B;PGAM5;BECN1;CSNK2B;SNAP29;ATG3;MVB12A;VPS28;VTI1B;MTERF3;VPS39;FUNDC1;LAMP2;VPS4A;RUBCNL;CHMP6;VPS37A;VPS36;CHMP3;GABARAPL2;ACBD5;VPS25;SQSTM1;VIPAS39
gsea,canonical Wnt signaling pathway (GO:0060070),0.4988086267334247,1.6204373066934876,0.024163568773234202,0.06651975260324013,0.974,11/23,25.35%,TCF7;GSK3B;PTEN;LEF1;APC;DVL1;FRAT1;FZD5;DVL3;WNT16;NR4A2
gsea,cellular response to light stimulus (GO:0071482),-0.5057788612864682,-1.619897503618382,0.037199124726477024,0.04442743616782872,0.973,6/21,23.59%,COPS9;GNB1;NSMCE3;RPL26;TRIAP1;CASP9
gsea,negative regulation of cell adhesion (GO:0007162),-0.48989652940560346,-1.6191436971933946,0.020833333333333332,0.04449884643074588,0.973,8/23,26.35%,ARHGDIB;ITGB1BP1;RHOA;RND1;CD164;SPINT2;JAG1;ERBB3
gsea,positive regulation of immune response (GO:0050778),-0.547409963762001,-1.6189897933551636,0.033797216699801194,0.04434870221913962,0.973,8/16,11.37%,CYBA;PYCARD;ITGB2;IFI35;NMI;IL12RB1;LGALS9;SASH3
gsea,RNA export from nucleus (GO:0006405),0.5151384623971036,1.617735613460746,0.016227180527383367,0.06727715621494768,0.974,12/20,21.14%,YTHDC1;NUP50;AGFG1;CHTOP;FIP1L1;SMG5;U2AF1L4;POLDIP3;WDR33;SMG1;ZC3H11A;SLU7
gsea,histone H4 acetylation (GO:0043967),0.5503604799892324,1.6163929461190636,0.025390625,0.06726975284527814,0.976,8/16,13.84%,ATF2;MEAF6;EP300;LEF1;ING3;OGT;KANSL3;NAA60
gsea,mRNA transport (GO:0051028),0.5195308938481606,1.6163551396293188,0.022357723577235773,0.06594730662491995,0.976,12/19,21.14%,YTHDC1;NUP50;AGFG1;CHTOP;FIP1L1;SMG5;U2AF1L4;POLDIP3;WDR33;SMG1;ZC3H11A;SLU7
gsea,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.5195308938481606,1.6163551396293188,0.022357723577235773,0.06594730662491995,0.976,12/19,21.14%,YTHDC1;NUP50;AGFG1;CHTOP;FIP1L1;SMG5;U2AF1L4;POLDIP3;WDR33;SMG1;ZC3H11A;SLU7
gsea,erythrocyte differentiation (GO:0030218),-0.5588806805695593,-1.6135943329713645,0.014084507042253521,0.04597053120185536,0.975,5/15,13.32%,ID2;HCLS1;RPS19;UBA5;CDK5RAP3
gsea,positive regulation of protein metabolic process (GO:0051247),0.4289508395793701,1.6134320347771545,0.015873015873015872,0.06671067732974108,0.977,21/42,31.08%,CDKN1B;KLF2;BCL10;MAP2K5;TGFB1;IL18;GSK3B;ITCH;GSK3A;WWP2;FOXO1;NR1H2;RANBP9;APC;SORL1;CSNK2A1;APC2;NEDD4L;NKD1;DACT1;SMURF1
gsea,dephosphorylation (GO:0016311),0.40297115877060513,1.6128441917886838,0.009671179883945842,0.06634163663330556,0.977,25/59,32.25%,PTPRC;PPP1R12A;PPP1CC;PTPN1;PPP2R5E;STK11;PPP3CC;PPM1D;PTEN;PPM1H;PTPRA;PLPPR3;PTPN22;DUSP8;PNKP;INPP5K;PPM1B;MTMR6;PTPN4;PPP2R5C;CDC14B;PPP6C;CTTNBP2NL;PLPPR2;FBXW11
gsea,purine ribonucleotide metabolic process (GO:0009150),-0.5425055763948626,-1.6081933500462837,0.03,0.04752145817831454,0.977,10/16,26.98%,ACOT2;ACOT13;BAD;SULT4A1;ACAT1;ABHD14B;AK3;ACOT8;CROT;ACOT6
gsea,sphingolipid metabolic process (GO:0006665),-0.42322678013350706,-1.6052418509046242,0.009784735812133072,0.048295800675974956,0.978,20/47,27.72%,DEGS1;ESYT1;PPP2R1A;ASAH1;CERS2;UGCG;TECR;ORMDL1;SUMF1;SERINC1;ORMDL2;PLA2G15;VAPB;GBA;GAL3ST1;CERS4;VAPA;ELOVL1;SPNS2;GLB1
gsea,brain development (GO:0007420),-0.4268675483363464,-1.604536051282948,0.012396694214876033,0.048354924406016866,0.979,11/38,34.60%,UFM1;IER3IP1;EOMES;NDUFS4;UFC1;CDK5RAP3;TGFBR2;UBE3A;UGP2;MAP1S;PAFAH1B2
gsea,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4859992331732261,1.6027845666799234,0.016100178890876567,0.07042841973416863,0.98,12/26,18.63%,RAF1;STK4;PDE4D;TGFB1;PTEN;AKAP9;NSD1;DMD;CAPRIN2;INPP5K;ARAF;BRAF
gsea,intracellular protein transport (GO:0006886),-0.3490831538773694,-1.601176141334251,0.002012072434607646,0.04925343067041373,0.979,65/124,40.86%,TMED9;SURF4;ARF1;SEC13;CDC37;RPL11;ARF5;PDCD6;STX7;TMED5;SNF8;VPS29;SAR1A;SAR1B;RAB5C;ERP29;ARF4;ARL5A;MAIP1;TMED7;YWHAH;EHD1;TBC1D10C;ARL4A;RAB1A;FAM91A1;VPS26B;FAM53A;TBC1D16;ARL6;SNX8;RAB28;AP1S3;RAB1B;VPS28;TMED3;SCFD1;VPS26A;SNX15;RUNDC1;AP4S1;RANBP17;SYNRG;SNX17;STXBP2;NAPA;STRADB;LAMP2;TPR;LAPTM5;SPRN;COPZ1;VPS36;CAMSAP3;SNX6;RTN2;STXBP1;RAB22A;IPO13;NAPG;RAB19;VPS25;STX3;AP1M2;VIPAS39
gsea,negative regulation of programmed cell death (GO:0043069),-0.36432078578204713,-1.5992268930283249,0.00646551724137931,0.04977510741453519,0.979,46/97,40.90%,YWHAZ;GSTP1;RPS6KA1;UFM1;PRDX2;IL2RB;TMBIM6;TMBIM4;NAA38;PRDX5;MIEN1;CAT;PDCD10;BAG1;HIGD2A;CIB1;ARF4;CFLAR;CTNNB1;HTATIP2;TAF9B;GLO1;BFAR;TMEM14A;DNAJC3;TRIAP1;PSMD10;CASP2;BNIP3L;MYD88;NCKAP1L;BCL2L2;PSEN1;NTRK1;HPN;LAPTM5;PRDM9;HGF;WFS1;SEMA4D;OPN3;IKBKB;NOL3;TREM2;SQSTM1;LTK
gsea,positive regulation of endothelial cell migration (GO:0010595),0.5083610962258299,1.5983983315364572,0.018726591760299626,0.07192842070403802,0.981,8/21,15.97%,HMGB1;HIF1A;FOXP1;ETS1;TGFB1;AKT3;MAPK14;ATOH8
gsea,negative regulation of apoptotic process (GO:0043066),-0.3465557580942502,-1.5972227322505923,0.004454342984409799,0.050210757418415825,0.98,60/128,40.90%,YWHAZ;GSTP1;RPS6KA1;UFM1;PRDX2;IL2RB;TMBIM6;TMBIM4;HCLS1;NAA38;PRDX5;MIEN1;DNAJB6;CAT;PDCD10;LAMTOR5;BAG1;HIGD2A;CIB1;ARF4;CFLAR;CTNNB1;HTATIP2;TAF9B;GLO1;BEX3;BFAR;LAMP3;TMEM14A;DNAJC3;TRIAP1;PSMD10;CASP2;AGAP2;BNIP3L;MYD88;NCKAP1L;ERBB3;FZD9;BCL2L2;PSEN1;NTRK1;TYRO3;HPN;MAEA;SIX1;TRIM27;PRDM9;HGF;FGF20;SNX6;UNC5B;WFS1;SEMA4D;OPN3;IKBKB;NOL3;TREM2;SQSTM1;LTK
gsea,mitotic cell cycle phase transition (GO:0044772),0.41440643779919,1.5946305870164375,0.011741682974559686,0.07315214849904952,0.983,25/51,30.05%,FOXM1;CDKN1B;PPP2R2D;PPP1R12A;SSNA1;PAFAH1B1;CCNI;DNM2;GPR132;MAPRE1;AKAP9;ENSA;CSNK1D;FBXL17;CEP131;MAX;PPP1R12B;CHMP7;FBXL3;BRSK2;FBXL6;ACVR1B;PPP6C;RPS6KB1;CEP63
gsea,nucleic acid metabolic process (GO:0090304),-0.51335039127581,-1.5931880685148165,0.023762376237623763,0.051452133454137475,0.981,6/19,9.70%,POLR2K;POLR2G;POLR2J;HNRNPH2;POLR2D;HNRNPL
gsea,circulatory system development (GO:0072359),0.4731702198260073,1.5914761458165034,0.026565464895635674,0.074266187707184,0.986,13/28,27.44%,CDKN1B;STK11;TGFB1;AKAP13;PTEN;TGFBR1;TCF25;TAB2;POU6F1;SOX4;PKD1;CXADR;MEF2A
gsea,protein complex oligomerization (GO:0051259),-0.44228579209306074,-1.591355632393469,0.016632016632016633,0.052044747606038645,0.982,14/31,29.98%,PYCARD;G3BP2;CHMP2A;EHD1;PDCD6IP;ELAVL1;RNF135;PKD2;SPAST;CUTC;TWNK;ATL1;KCNC3;UGDH
gsea,negative regulation of cell growth (GO:0030308),0.4506269094481649,1.5911788084187375,0.01972386587771203,0.07372939293236352,0.986,14/35,17.30%,BTG1;CDKN1B;DIP2B;STK11;VGLL4;TGFB1;GSK3A;SERTAD3;CAPRIN2;CDKN2AIP;NDRG3;NAIF1;MAG;SMAD4
gsea,regulation of JNK cascade (GO:0046328),0.4651561850011144,1.5889093468608986,0.025,0.07430748278343098,0.987,15/28,29.53%,HMGB1;GPS2;NCOR1;ITCH;MAP4K2;CYLD;MAPK8IP3;IGF1R;TRAF6;CD27;WNT16;TAOK3;TIRAP;DACT1;ZMYND11
gsea,DNA repair (GO:0006281),0.3912345987925334,1.5882320069434144,0.003937007874015748,0.07390648247101242,0.987,24/62,22.10%,RAD21;RAD51B;UBE2B;POLD4;XRCC3;UBC;KAT5;BABAM1;BABAM2;WDR33;UBXN1;NOP53;ATRIP;NABP2;ASCC3;PNKP;HMGA2;PARP4;MPG;XRCC4;INIP;UVRAG;EYA1;ACTR8
gsea,mitotic cytokinesis (GO:0000281),-0.546257262754758,-1.5873350107470299,0.02620967741935484,0.05327376611195326,0.985,8/15,15.11%,UNC119;CHMP4B;MITD1;TTC19;PDCD6IP;ARL3;SPAST;KLHDC8B
gsea,epithelial to mesenchymal transition (GO:0001837),0.5169964149869766,1.58720758030954,0.023465703971119134,0.07383266594644948,0.987,10/19,20.05%,HIF1A;DDX5;TGFB1;GSK3B;TGFBR1;LEF1;HMGA2;LOXL3;LIMS1;RBPJ
gsea,regulation of Rho protein signal transduction (GO:0035023),-0.542787093065677,-1.587055203137824,0.01680672268907563,0.053115127788355636,0.985,3/16,5.09%,ARHGDIB;RAC1;PDCD10
gsea,small GTPase mediated signal transduction (GO:0007264),-0.44362755535964404,-1.5865796586613756,0.026717557251908396,0.05305792456070059,0.985,14/36,15.26%,GNB1;RAC1;G3BP2;RGS19;RASSF1;LAT;NUCB1;GRB2;ARHGAP1;ARHGAP30;RRAGC;ARL3;RIT1;RRAS
gsea,regulation of protein phosphorylation (GO:0001932),0.39070165233877685,1.5858008140617226,0.014466546112115732,0.0738428779594367,0.987,31/68,28.52%,FYN;ANKRD54;KRAS;STK4;BRD4;PPP2R5E;TGFB1;NPTN;CHP1;PTEN;SOD1;RB1CC1;RALBP1;NOP53;NSD1;AKAP8L;AKT2;SLC9A3R1;CSNK1D;TESK1;PDE8A;INPP5K;CRKL;F2;INSR;PPIL4;PPP2R5C;MAPK3;DVL3;PTK2;SPTBN4
gsea,protein lipidation (GO:0006497),-0.47067482836898494,-1.5855514479642283,0.018255578093306288,0.05322565270940735,0.986,11/26,25.32%,PIGP;SELENOK;UGCG;DPM1;DPM2;ZDHHC7;ZDHHC20;PIGM;ZDHHC18;PIGW;ZDHHC3
gsea,positive regulation of angiogenesis (GO:0045766),0.5217924088964574,1.5844227536461633,0.024096385542168676,0.07391437771294385,0.987,7/20,13.32%,BTG1;HIF1A;ETS1;HSPB6;STIM1;JAK1;HMGA2
gsea,regulation of telomere maintenance via telomerase (GO:0032210),0.5272789626892913,1.5832021177576232,0.030364372469635626,0.07390337716445139,0.987,10/17,22.62%,TERF1;PRKCQ;TNKS;MAPK1;SMG5;TNKS2;PNKP;MAP2K7;HMBOX1;MAPK3
gsea,regulation of hydrolase activity (GO:0051336),0.50078873119186,1.5813584031573718,0.016216216216216217,0.07426162984491044,0.987,15/23,32.25%,ARHGAP15;RAPGEF6;PAFAH1B1;SOD1;TBC1D15;RALBP1;PLXNA3;OCRL;RAP1GAP;PTK2;FGD1;CRK;PLXNB1;FGD4;FBXW11
gsea,cellular response to cytokine stimulus (GO:0071345),0.3620341808285973,1.5812670370239787,0.00558659217877095,0.07366243939867397,0.987,54/108,34.40%,TCF7;CDKN1B;IFNGR1;MCL1;HIF1A;FYN;STAT4;IFNAR1;LCK;TGFB1;IL18;GSK3B;RPL13A;SELPLG;GSK3A;UBC;FOXO1;PTPN2;TNFRSF1B;LEF1;STAT3;EGR1;SHPK;IL10RB;CNTF;JAK1;INPP5D;DAPK3;MAPK11;AIM2;INPP5K;LDLRAP1;ZFAND6;CRKL;PDE2A;JAK3;PTPN4;TRAF6;RC3H1;RELA;GAB2;IRAK2;STX1A;CEBPA;CRK;IL11;IL20RA;TBK1;IRAK1;NR1D1;NUMBL;IL3RA;IL18BP;IL12A
gsea,positive regulation of vasculature development (GO:1904018),0.5493959627759584,1.5802828270771458,0.02486678507992895,0.07350881637740868,0.987,6/17,13.32%,BTG1;HIF1A;ETS1;HSPB6;STIM1;HMGA2
gsea,modification-dependent protein catabolic process (GO:0019941),-0.3709839373414273,-1.5796927246161472,0.00784313725490196,0.05531487894224715,0.988,30/84,27.92%,NEDD8;RBX1;NDFIP2;UBE2L3;UBE2G2;FBXO22;UBE2E1;NTAN1;CDC26;UBE2D1;PTTG1;UBE2R2;RNF14;OS9;PPP1R11;UBE2A;RNF20;PSMD13;TRIM32;BFAR;KCTD6;ZNRF3;PSMF1;RNF6;AMFR;RNF146;RNF11;ANAPC16;RNF114;UBE2I
gsea,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.47063407927755985,1.5772240326356708,0.014814814814814815,0.0745542971935913,0.987,10/28,21.64%,ING2;STK11;TGFB1;EP300;TGFBR1;RNF111;SMAD4;RBPJ;ZEB2;SH2B1
gsea,regulation of cell population proliferation (GO:0042127),0.3290652502382364,1.5735614352674872,0.0017953321364452424,0.07587378049442364,0.987,83/168,42.20%,FOXM1;EZH2;BTG1;HMGB2;CDKN1B;NR4A3;STAT4;RAF1;PIAS1;RBM5;KRAS;ETS1;STK11;TGFB1;CNOT6L;PPM1D;CHTOP;TES;PTEN;SRPK2;TGFBR1;GID8;RTKN2;PTPN2;LEF1;RPS15A;STAT3;APC;ABI1;MECP2;AKT2;XIAP;CNTF;SERTAD1;CDK10;SLC9A3R1;RHOG;CSNK2A1;ADAM10;BCL6B;CRKL;VIPR1;SOX4;MEIS3;INSR;IGF1R;LIMS1;TBX6;CEP131;RELA;PPP2R5C;GAB2;CTBP1;DLG3;ADORA3;NACC2;TMEM115;CEBPA;KDM4C;BEX4;PTK2;IL11;CNOT6;MYO16;ATP8A2;CAPN1;AGO3;CDK13;ING4;TENM1;IRF6;GPLD1;AVPR2;ZBTB49;SGK3;STOX1;VHL;BMPR1A;IL15;CADM4;MLXIPL;CD47;TFAP2A
gsea,positive regulation of cellular protein localization (GO:1903829),0.4757962155504939,1.5707969408897324,0.03435114503816794,0.0766696844538712,0.988,8/24,15.39%,FYN;TGFB1;GSK3B;CROCC;APC;PARD6A;TESK1;F2
gsea,negative regulation of neuron projection development (GO:0010977),-0.5443819623218568,-1.5696050171669775,0.019230769230769232,0.058971241558286425,0.993,4/15,7.82%,THY1;RHOA;RTN4;CIB1
gsea,positive regulation of gene expression (GO:0010628),0.3494395359867661,1.5692464735956921,0.005272407732864675,0.07687860243364407,0.988,59/120,38.93%,IFNGR1;HIF1A;CD28;DDX5;TNRC6C;CIRBP;TNRC6B;KRAS;PCIF1;ETS1;TGFB1;ITK;GSK3B;ATF2;SF3B1;WBP2;MAPK1;GSK3A;EP300;SRPK2;TGFBR1;SOD1;POLDIP3;LEF1;STAT3;MAPK14;PTPN22;PRKAG1;EGR1;CNTF;MAPK11;YTHDF1;HMGA2;PDE2A;SOX4;BRAF;LIMS1;RBPJ;MED26;MAPK3;ANK3;SMO;WNT16;CD3E;SCAMP5;RPS6KB1;SLC24A3;AGO3;DHX36;TAF1C;TTBK1;UPF3A;LURAP1;CITED1;RBM22;AVPR2;CD46;STOX1;TLR6
gsea,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.5135248726783572,-1.5683631620509246,0.024742268041237112,0.0592468024627538,0.993,12/18,32.26%,PYCARD;MTCH1;PDCD2;BAD;CFLAR;BEX3;CASP2;CASP8;CASP9;TRADD;MAPT;LAPTM5
gsea,nucleus organization (GO:0006997),-0.4848550125574285,-1.5682083852834205,0.031007751937984496,0.05910284381625124,0.993,12/22,31.31%,RPS19;CHMP2A;CHMP4B;CHMP5;CHMP2B;PDCD6IP;CHMP1B;BIN1;CHMP1A;VPS4A;TPR;CHMP6
gsea,protein methylation (GO:0006479),0.5281687295116498,1.5658409428127065,0.032692307692307694,0.07800075628685502,0.988,5/16,11.80%,EZH2;NSD3;PCMT1;NSD1;CAMKMT
gsea,positive regulation of endocytosis (GO:0045807),-0.5368314000249583,-1.5593674797328718,0.03711340206185567,0.06264776160315666,0.993,5/16,25.18%,CDC42;B2M;VPS28;STAP1;NCKAP1L
gsea,regulation of cellular metabolic process (GO:0031323),0.5166332007351647,1.554128819404977,0.027932960893854747,0.08386984635449171,0.993,5/17,8.32%,FOXM1;PANK2;MBOAT7;LAMTOR1;MKLN1
gsea,cellular response to lipopolysaccharide (GO:0071222),0.4502030383195418,1.55125638118272,0.037037037037037035,0.08476765369660386,0.993,14/27,20.18%,HMGB2;HMGB1;BCL10;TGFB1;IL18;PAF1;TNFRSF1B;MAPK14;PTPN22;PABPN1;SHPK;NFKBIL1;TRAF6;RELA
gsea,visual perception (GO:0007601),-0.46305150704570025,-1.5505766486322135,0.02145922746781116,0.06599944833539605,0.993,10/25,30.21%,UNC119;PITPNA;DNAJC19;EML2;DRAM2;RDH10;RD3;CABP4;CABP1;BEST1
gsea,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.4781278429154805,-1.550528310036576,0.04121475054229935,0.0657533425268629,0.993,10/21,34.06%,IFI35;NMI;ILK;RHOA;LGALS9;NR3C2;AGER;TRADD;LAPTM5;RPS3
gsea,calcium ion homeostasis (GO:0055074),0.5180678024928975,1.5490488966061402,0.03409090909090909,0.08526849966601094,0.994,9/17,30.34%,TPT1;ATP2B1;NPTN;STIM1;SLC10A7;SLC24A1;ATP2C1;SLC24A3;ATP2A1
gsea,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.5025397762278823,-1.5482252679377349,0.05010438413361169,0.06658717844396969,0.993,8/17,23.10%,RPL11;PDCL3;SGTA;COMMD1;RPS7;CDK5RAP3;UBE3A;GNA12
gsea,positive regulation of hydrolase activity (GO:0051345),-0.4275083142662604,-1.546441129898189,0.036016949152542374,0.06707268748651611,0.994,16/36,40.72%,CALM1;THY1;CALM3;NDUFA13;ZC3H15;RHOA;RAP1A;TBC1D20;F11R;SNX18;NTRK1;MAPRE2;RPS3;CDKL5;SEMA4D;RAPGEF3
gsea,sulfur compound biosynthetic process (GO:0044272),-0.4185881327262646,-1.5420846108203559,0.03225806451612903,0.06873938991620707,0.994,11/36,21.71%,GSTP1;AKR1A1;ESD;CNDP2;CHST14;GCLM;PAPSS1;SLC35B3;HAGH;B4GALT2;GGT1
gsea,negative regulation of gene expression (GO:0010629),0.3608933456433741,1.5410847718983662,0.009328358208955223,0.08929851277307337,0.995,46/88,40.17%,EZH2;HIF1A;CD28;FOXP1;NCOR1;TNRC6C;TNRC6B;PCIF1;ATP2B1;TGFB1;RPL13A;NPTN;PPM1D;WWP2;PHF1;NDFIP1;PTPN22;SAMD4B;SFMBT2;MECP2;DAPK3;DDX6;ADAM10;CRKL;MPHOSPH8;ATOH8;ESR1;SMO;TERT;CD3E;N4BP1;EPC1;SLC24A3;LGR4;AGO3;DHX36;TTBK1;SNX12;FLCN;YY1;LSM14A;PAIP2;CD46;STOX1;VHL;BMPR1A
gsea,regulation of protein dephosphorylation (GO:0035304),-0.5216119182866046,-1.5376429730765637,0.05576923076923077,0.0704841687489978,0.995,6/16,20.13%,CALM1;CALM3;ARPP19;CAMTA1;GBA;PTPA
gsea,glycosaminoglycan biosynthetic process (GO:0006024),0.4447914019197006,1.5353766083537814,0.032567049808429116,0.09187427075956217,0.996,9/28,18.71%,B3GNT2;B4GALT1;CHST12;OMD;SLC10A7;B4GALT6;EXT1;OGN;AGRN
gsea,protein polymerization (GO:0051258),-0.4981933203343978,-1.5351477728570042,0.056862745098039215,0.07124924889110101,0.995,11/18,31.80%,RAC1;CHMP2A;CHMP4B;WAS;RNF135;ARL6;PSTPIP1;WASL;WASHC3;MSRB1;MAPT
gsea,regulation of protein binding (GO:0043393),-0.4077223682159626,-1.5343484825322737,0.020964360587002098,0.07130661221279244,0.995,16/38,29.38%,PPP1CA;TMBIM6;RPL11;ITGB1BP1;B2M;FKBP1A;NMD3;LRPAP1;MITD1;PRKACA;DERL1;AMFR;CTNNBIP1;DISC1;PSEN1;SNAPIN
gsea,ribosome biogenesis (GO:0042254),-0.5556726536185578,-1.5332134278555187,0.10082304526748971,0.07144386438766992,0.995,21/54,13.89%,RPS6;RPL28;RPL35;MRPL36;RBIS;RPL27;RPL32;RPL37;RPL11;C1D;RPS19;RPL38;RPL6;RPL12;RPL24;IMP3;RPL36A;RPL26;RPL39;RPS7;RIOK1
gsea,nitrogen compound transport (GO:0071705),-0.40944413640668376,-1.5327747685934783,0.026915113871635612,0.07137297446294459,0.995,16/39,25.64%,CD3G;TMEM30A;ARL6IP5;CHMP2A;CHMP2B;SCARB2;VAMP2;CHMP1B;SLC7A4;SNX4;SLC36A1;SLC7A7;RD3;CHMP1A;TOM1;SLC29A4
gsea,T cell activation (GO:0042110),0.48826663303830276,1.5325401439024342,0.04669260700389105,0.09297591625852861,0.996,12/26,16.42%,PTPRC;CD28;LCK;CD8A;ITK;LFNG;LMBR1L;PTPN2;PTPN22;CD2;RHOH;SOX4
gsea,chemical synaptic transmission (GO:0007268),-0.3617659295748688,-1.5271254007215067,0.014457831325301205,0.0737880076068271,0.996,23/66,29.68%,CALM1;UNC119;RPS6KA1;CNP;TSPOAP1;RAB3A;VAMP2;PRKACA;BSN;KCNK3;SNCB;LIN7C;GPR176;LIN7B;KIF5A;NQO1;SYNJ2BP;CACNB4;STXBP2;NAPA;SDCBP;SNAPIN;HTR6
gsea,neuron differentiation (GO:0030182),-0.42428092296220454,-1.5269918740662372,0.021052631578947368,0.07355005458939631,0.996,9/34,29.98%,ID2;MTPN;NGRN;UGCG;CTNNB1;RUNX3;VAX2;MAP2K1;UGDH
gsea,regulation of organelle organization (GO:0033043),-0.40796143426221815,-1.5260400673590984,0.030434782608695653,0.07379328974047061,0.996,14/39,40.51%,TMED9;SURF4;PDCD10;SAR1A;SAR1B;SCARB2;FIS1;MIEF2;F11R;SIRT7;MAPT;CAMSAP3;SPEF1;SQSTM1
gsea,cellular protein localization (GO:0034613),-0.3371168183326159,-1.5258704071248803,0.007984031936127744,0.07359417828910131,0.996,58/123,40.86%,TMED9;ARF1;SEC13;RRAGA;ARF5;PDCD6;STX7;TMED5;LAMTOR2;VPS29;SAR1A;SAR1B;RAB5C;ERP29;ARF4;ARL5A;TMED7;YWHAH;EHD1;CTNNB1;TBC1D10C;ARL4A;ABHD17A;RAB1A;RRAGC;FAM91A1;VPS26B;CORO1B;LAMTOR3;TBC1D16;ARL6;SNX8;RAB28;RAB1B;TMED3;SCFD1;VPS26A;SNX15;RUNDC1;TM9SF3;HPS6;SYNRG;SNX17;STXBP2;NAPA;OCLN;LAPTM5;TM9SF2;COPZ1;SNX6;STXBP1;RAB22A;PTPRU;NAPG;NPHP1;RAB19;STX3;VIPAS39
gsea,regulation of DNA metabolic process (GO:0051052),-0.5156321102386312,-1.525432862830413,0.04439746300211417,0.07354438277368866,0.996,4/16,9.88%,SUB1;UBE2V1;MPV17;SMARCAD1
gsea,negative regulation of protein-containing complex assembly (GO:0031333),0.5158629215554251,1.5242183444582695,0.04206500956022945,0.09757438914288764,0.996,8/18,9.83%,HMGB1;RAF1;GSK3B;RPL13A;EP300;NOP53;RIOK3;SORL1
gsea,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.4487414712946337,-1.5241736262754844,0.02927927927927928,0.0738217817677698,0.996,8/28,17.20%,CALM1;CALM3;PDCD10;RHOA;CIB1;PKD2;PSMD10;CCNY
gsea,negative regulation of cell motility (GO:2000146),-0.4526907330211558,-1.5232595019966968,0.028634361233480177,0.07398248966419077,0.996,8/24,28.57%,THY1;WAS;STK26;RNF20;SPINT2;MAGI2;JAG1;EPHA1
gsea,regulation of DNA binding (GO:0051101),0.5036943082313307,1.5232045342023814,0.03619047619047619,0.09742878151758817,0.996,8/18,13.32%,HMGB2;HMGB1;TGFB1;LEF1;RSF1;KDM1A;CEBPG;HMGA2
gsea,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.44109147134084736,-1.5204297965374594,0.02,0.07498283390995798,0.996,11/28,34.06%,LIME1;IFI35;NMI;ILK;RHOA;LGALS9;NR3C2;AGER;TRADD;LAPTM5;RPS3
gsea,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.48018311676630976,-1.5183142896741857,0.03648068669527897,0.0756571929587212,0.996,7/20,37.04%,CALM1;ZDHHC7;ZDHHC3;GUCA1A;RGS3;PDE6H;YWHAB
gsea,second-messenger-mediated signaling (GO:0019932),-0.5161912680472436,-1.5173062483497866,0.05150214592274678,0.07587755153674951,0.996,4/15,15.55%,PPP2R1A;LAT;P2RY12;TRPM4
gsea,regulation of cell migration (GO:0030334),-0.33967358826427396,-1.516875843299673,0.009592326139088728,0.0758793530361918,0.996,31/91,39.55%,THY1;FERMT3;RAC1;MIEN1;PDCD10;FAM89B;RHOA;CIB1;MGAT3;STK26;SNAI1;RNF20;TRIM32;MAGI2;SEMA6B;FGF23;YTHDF3;GNA12;JAG1;PARD6B;EPHA1;TRADD;SDCBP;FER;STK24;HGF;CAMSAP3;FGF20;SEMA4D;PTPRU;CBLL1
gsea,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.4646657083121642,1.5164618426377066,0.037267080745341616,0.10093369058892435,0.997,11/23,20.24%,TNRC6C;TNRC6B;PPM1D;PTEN;CBFB;LEF1;MECP2;MED31;MED27;RELA;MED26
gsea,regulation of vesicle-mediated transport (GO:0060627),0.4168543395462186,1.5134632313865675,0.024242424242424242,0.10201429376140381,0.999,16/37,38.09%,RAB11B;PTPRC;PTPN1;RAB10;MAPK1;RAB11A;CD22;ATP9A;MAPK3;CPLANE2;SRC;ARFGAP1;RAB21;SNX12;RAB5A;ABL2
gsea,RNA 3'-end processing (GO:0031123),0.48239023884797,1.5131491626785232,0.03913894324853229,0.10148485495386513,0.999,14/22,21.14%,TUT4;CHTOP;FIP1L1;CPSF7;U2AF1L4;POLDIP3;WDR33;RPRD2;PABPN1;TUT7;LIN28B;TENT2;ZC3H11A;SLU7
gsea,gland development (GO:0048732),0.5259175892471868,1.5128918929847337,0.04911591355599214,0.10091736492729725,0.999,5/15,11.57%,ARID5B;TGFBR1;SOD1;CEBPG;SLC9A3R1
gsea,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5232019505174133,-1.5120296794121768,0.047325102880658436,0.07788085826913994,0.997,4/16,15.90%,CDC42;GRB2;DOK1;MVB12A
gsea,cellular amide metabolic process (GO:0043603),-0.43941608705422414,-1.5087700905201027,0.041584158415841586,0.07932051352276757,0.998,18/28,42.12%,PLAAT3;PPP2R1A;ACOT2;ACOT13;ORMDL1;ORMDL2;SLC5A6;ACOT8;PLA2G15;ACOT6;MTHFS;SLC46A1;NAPEPLD;PCCB;ACOT7;SMPD2;MME;ACOT9
gsea,negative regulation of growth (GO:0045926),0.4266660035359827,1.508483626520251,0.03536345776031434,0.10317842581017916,0.999,11/33,17.30%,BTG1;CDKN1B;STK11;VGLL4;TGFB1;SERTAD3;CAPRIN2;CDKN2AIP;NDRG3;NAIF1;SMAD4
gsea,negative regulation of developmental process (GO:0051093),0.5461965491024914,1.5067850697372367,0.03914590747330961,0.10354175067403561,0.999,2/15,2.93%,FOXM1;TGFB1
gsea,snRNA transcription by RNA polymerase II (GO:0042795),-0.48197302712571305,-1.506750203016568,0.04500978473581213,0.07976296154013024,0.998,10/22,23.34%,SNAPC5;POLR2K;POLR2G;PHAX;POLR2J;POLR2D;TAF13;SNAPC1;POLR2I;GTF2B
gsea,snRNA transcription (GO:0009301),-0.48197302712571305,-1.506750203016568,0.04500978473581213,0.07976296154013024,0.998,10/22,23.34%,SNAPC5;POLR2K;POLR2G;PHAX;POLR2J;POLR2D;TAF13;SNAPC1;POLR2I;GTF2B
gsea,regulation of intracellular signal transduction (GO:1902531),0.3282694461253904,1.505589109831416,0.009823182711198428,0.1035510002051059,0.999,72/137,32.17%,ARHGAP15;GNA13;ARHGEF1;ING2;ARHGAP45;ANKRD54;STK4;STK11;AKAP13;PAK2;ARHGAP33;VRK2;CDK5;MEAF6;PIP4K2A;MAPK1;PTEN;PPP1R16B;EP300;PRKAR1A;FAM13B;KAT5;ARHGAP17;ARHGAP4;CYLD;CAPN3;ARHGAP18;DLG1;MAPK14;RALBP1;PTPN22;NOP53;ATRIP;PRKAG1;TAF4;XIAP;PPP1R13B;RHOG;CSNK2A1;MAPKAP1;MAPK11;RHOH;ZFAND6;PIP4P1;PDE2A;ARAF;OCRL;RMI1;MOB3B;PRKAB2;TRIO;RHOT1;TAF11;TRAF6;RELA;PPP2R5C;GMIP;ATP6AP2;PIP5K1A;TTC5;MAPK3;ARHGAP29;CASTOR2;TAF7;TAOK3;STARD8;FGD1;CRK;RFFL;FGD4;STARD13;RASGRF2
gsea,positive regulation of response to external stimulus (GO:0032103),-0.42087285190994506,-1.5046655432770315,0.036613272311212815,0.08041251033627762,0.998,11/31,31.93%,CYBA;IFI35;GPSM3;NMI;DDT;P2RY12;THBD;SETD4;TRADD;LY96;NAPEPLD
gsea,protein targeting to ER (GO:0045047),-0.5653430321761445,-1.5035862945769418,0.1315240083507307,0.08070794954910643,0.998,26/63,11.30%,RPS6;SEC61G;RPL28;RPL35;SRP19;RPL27;RPL32;SRP9;RPL37;RPL11;SRP14;SPCS2;RPS19;RPL38;SPCS1;RPL6;RPL12;RPL24;CHMP4B;RPL36A;RPL26;RPS13;SGTA;RPL39;RPS11;RPS7
gsea,iron ion homeostasis (GO:0055072),-0.4715406997615368,-1.5027354556697032,0.04950495049504951,0.08080291605969167,0.998,10/19,32.38%,FTH1;NEDD8;B2M;ATP6V1A;ATP6V0D1;BOLA2;IREB2;FBXL5;SLC46A1;ISCU
gsea,membrane lipid biosynthetic process (GO:0046467),-0.49428828003702896,-1.501839452245974,0.045275590551181105,0.08089721613862372,0.998,7/18,25.51%,DEGS1;CERS2;VAPB;CERS4;VAPA;ELOVL1;SPNS2
gsea,negative regulation of inflammatory response (GO:0050728),-0.3896839586545542,-1.500342591311832,0.024875621890547265,0.08134546539260064,0.998,18/46,30.72%,GSTP1;CD3G;GNG2;GNB1;RPS19;PRKACA;GPR150;GPR176;ADCY3;GBA;OTULIN;GGT1;GPR45;ADCY9;ADCY7;HTR6;TYRO3;POMC
gsea,axonogenesis (GO:0007409),0.3859552836599945,1.500119130594414,0.02486678507992895,0.10661995957950636,0.999,28/56,29.87%,FYN;PRKCQ;RAB10;NPTN;LYPLA2;CDK5;MAPK1;PTEN;PTPRA;RANBP9;SPTB;SPTBN2;SEMA4F;EFNB1;B4GALT6;NTNG2;GAB2;SLC9A6;RAP1GAP;MAPK3;ANK3;BRSK2;NLGN3;EPHB6;SEMA6C;PTK2;SPTBN4;SRC
gsea,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3671721786900766,-1.4995841323724945,0.021235521235521235,0.081354327938563,0.998,20/61,29.16%,S100A13;LITAF;TFG;NDFIP2;UBE2V1;FKBP1A;LAMTOR5;RHOA;LGALS9;TRIM13;CFLAR;TMEM9B;TRIM32;TICAM1;CASP8;VAPA;MYD88;GOLT1B;TRIM62;TRADD
gsea,regulation of ATP metabolic process (GO:1903578),-0.518305006057174,-1.4987381622464375,0.056,0.08145877354695717,0.998,4/15,10.79%,UQCC2;COX7A2;SEC13;FIS1
gsea,cellular metal ion homeostasis (GO:0006875),0.4644158227615655,1.498561987757382,0.03544776119402985,0.10704468177922709,0.999,12/23,32.12%,TPT1;ATP2B1;NPTN;STIM1;SLC10A7;LETM2;NEDD4L;SLC24A1;ATP2C1;SLC24A3;ATP2A1;ATP4A
gsea,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.5127308106883973,1.4966738139754863,0.06346153846153846,0.10740275636887486,0.999,8/15,28.78%,CDKN1B;CNOT6L;EP300;CNOT4;SOX4;CRADD;CNOT2;CNOT6
gsea,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.4678760267407538,-1.4959772893267167,0.04771784232365145,0.08265860341180313,0.998,11/21,37.69%,COPS9;RPL11;SVBP;CTNNB1;ARRB2;VPS28;SIRT7;PER2;RPS3;MINAR1;HDAC8
gsea,cellular response to peptide (GO:1901653),0.5007306580015706,1.4946422687263543,0.045207956600361664,0.10814912423376809,0.999,6/18,17.89%,FYN;GSK3B;CDK5;PTPN22;LRP1;IGF1R
gsea,regulation of MAPK cascade (GO:0043408),0.4232166991007448,1.494592352255106,0.046,0.1074092354526153,0.999,16/34,28.25%,HMGB1;PTPRC;STK4;PAK2;VRK2;MAPK1;LAMTOR1;TRAF7;STYX;INSR;IGF1R;ATP6AP2;MAPK3;TAOK3;NBR1;IL11
gsea,positive regulation of protein ubiquitination (GO:0031398),-0.425552205680343,-1.4943838894000565,0.059548254620123205,0.08313345366410149,0.998,15/33,22.90%,RBX1;NDFIP2;UBE2L3;DCUN1D5;NSMCE3;PDCD6;FKBP1A;UBE2D1;COMMD1;FBXO4;CDK5RAP3;DERL1;PSMD10;AMER1;UBE3A
gsea,DNA replication (GO:0006260),0.5007545478975999,1.4942043057805772,0.052845528455284556,0.10696528133434492,0.999,11/16,34.64%,POLD4;KAT5;ATRIP;PNKP;RMI1;PTMS;RBMS1;KIN;ING4;POLB;RAD9B
gsea,defense response to bacterium (GO:0042742),-0.4667987433559515,-1.4936473007921618,0.039301310043668124,0.08321349802844616,0.999,6/21,12.32%,PYCARD;ROMO1;RPS19;RPL39;RAB1A;PPP1R11
gsea,regulation of defense response (GO:0031347),0.4749677438013272,1.4932005765395373,0.04664179104477612,0.1069501373173187,0.999,13/21,30.50%,FOXP1;BRD4;CYLD;PTPN22;SHPK;XIAP;BCL6B;RELA;NR1D2;MGLL;TIRAP;N4BP1;APPL1
gsea,inorganic cation transmembrane transport (GO:0098662),-0.35688246649251937,-1.4920737552026753,0.022556390977443608,0.08376037825500261,0.999,32/64,40.67%,FKBP1A;ITGAV;TMEM165;ATP6V1F;UCP2;TMCO1;ATP6V1A;KCNA4;ATP6V1H;UCP3;PKD2;TRPM4;ATP6V0D1;KCNK3;KCNK12;KCNK6;ATP1B3;SLC36A1;SLC30A5;KCNA7;SLC4A11;RHD;KCNC3;TMEM175;HPN;SLC46A1;MCOLN3;SLC36A3;NNT;KCNH1;KCNB1;KCNAB3
gsea,positive regulation of protein localization to membrane (GO:1905477),-0.41242653277345437,-1.491450285557231,0.0423728813559322,0.0837693638780833,0.999,9/34,12.90%,YWHAZ;PDCD5;ITGB2;ITGB1BP1;CIB1;BAD;YWHAH;FIS1;MIEF2
gsea,cellular transition metal ion homeostasis (GO:0046916),-0.4239062153571514,-1.4903240758853158,0.034482758620689655,0.08404659013167397,0.999,14/28,32.38%,FTH1;ARF1;NEDD8;ATOX1;ATP6V1A;SLC31A2;ATP6V0D1;BOLA2;SLC30A5;SLC30A9;IREB2;FBXL5;SLC46A1;ISCU
gsea,cellular response to BMP stimulus (GO:0071773),0.5247593813318491,1.4894486953623054,0.0450281425891182,0.10801252401622428,0.999,6/15,31.64%,DDX5;TGFB1;SMAD4;MAPK3;SMURF1;ACVR2A
gsea,BMP signaling pathway (GO:0030509),0.5247593813318491,1.4894486953623054,0.0450281425891182,0.10801252401622428,0.999,6/15,31.64%,DDX5;TGFB1;SMAD4;MAPK3;SMURF1;ACVR2A
gsea,inflammatory response (GO:0006954),-0.4017016208029438,-1.4880049725033095,0.036637931034482756,0.08475910200826746,0.999,14/39,42.35%,CYBA;RAC1;ITGB2;PRDX5;LAT;LGALS9;TAC4;CD96;F11R;XCR1;HYAL1;PLA2G4C;IKBKB;PTGER3
gsea,regulation of macromolecule metabolic process (GO:0060255),0.40097358173686704,1.485865697101361,0.0297951582867784,0.10955711694183176,0.999,17/42,31.38%,HIF1A;PTPRC;FOXP1;PCBP2;NKAP;AFF4;CGGBP1;LAMTOR1;MKLN1;ZUP1;RFXANK;TRIM68;PCBP3;SORT1;POGZ;MTMR9;NKAPL
gsea,mRNA catabolic process (GO:0006402),-0.49600306613560785,-1.4847524464285025,0.07291666666666667,0.08624511642459241,0.999,6/17,14.41%,RNH1;LSM5;LSM6;NUDT16L1;DCP2;YTHDF2
gsea,protein tetramerization (GO:0051262),-0.4984376229143485,-1.4844780803722888,0.055441478439425054,0.08613178991949526,0.999,7/16,16.20%,SSBP1;B2M;ACOT13;PKD2;USP16;TRPM4;CUTC
gsea,sensory perception of light stimulus (GO:0050953),-0.43555628271284696,-1.4822802068837884,0.0405982905982906,0.08704441281218081,0.999,10/26,30.21%,UNC119;PITPNA;DNAJC19;EML2;DRAM2;RDH10;RD3;CABP4;CABP1;BEST1
gsea,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4091745092865675,1.4821887156184135,0.047186932849364795,0.11157505768976629,0.999,14/37,22.06%,ING2;STK11;TGFB1;EP300;TGFBR1;UBC;RNF111;CD109;SMAD4;LDLRAD4;IL17RD;DAND5;ZEB2;HTRA4
gsea,positive regulation of inflammatory response (GO:0050729),-0.4891871053783415,-1.479265127549142,0.049484536082474224,0.0882984971368703,0.999,9/16,31.93%,RPS19;IFI35;GPSM3;NMI;DDT;SNX4;SETD4;TRADD;NAPEPLD
gsea,regulation of inflammatory response (GO:0050727),0.3899445421093653,1.4772640978492635,0.041970802919708027,0.11408259465613768,0.999,19/45,26.59%,FOXP1;GPS2;BRD4;ETS1;IL18;PTPN2;TNFRSF1B;CYLD;PRKCD;SHPK;XIAP;FNDC4;BCL6B;PDE2A;RELA;SHARPIN;NR1D2;MGLL;CEBPA
gsea,stress-activated MAPK cascade (GO:0051403),0.42361599772196373,1.4756616787142476,0.046065259117082535,0.114338599272075,0.999,16/29,32.25%,GPS2;MAPK1;CCM2;UBC;MAP4K2;TAB2;MAPK14;MAPK11;MAP2K7;CRKL;TRAF6;MAPK3;IRAK2;MAP2K4;IRAK1;FBXW11
gsea,transcription by RNA polymerase II (GO:0006366),0.3324020904515527,1.4754049899302644,0.010948905109489052,0.11377013211888327,0.999,55/103,40.83%,NR4A1;NR4A3;NCOR1;NR2C2;DDX5;IRF9;MED18;KLF13;AFF4;SOX5;RTF1;FIP1L1;PAF1;GTF2A2;CPSF7;RNGTT;MAML1;CBFB;NR1H2;WDR33;RXRB;RPRD2;TAF4;NABP2;PABPN1;TAF8;MED27;CCNT1;NR6A1;TAF11;ELL3;RBPJ;MED26;NR1D2;CCNT2;INTS12;ESR1;NRBP1;TSC22D1;TAF7;NR4A2;RREB1;NR1D1;TAF1C;CDK13;TEAD1;SNAPC3;NUDT21;SNAPC2;NR2C1;NELFA;TAF12;TEAD2;TAF5L;TRIP11
gsea,negative regulation of protein kinase activity (GO:0006469),-0.4203685584584058,-1.47531266499882,0.039832285115303984,0.09003670368038465,0.999,13/31,36.17%,THY1;PYCARD;GSTP1;RTRAF;ITGB1BP1;CDK5RAP3;GSKIP;CDKN1C;EPHA1;DBNDD1;TRIM27;DTNBP1;LRP5
gsea,regulation of macroautophagy (GO:0016241),-0.3769976624738043,-1.4749194623056279,0.023060796645702306,0.08992060597428563,0.999,27/52,39.71%,LAMTOR4;RRAGA;LAMTOR2;LAMTOR5;TRIM13;CAPNS1;ATP6V1A;RRAGC;ATP6V1G2;ATP6V1H;VPS26B;SH3GLB1;PRKACA;LAMTOR3;ATP6V0D1;GBA;BNIP3L;VPS26A;ATP6V1E1;EXOC1;QSOX1;PAFAH1B2;ATP6V1B2;EPM2A;SNX6;ATP6V0B;UBQLN2
gsea,protein K63-linked ubiquitination (GO:0070534),0.49470072278278143,1.471817793278852,0.0658682634730539,0.11562059525834789,0.999,10/16,19.74%,UBE2B;ITCH;PELI1;HECTD1;WWP2;RNF115;ARIH2;UBE2G1;RNF4;TRAF6
gsea,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.4829033535980903,-1.4712331900266507,0.0728744939271255,0.09152998952663657,0.999,9/19,15.90%,CHMP2A;VTA1;CHMP4B;CHMP5;CHMP2B;LEPROT;CHMP1B;TMEM50A;MVB12A
gsea,double-strand break repair via homologous recombination (GO:0000724),0.4441646822643641,1.4693242051089703,0.044921875,0.11682769552858165,0.999,9/24,16.12%,RAD21;RAD51B;RNF138;NIPBL;XRCC3;NSMCE2;NABP2;AP5S1;RMI1
gsea,epithelial cell differentiation (GO:0030855),-0.48884657777981333,-1.4677172135955334,0.055793991416309016,0.093116353304382,0.999,6/16,24.50%,EDF1;CTSB;CASP6;ZDHHC7;ACADVL;JAG1
gsea,mRNA metabolic process (GO:0016071),-0.4447776068148126,-1.4670008740303304,0.06896551724137931,0.0931642549006022,0.999,14/25,25.62%,RNH1;LSM5;LSM6;NUDT16L1;DCP2;SNRPG;SRSF11;AURKAIP1;LSM10;PRKACA;YTHDF2;PRMT9;SRSF5;RNASE4
gsea,cellular protein modification process (GO:0006464),-0.28440741516474,-1.4650600844427268,0.0,0.09385224789369924,0.999,147/349,46.78%,PSMB8;PSMB3;ELOB;PSMA2;PSMA7;PSMB10;YWHAZ;CD3G;PPP1CA;GMFG;PSMA1;NEDD8;DAD1;UBL5;PSME1;PSMB1;PPP2R1A;RBX1;PSMB4;PSMD8;UBE2L3;PTPN18;FBXO22;UBE2E1;FBXO6;NUCB1;PGGT1B;ILK;UBE2F;UGCG;MAN2B1;CSK;PNPLA2;PHPT1;COPS8;ARF4;ALG5;RAB3A;STK26;PSMB9;KBTBD13;PIGS;APLP2;COMMD1;RAB1A;RUNX3;SUMF1;FUCA2;PPP2R2A;FBXO4;WSB2;ATG3;PSMD13;PRKACA;PRPF4B;APOA2;KCTD6;GGCX;FBXO17;PIGT;DNAJC3;PSMF1;TGFBR2;PSMD10;UBE2D3;JMJD4;KBTBD8;DUSP9;FBXO9;RAB8A;RAB1B;PTPN14;PTPRR;ASB6;OBSL1;FGF23;FNIP2;SDHAF2;PSMD4;TMEM132A;MAPK9;ASB8;PDF;B3GALT1;STRADB;SIRT7;MAP2K1;MANBA;UBE2I;PMM2;MBTPS1;NTRK1;KLHL2;TSSK6;FBXO7;NEK3;FER;COPS6;FBXL5;CUL2;ASB5;QSOX1;MAP4K5;LIPT1;MSRA;PP2D1;PRAG1;RPS6KA4;MAP3K9;ENGASE;FBXL2;STK24;PTP4A2;CDC42BPB;MACROD2;CUL9;SETD3;PDP2;CDKL5;LIPE;FBXO41;BMPR2;WFS1;PTPRU;ILKAP;PARP16;ASB13;IKBKB;CHML;LTK;DAPP1;STK36;CDK9;CDC42BPG;PRKACB;RNF7;RCE1;MXRA8;B3GNT9;PSMD5;PPM1E;PSMD9;PRKAB1;FBXL22;MTMR2;LCMT1;CSNK1A1
gsea,RNA splicing (GO:0008380),-0.4353198599198411,-1.4649528468182833,0.04809619238476954,0.09361919266399632,0.999,14/31,18.24%,PPP2R1A;LSM4;LSM6;SNRPD2;SNRPG;SRSF11;RNPC3;ZCRB1;USB1;RRAGC;RP9;PRPF4B;BCAS2;ZMAT5
gsea,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.4708215454341006,-1.4648240356955953,0.056016597510373446,0.09340804780821527,0.999,8/19,10.79%,PYCARD;NDUFA13;PDCD5;PDCD6;ARL6IP5;BAD;BCAP31;FIS1
gsea,protein modification process (GO:0036211),-0.41718787154272985,-1.4638822021484654,0.029013539651837523,0.0936657695089525,0.999,13/31,34.40%,NEDD8;UBL5;UBE2L3;FBXO22;MAN2B1;ATG3;GGCX;UBE2D3;MANBA;UBE2I;LIPT1;MSRA;FBXL2
gsea,glycosaminoglycan catabolic process (GO:0006027),0.4921312080025365,1.4637636204824134,0.06415094339622641,0.12010391101102316,0.999,7/16,26.53%,TGFB1;CHP1;OMD;OGN;AGRN;IDS;HEXB
gsea,regulation of interleukin-6 production (GO:0032675),-0.4642865068655877,-1.46237426558653,0.047325102880658436,0.0941892565747881,0.999,8/20,26.97%,CYBA;PYCARD;LGALS9;GBA;MYD88;NCKAP1L;AGER;SETD4
gsea,response to tumor necrosis factor (GO:0034612),-0.44840221995685164,-1.460239843121802,0.05496828752642706,0.09510114456952627,0.999,7/23,21.71%,PYCARD;ASAH1;CIB1;TRIM32;GBA;CASP8;GGT1
gsea,cellular response to lipid (GO:0071396),-0.38504942011954507,-1.4601636326799758,0.03861788617886179,0.09483963871411348,0.999,15/42,31.57%,PYCARD;GSTP1;NDUFA13;TWF2;UBE2L3;CHMP5;RHOA;TICAM1;ADCY3;SNW1;STAP1;FAM210B;MYD88;NR3C1;LY96
gsea,post-Golgi vesicle-mediated transport (GO:0006892),-0.3790789940550668,-1.4590453943334156,0.05019305019305019,0.09518979436986419,0.999,20/45,26.43%,FTH1;ARF1;GOLGA7;CHMP2A;AP1S1;SNAP23;RABIF;COMMD1;VAMP2;ARL3;BLOC1S1;AP1S3;BLOC1S3;GOPC;SCFD1;CCDC93;AP4S1;RABEP1;NAPA;CLTA
gsea,positive regulation of cellular protein metabolic process (GO:0032270),0.4101861220455923,1.4584178034355393,0.05714285714285714,0.12327300359215253,0.999,16/36,16.42%,CD28;CIRBP;CYFIP2;PCIF1;VGLL4;TGFB1;TBC1D10A;ASPSCR1;POLDIP3;NR1H2;CAPN3;PTTG1IP;OGT;IST1;YTHDF1;SOX4
gsea,heart development (GO:0007507),0.3987173519221651,1.4580620290930482,0.03868471953578337,0.12278861361252218,0.999,18/39,27.44%,CDKN1B;NIPBL;MEF2D;TGFB1;AKAP13;PTEN;TGFBR1;TCF25;TAB2;POU6F1;SOX4;INSR;DAND5;MESP2;PKD1;CXADR;PTK2;MEF2A
gsea,histone acetylation (GO:0016573),0.44982217651436834,1.4543708709529204,0.06903353057199212,0.12484069009810846,0.999,14/23,33.42%,PHF20L1;ATF2;MEAF6;EP300;KAT5;BRD1;LEF1;ING3;NAA60;MRGBP;EPC1;YEATS4;MSL3;ING4
gsea,regulation of signal transduction by p53 class mediator (GO:1901796),0.37629349913298477,1.4535108209792573,0.0412573673870334,0.12466918911618029,0.999,23/42,24.92%,ING2;STK11;CDK5;MEAF6;PIP4K2A;EP300;KAT5;MAPK14;NOP53;ATRIP;PRKAG1;TAF4;PPP1R13B;CSNK2A1;MAPKAP1;MAPK11;PIP4P1;RMI1;PRKAB2;TAF11;PPP2R5C;TTC5;TAF7
gsea,cellular response to starvation (GO:0009267),-0.3655218127600382,-1.4518546216101376,0.04602510460251046,0.09887791233414094,0.999,29/59,44.11%,LAMTOR4;SEC13;RRAGA;LAMTOR2;LAMTOR5;MAP1LC3B;STK26;ATP6V1F;BECN1;ATP6V1A;RRAGC;ATP6V1G2;ATP6V1H;SH3GLB1;LAMTOR3;ATP6V0D1;KPTN;LAMP2;ATP6V1E1;STK24;ATP6V1B2;BMPR2;GABARAPL2;ATP6V0B;BMT2;SREBF1;GABARAPL1;MAP1LC3A;CPEB4
gsea,mRNA export from nucleus (GO:0006406),0.4486849620316162,1.4517425230065866,0.08519269776876268,0.12524545414421173,0.999,13/22,21.14%,YTHDC1;NUP50;AGFG1;CHTOP;FIP1L1;SMG5;U2AF1L4;POLDIP3;WDR33;PABPN1;SMG1;ZC3H11A;SLU7
gsea,positive regulation of intracellular transport (GO:0032388),-0.48159333762979306,-1.4515188734250206,0.06041666666666667,0.0987304895063594,0.999,9/17,30.13%,OAZ1;PDCD10;EHD1;VAMP2;TBC1D20;ZFAND1;OAZ2;B3GAT3;TPR
gsea,positive regulation of cell population proliferation (GO:0008284),0.3197708638756749,1.4493443448793841,0.01773049645390071,0.12625708962521487,0.999,46/102,32.49%,FOXM1;EZH2;NR4A3;PTPRC;FOXP1;TOX;KRAS;TGFB1;IL18;CNOT6L;CHTOP;PTEN;SRPK2;TGFBR1;GID8;RTKN2;LEF1;RPS15A;MECP2;AKT2;KDM1A;CNTF;SERTAD1;RHOG;CSNK2A1;HMGA2;ADAM10;CRKL;VIPR1;SOX4;MEIS3;INSR;PRKCH;IGF1R;TBX6;CEP131;RBPJ;RELA;GAB2;TERT;KDM4C;PTK2;IL11;CNOT6;CAPN1;CDK13
gsea,Notch signaling pathway (GO:0007219),0.46156012747521913,1.448259908290045,0.05825242718446602,0.12631900217035508,0.999,10/20,26.82%,DTX3;ITCH;EP300;TRAF7;MAML1;ADAM10;RBPJ;DTX2;NCSTN;PSENEN
gsea,negative regulation of autophagy (GO:0010507),0.5057436926587942,1.4478099767523978,0.05172413793103448,0.12588600917644074,0.999,6/17,12.61%,MCL1;STAT3;TAB2;PTPN22;BMF;SMG1
gsea,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4681630101261275,1.4477879796638964,0.06534653465346535,0.12512782297703667,0.999,11/19,29.38%,BCL10;RNF31;UBC;TAB2;RBCK1;NFKBIL1;TRAF6;RELA;SHARPIN;IRAK2;TBK1
gsea,protein autoubiquitination (GO:0051865),0.4238762743953506,1.4467918502743589,0.06288032454361055,0.12514859390763888,0.999,12/28,23.71%,RNF181;UBE2B;UHRF2;ITCH;WWP2;RNF115;CNOT4;TRIM68;RNF4;RNF13;TRAF6;RNF185
gsea,regulation of small GTPase mediated signal transduction (GO:0051056),0.37988612013267675,1.445353928194471,0.04562043795620438,0.12539766702014846,0.999,26/53,33.73%,FOXM1;ARHGAP15;GNA13;ARHGEF1;ARHGAP45;AKAP13;ARHGAP33;FAM13B;ARHGAP17;ARHGAP4;ARHGAP18;RALBP1;RHOG;RHOH;OCRL;TRIO;RHOT1;GMIP;ARHGAP29;STARD8;FGD1;SRC;FGD4;STARD13;RASGRF2;FLCN
gsea,positive regulation of multicellular organismal process (GO:0051240),0.34322676856205236,1.4441541829831879,0.02185792349726776,0.12565299332181848,0.999,37/76,42.63%,EZH2;CD28;NR2C2;HMCES;TGFB1;IL18;ITK;TAPT1;SOX5;TGFBR1;SOD1;LEF1;APC;RFX3;SORL1;KDM1A;OGT;INPP5K;LRP1;PRKAB2;PRKCH;SMAD4;IGF1R;FOXJ1;SMO;TERT;RREB1;ACVR1B;SCAMP5;LURAP1;AVPR2;FOXC1;BMPR1A;IL15;MDK;HDAC3;ADIPOR2
gsea,positive regulation of mitochondrion organization (GO:0010822),-0.4851501981566722,-1.4425276945265926,0.07520325203252033,0.10377117000235311,0.999,5/16,12.90%,PYCARD;PDCD5;BAD;FIS1;MIEF2
gsea,nervous system development (GO:0007399),-0.3178648461382265,-1.4423219601535173,0.006880733944954129,0.1035774971399259,0.999,41/100,49.69%,COX7B;UNC119;GSTP1;ITM2B;MTF1;DBNL;NDUFV2;ATXN10;MAB21L2;NDUFS2;UNC119B;VAX2;PKD2;PTS;DAGLB;NINJ2;SEMA6B;OBSL1;JAG1;ERBB3;JRKL;RAPGEFL1;FZD9;TYRO3;CSPG5;MAP1S;POU3F1;ZIC5;FAT4;GLIS2;GJB1;DAGLA;TMOD2;DOC2A;NBL1;NRTN;DLG4;GRHL2;NRXN2;FEZ2;TAGLN3
gsea,positive regulation of cellular metabolic process (GO:0031325),-0.4247500893571206,-1.439295462142428,0.05458089668615984,0.10505184616887435,0.999,12/26,22.02%,ROMO1;CHCHD2;GHITM;GRB2;ARRB2;RAB1A;DHRS4;APOA2;TGFBR2;MAGI2;RAB1B;ATAD1
gsea,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.4080177759267745,-1.4391142682233933,0.054502369668246446,0.1045031138928119,0.999,13/30,30.72%,CD3G;GNG2;GNB1;PRKACA;GPR150;GPR176;ADCY3;GGT1;GPR45;ADCY9;ADCY7;HTR6;POMC
gsea,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.4080177759267745,-1.4391142682233933,0.054502369668246446,0.1045031138928119,0.999,13/30,30.72%,CD3G;GNG2;GNB1;PRKACA;GPR150;GPR176;ADCY3;GGT1;GPR45;ADCY9;ADCY7;HTR6;POMC
gsea,positive regulation of T cell proliferation (GO:0042102),0.4786718577180429,1.4390539344597701,0.06570841889117043,0.12884988327321953,1.0,5/17,15.94%,HMGB1;PTPRC;CD28;IL18;JAK3
gsea,positive regulation of protein-containing complex assembly (GO:0031334),0.4381642555094775,1.4387086185497036,0.056862745098039215,0.1283440022395968,1.0,10/25,33.16%,SKAP1;TERF1;TGFB1;GSK3B;BMF;ESR1;TIRAP;SRC;TTBK1;XPA
gsea,regulation of autophagy (GO:0010506),0.33483880173088215,1.4383365818159453,0.021696252465483234,0.12793065707034257,1.0,44/92,38.62%,HMGB1;MCL1;STK11;GSK3B;CDK5;PIP4K2A;ATP6V1D;GSK3A;EP300;LAMTOR1;TMEM59;KAT5;FOXO1;ATG101;STAT3;RB1CC1;TAB2;PTPN22;ATP6V1G1;PRKAG1;BMF;TRIM68;DAPK3;EXOC7;RHEB;ATP6V0C;PSAP;PRKAB2;NPRL2;FZD5;ATG13;TPCN1;SNX32;ATP6V0A1;RRAGD;MTMR9;CAPN1;CISD2;ORMDL3;FLCN;PIP4K2C;FOXK1;ABL2;ATP6V1C1
gsea,regulation of viral transcription (GO:0046782),-0.49087768430915435,-1.437426105108648,0.08102766798418973,0.10531123451004522,0.999,9/16,27.24%,POLR2K;POLR2G;TRIM13;POLR2J;POLR2D;TRIM32;TRIM11;POLR2I;TRIM62
gsea,RNA processing (GO:0006396),-0.366548788070918,-1.435505064175624,0.027139874739039668,0.10607141411553207,0.999,22/59,22.19%,RBM3;PPP2R1A;LSM5;LSM4;LSM6;SNRPD2;SNRPG;SRSF11;RNPC3;ZCRB1;HNRNPL;USB1;AURKAIP1;RRAGC;CLP1;PRKACA;RP9;PRPF4B;BCAS2;ZMAT5;PRMT9;SRSF5
gsea,ncRNA processing (GO:0034470),-0.497789662705794,-1.4354293648513128,0.14225053078556263,0.10578088409861808,0.999,20/59,11.30%,RPS6;RPL28;RPL35;RPL27;RPL32;RPL37;RPL11;C1D;RPS19;RPL38;RPP21;RPL6;RPL12;RPL24;IMP3;RPL36A;RPL26;RPL39;POP7;RPS7
gsea,sphingolipid biosynthetic process (GO:0030148),-0.4372024740293331,-1.4331361193789398,0.054878048780487805,0.10687214885773559,0.999,9/24,25.51%,DEGS1;ASAH1;CERS2;VAPB;GBA;CERS4;VAPA;ELOVL1;SPNS2
gsea,regulation of phosphorylation (GO:0042325),0.3960803477210451,1.427564186386332,0.04990403071017274,0.13568329868709203,1.0,13/36,27.21%,CDKN1B;HIF1A;NUP50;BCL10;NLRC5;EP300;NOP53;PRKAG1;OGT;TESK1;GCK;BTBD10;PTK2
gsea,regulation of gene silencing by miRNA (GO:0060964),-0.4892445711399177,-1.42702579473041,0.09163346613545817,0.11012848628874235,1.0,6/17,11.24%,SEC13;POLR2K;POLR2G;POLR2J;POLR2D;ELAVL1
gsea,carbohydrate homeostasis (GO:0033500),-0.4430341329082894,-1.4247504472091754,0.053497942386831275,0.11114957534023413,1.0,5/22,17.37%,RPS6;CYB5R4;SELENOT;BAD;SLC8B1
gsea,positive regulation of cellular biosynthetic process (GO:0031328),0.37158855402719443,1.4222609604636154,0.04331450094161959,0.13891695723333097,1.0,24/47,34.09%,HIF1A;CD28;KLF2;CIRBP;PCIF1;CHP1;CNEP1R1;PTPN2;POLDIP3;NR1H2;EGR1;AKT2;YTHDF1;SOX4;GCK;INSR;ELOVL5;ZEB2;STAR;RPS6KB1;APPL1;NR1D1;UPF3A;GPLD1
gsea,regulation of apoptotic signaling pathway (GO:2001233),-0.48170749796947665,-1.419961762510788,0.0736196319018405,0.11402330873984691,1.0,7/16,36.40%,PYCARD;TMBIM6;STYXL1;BCL2L12;BCL2L14;RPS3;TPD52L1
gsea,regulation of endothelial cell migration (GO:0010594),-0.46413768374053915,-1.4183025042819943,0.0855397148676171,0.11472758176634168,1.0,6/18,22.41%,RAC1;ITGB1BP1;PDCD6;SVBP;RRAS;SYNJ2BP
gsea,negative regulation of cold-induced thermogenesis (GO:0120163),0.502164073527143,1.4179945496279658,0.09737827715355805,0.14136125436578234,1.0,10/16,33.73%,STK11;IP6K1;LNPEP;NR1H2;RHEB;RBPJ;PLCL2;LGR4;NR1D1;FLCN
gsea,rRNA processing (GO:0006364),-0.5215114715405663,-1.4163803606650642,0.1875,0.11551535837785543,1.0,21/52,15.24%,RPS6;RPL28;RPL35;RPL27;RPL32;RPL37;RPL11;C1D;RPS19;RPL38;RPL6;RPL12;RPL24;IMP3;LSM6;RPL36A;RPL26;RPL39;RPS7;RIOK1;NSA2
gsea,fat cell differentiation (GO:0045444),0.4522449090225908,1.4154601753787583,0.07581967213114754,0.14245623710239808,1.0,14/22,28.25%,NR4A1;NR4A3;OSBPL11;EP300;SENP2;OSBPL8;FOXO1;AKT2;HMGA2;BBS2;CTBP1;NR4A2;CEBPA;IL11
gsea,regulation of ion transport (GO:0043269),0.4595115703668192,1.4138218140325922,0.08123791102514506,0.1430123738826877,1.0,9/19,34.32%,RAB11B;SIK1;WWP2;TOR1A;ANK3;NEDD4L;SPTBN4;PXK;VAMP3
gsea,regulation of cell growth (GO:0001558),-0.3531612806798664,-1.411912439461972,0.05533596837944664,0.11795382500118737,1.0,23/55,38.12%,CDC42;RPS6KA1;NDUFA13;PPP2R1A;MTPN;DCUN1D5;LAMTOR2;RTN4;CIB1;NDUFS3;CCDC85B;TAF9B;TRIM32;MAD2L2;PSMD10;SDCBP;HPN;EGLN2;SERTAD2;HYAL1;CRLF3;MINAR1;BMPR2
gsea,positive regulation of cell death (GO:0010942),0.5004807779192961,1.40866934128402,0.09038461538461538,0.14625706786541265,1.0,6/15,13.23%,CDKN1B;FYN;GSK3B;APC;EGR1;LRP1
gsea,recombinational repair (GO:0000725),-0.4479132158239222,-1.4078531502675697,0.08348794063079777,0.12030542387991877,1.0,7/20,32.02%,SEM1;SWI5;MORF4L1;SFR1;SWSAP1;HUS1B;AP5Z1
gsea,response to reactive oxygen species (GO:0000302),-0.4276086825044634,-1.4075051819387019,0.06423982869379015,0.12016514289281452,1.0,16/24,35.22%,GSTP1;ROMO1;PRDX5;CAT;PDCD10;MPV17;STK26;PKD2;GLRX2;MAPK9;PXN;FER;MAPT;RPS3;STK24;HYAL1
gsea,cell cycle G2/M phase transition (GO:0044839),0.3947153058643629,1.4071587241159143,0.07198443579766536,0.14662339510628133,1.0,18/36,32.25%,FOXM1;PPP1R12A;SSNA1;PAFAH1B1;DNM2;MAPRE1;AKAP9;ENSA;AKAP8L;CSNK1D;FBXL17;CEP131;PPP1R12B;FBXL3;BRSK2;FBXL6;CEP63;FBXW11
gsea,positive regulation of cellular amide metabolic process (GO:0034250),0.43254966775836484,1.4056143230848068,0.0835030549898167,0.1471072579132246,1.0,11/24,20.18%,IFNGR1;CD28;CIRBP;PCIF1;GSK3A;NSMAF;POLDIP3;PRKCD;YTHDF1;SOX4;RELA
gsea,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.46271837852569125,-1.4027426794318774,0.09690721649484536,0.12294847209799648,1.0,7/17,10.79%,PYCARD;NDUFA13;BAD;NDUFS3;BCAP31;BECN1;FIS1
gsea,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.49517347202275813,1.4008486878067865,0.09902912621359224,0.15039915477363539,1.0,5/15,7.40%,PTPRC;GPS2;NLRC5;PTPN2;NR1H2
gsea,positive regulation of cell differentiation (GO:0045597),0.33968120879679725,1.3993446583555478,0.05078125,0.1507489304135148,1.0,35/68,44.55%,EZH2;BTG1;SPAG9;TGFB1;IL18;SUCO;SOX5;TCF3;TGFBR1;LEF1;MAPK14;CDON;MAPK11;ASXL2;PRKCH;SMAD4;MEF2A;HIF1AN;DHX36;ACVR2A;CREBL2;NUDT21;AAMDC;BLOC1S6;FOXC1;ACVR2B;VHL;LRRC8A;BMPR1A;ATP6AP1;MDK;SYAP1;RUNX2;SMYD1;BNIP2
gsea,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.44410572215928856,1.3967732086249964,0.07869481765834933,0.15209907664003033,1.0,10/19,19.36%,RPS27;PPP1CC;EML4;PAFAH1B1;TNKS;B9D2;MAPRE1;MECP2;SBDS;CEP126
gsea,regulation of cellular catabolic process (GO:0031329),-0.4193702420442236,-1.3964389254233662,0.096579476861167,0.12677540026432477,1.0,8/26,18.94%,RRAGA;VPS29;SCARB2;RRAGC;RMC1;LAMP3;DRAM2;RAB8A
gsea,regulation of insulin secretion (GO:0050796),-0.4341461215598682,-1.3963218624849554,0.0625,0.1264970488306199,1.0,4/23,17.37%,UQCC2;BAD;RAP1A;SLC8B1
gsea,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.4200115782610415,-1.3954183860829745,0.09036144578313253,0.1268333152507738,1.0,8/23,31.18%,PYCARD;GSTP1;ITGAV;CFLAR;CASP8;BCL2L12;TRADD;BCL2L14
gsea,negative regulation of kinase activity (GO:0033673),-0.40570817133260617,-1.3940605262141685,0.10082304526748971,0.12740979694923016,1.0,11/26,36.11%,THY1;GSTP1;RTRAF;ITGB1BP1;GSKIP;CDKN1C;EPHA1;MAPT;DBNDD1;TRIM27;DTNBP1
gsea,cytoplasmic translation (GO:0002181),-0.5460045135985131,-1.3935088430212266,0.2192622950819672,0.1273586776356988,1.0,23/57,11.30%,TMA7;RPS6;RPL28;RPL35;RPL27;RPL32;RWDD1;RPL37;RPL11;EIF3M;RPS19;RPL38;EIF3I;RPL6;RPL12;RPL24;ZC3H15;RPL36A;RPL26;RPS13;RPL39;RPS11;RPS7
gsea,positive regulation of protein catabolic process (GO:0045732),0.3918931014259228,1.3920525547051557,0.0594059405940594,0.15515538398285852,1.0,19/33,35.09%,CDKN1B;VGLL4;GSK3B;ITCH;GSK3A;WWP2;FOXO1;TNFRSF1B;PTTG1IP;APC;SORL1;CSNK2A1;APC2;NEDD4L;NKD1;DACT1;SMURF1;GPLD1;SNX33
gsea,sensory perception of mechanical stimulus (GO:0050954),-0.44684370760496955,-1.3907504393365613,0.10185185185185185,0.1287784931174196,1.0,8/19,38.64%,WDR1;NDUFB9;EML2;OTOS;MYH14;CHRNB2;LHFPL3;WFS1
gsea,regulation of angiogenesis (GO:0045765),0.4037459685558032,1.3899709428621467,0.08585858585858586,0.15601827808143834,1.0,11/32,23.24%,BTG1;HIF1A;ETS1;HSPB6;ATF2;PPP1R16B;STIM1;MECP2;KRIT1;HMGA2;SP100
gsea,regulation of interleukin-8 production (GO:0032677),0.43072426630202715,1.3888193704412992,0.10609037328094302,0.15619079028137592,1.0,10/20,28.09%,HMGB1;PTPRC;BCL10;MAP2K5;STAT3;PTPN22;CD2;RELA;TLR1;TIRAP
gsea,positive regulation of phosphorylation (GO:0042327),0.3492782428098599,1.38690981463472,0.04964539007092199,0.15676270823296198,1.0,23/60,27.21%,HIF1A;KRAS;STK4;BCL10;TGFB1;NPTN;RB1CC1;RALBP1;AKT2;CSNK1D;TESK1;PDE8A;CRKL;F2;INSR;IGF1R;DSTYK;MAPK3;EPHB6;DVL3;PRXL2C;BTBD10;PTK2
gsea,negative regulation of cellular process (GO:0048523),-0.2949414260499938,-1.3821606589938578,0.022123893805309734,0.1348805960623496,1.0,67/143,51.29%,ARHGDIB;FTH1;ANXA6;NDUFA13;PDCD5;TMBIM6;PPP2R1A;ITGB1BP1;CHMP2A;IFI35;CHMP4B;NMI;RND1;RTN4;CIB1;COPS8;CD164;NDUFS3;LRPAP1;CTNNB1;BECN1;CCDC85B;CSNK2B;RUNX3;PKD2;PIP4P2;BTG3;MAGI2;PTPN14;BNIP3L;TNS2;CHMP1A;ERBB3;SIRT7;MAP2K1;SNX3;NTRK1;GNRH1;SERTAD2;SSTR3;MALSU1;HYAL1;IGFBP6;CRLF3;AQP11;MINAR1;PDE12;BMPR2;WFS1;SEMA4D;PTPRU;CNOT7;SPEF1;PARP16;CBLL1;TREM2;NOTCH4;TGFB1I1;RNF139;TNFRSF8;COL18A1;PRDM11;ATG5;ADARB1;NOS3;SIRT2;INCA1
gsea,regulation of cell cycle G2/M phase transition (GO:1902749),-0.4826988388227124,-1.3810937274642725,0.1062992125984252,0.13523145077388746,1.0,6/15,13.45%,DYNLL1;PPP2R1A;DCTN3;CETN2;DCTN2;PRKACA
gsea,regulation of cytoskeleton organization (GO:0051493),0.375863146107187,1.3800986473615522,0.0789980732177264,0.16152322419164716,1.0,21/39,31.90%,GSK3B;PAK2;MAPK1;KATNBL1;ARHGAP17;CDK2AP2;MARK2;CYLD;PRKCD;ARHGAP18;CELSR1;CDK10;RHOG;TESK1;LRP1;RHOH;MAPK3;PTK2;CRK;PLXNB1;MAP6D1
gsea,sensory perception of sound (GO:0007605),-0.43527257625711463,-1.3800725292005225,0.10823529411764705,0.13557657591272743,1.0,9/20,38.64%,WDR1;NDUFB9;EML2;OTOS;HPN;MYH14;CHRNB2;LHFPL3;WFS1
gsea,regulation of immune response (GO:0050776),0.41476898759818676,1.37803994048573,0.12452107279693486,0.16257700096738026,1.0,19/37,42.55%,KLRC1;KLRK1;FOXP1;LAG3;HCST;CD8A;CD22;PTPN22;XIAP;CXADR;CD3E;TIRAP;N4BP1;APPL1;ITGAL;GPR108;IL15;CD247;DENND1B
gsea,negative regulation of multicellular organismal process (GO:0051241),0.3592840840169408,1.3756225779269868,0.057971014492753624,0.16384975771445887,1.0,29/52,42.22%,IFNGR1;ATP2B1;STK11;IP6K1;TGFB1;GSK3B;NPTN;LNPEP;GSK3A;PTEN;NR1H2;RHEB;SPX;BBS2;LDLRAD4;IL17RD;RBPJ;PLCL2;MCC;N4BP1;LGR4;NR1D1;FLCN;RAB11FIP3;ACVR2B;ACOT11;IL15;MDK;HEY1
gsea,regulation of protein kinase activity (GO:0045859),-0.37355088411097326,-1.3749260810505197,0.06584362139917696,0.138914411551172,1.0,15/36,48.00%,THY1;GSTP1;RTRAF;ITGB1BP1;LAT;GSKIP;RAP1A;AGAP2;EPHA1;DBNDD1;TRIM27;DTNBP1;PPM1E;JTB;CACUL1
gsea,cellular iron ion homeostasis (GO:0006879),-0.4422186978814403,-1.374620826970428,0.08853118712273642,0.1387357358374636,1.0,10/18,35.54%,FTH1;NEDD8;ATP6V1A;ATP6V0D1;BOLA2;IREB2;FBXL5;SLC46A1;ISCU;TFR2
gsea,apoptotic process (GO:0006915),0.34655358131135217,1.373189286145656,0.05263157894736842,0.16507208577459437,1.0,56/56,98.99%,RAF1;CYFIP2;STK4;STK11;CDK11B;CDK5;CDIP1;EP300;DIABLO;TRAF7;FOXO1;CAPN3;PRKCD;BAG6;BMF;OGT;CD2;DPF2;DAPK3;IRF3;DPF1;PRUNE2;ATP2A1;ING4;ADAM15;KREMEN1;BNIP2;PPP2CA;DMPK;PPARD;TNFRSF19;PDE1B;BCL2L14;FXR1;TRADD;ERBB3;RFK;MYD88;CASP9;CASP8;ARHGEF6;CASP2;MAGEH1;TGFBR2;GLRX2;MAP3K10;CASP6;RRAGC;CFLAR;BAD;NUDT2;CIB1;RTN4;ITGB2;PPP2R1A;PYCARD
gsea,mRNA processing (GO:0006397),0.32698258717309225,1.3721347292889372,0.06526315789473684,0.16514617534531129,1.0,52/99,35.93%,SON;PCBP2;DDX5;SF1;YTHDC1;RBM5;FRG1;PUF60;TRA2A;TRA2B;SMNDC1;CD2BP2;SF3B1;CHTOP;FIP1L1;CPSF7;RNGTT;U2AF1L4;GEMIN7;POLDIP3;WDR33;ZMAT2;GPKOW;IK;RPRD2;PRPF18;ISY1;ESS2;PABPN1;AKAP8L;SNRNP48;CDC5L;ZRSR2;SYF2;DNAJC8;WBP4;XAB2;PRPF40B;PQBP1;SNRNP27;SF3B5;SNIP1;ZC3H11A;SLU7;PRCC;RAVER2;SRSF12;KIN;NUDT21;RBM22;CRNKL1;USP49
gsea,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.5459116319960156,-1.3713086657467144,0.22832980972515857,0.14079290698339972,1.0,22/58,11.30%,SEC61B;RPS6;RPL28;RPL35;SRP19;RPL27;RPL32;SRP9;RPL37;RPL11;SRP14;RPS19;RPL38;RPL6;RPL12;RPL24;RPL36A;RPL26;RPS13;RPL39;RPS11;RPS7
gsea,negative regulation of protein modification process (GO:0031400),0.4209623521181588,1.3662368509974063,0.0925553319919517,0.16986186458896912,1.0,10/24,14.93%,TGFB1;GSK3B;CHP1;PTEN;PPP1R16B;ENSA;DMD;PNKP;INPP5K;CRKL
gsea,regulation of lipid metabolic process (GO:0019216),-0.4047620402255119,-1.36495478788601,0.08547008547008547,0.145182617322785,1.0,11/26,42.29%,ID2;EDF1;SIN3B;CERS2;GPAM;NPC2;GGPS1;RUBCNL;SMARCD3;RARRES2;SREBF1
gsea,mitotic spindle organization (GO:0007052),0.3960340171255792,1.3645047057918465,0.08914728682170543,0.17053803832858314,1.0,12/27,19.36%,RPS27;PPP1CC;EML4;PAFAH1B1;TNKS;B9D2;RAB11A;MAPRE1;MECP2;SBDS;KIFC2;CEP126
gsea,positive regulation of MAPK cascade (GO:0043410),0.3661698795677297,1.3638120926251156,0.06923076923076923,0.17026594906418224,1.0,22/47,30.67%,EZH2;HMGB1;PTPRC;TGFB1;LAMTOR1;TRAF7;PTPN22;PDE8A;MAP2K7;CRKL;INSR;IGF1R;BRAF;DSTYK;MAPK3;KLHDC10;STK25;TAOK3;PRXL2C;TIRAP;IL11;IRAK1
gsea,"retrograde transport, endosome to Golgi (GO:0042147)",-0.36659154963421947,-1.360928606256308,0.09414225941422594,0.14777378400474048,1.0,14/39,27.95%,TMED9;SURF4;VPS29;TBC1D10C;YKT6;VPS53;VPS26B;PLEKHJ1;SNX8;SNX2;VPS26A;VTI1B;SNX3;BET1L
gsea,positive regulation of cell projection organization (GO:0031346),0.3734813948496473,1.3604554488817273,0.0900562851782364,0.17237922952394508,1.0,15/36,30.77%,TOX;NPTN;RETREG3;EP300;MARK2;DVL1;PLXNA3;SERPINI1;CAPRIN2;CAMK2B;SS18L1;CARMIL1;DVL3;CBFA2T2;PLXNB1
gsea,activation of protein kinase activity (GO:0032147),0.40301989707896796,1.3593380249197362,0.096579476861167,0.1725126270679946,1.0,15/29,32.55%,STK4;STK11;IL18;PAK2;PRKAR1A;OSBPL8;MARK2;PRKCD;MAPKAP1;INSR;TRAF6;TAOK3;TIRAP;IRAK1;ADCY5
gsea,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.43170081707049013,1.352945880332434,0.1095890410958904,0.17742368544413234,1.0,10/20,12.87%,CDKN1B;STK38;PTPN1;PTEN;PRKAR1A;PRKCD;APC;SORL1;TESK1;INPP5K
gsea,negative regulation of phosphorylation (GO:0042326),0.4258159353076642,1.3526592180790271,0.11342155009451796,0.17684334214612446,1.0,9/22,19.16%,CDKN1B;NCOR1;TGFB1;CHP1;PTEN;TESK1;INPP5K;CRKL;NPRL2
gsea,positive regulation of cellular component organization (GO:0051130),-0.3929182488506966,-1.3506420296847845,0.09151785714285714,0.1554485225990802,1.0,15/29,40.72%,TMED9;SURF4;TMEM30A;SUMO1;SH3GLB1;BRK1;GBA;FNIP2;RPS3;CALY;HYAL1;TFR2;CBLL1;TREM2;RAPGEF3
gsea,positive regulation of interleukin-1 production (GO:0032732),-0.4362506767912796,-1.350182823272979,0.11293634496919917,0.1553220459914854,1.0,9/18,33.70%,S100A13;PYCARD;LGALS9;TRIM16;CASP8;MYD88;AGER;PANX1;GSDMD
gsea,cotranslational protein targeting to membrane (GO:0006613),-0.5283766456691195,-1.3484344377095998,0.2468354430379747,0.15631921519065814,1.0,23/59,11.30%,RPS6;RPL28;RPL35;SRP19;RPL27;RPL32;SRP9;RPL37;RPL11;SRP14;RPS19;RPL38;RPL6;RPL12;RPL24;TRAM1;RPL36A;RPL26;RPS13;RPL39;SSR1;RPS11;RPS7
gsea,regulation of interleukin-1 beta production (GO:0032651),-0.43604575289162284,-1.3480496327543166,0.12127659574468085,0.1561873962566539,1.0,9/18,33.70%,PYCARD;GSTP1;LGALS9;TRIM16;CASP8;MYD88;AGER;PANX1;GSDMD
gsea,regulation of tumor necrosis factor production (GO:0032680),-0.3946841879746543,-1.348038766063547,0.08213552361396304,0.15575668657919242,1.0,11/27,34.45%,CYBA;PYCARD;GSTP1;LGALS9;DDT;AGER;SETD4;PSEN1;POMC;LY96;TRIM27
gsea,G2/M transition of mitotic cell cycle (GO:0000086),0.38504174955912707,1.3472657761818687,0.09362549800796813,0.18118262568672241,1.0,17/35,32.25%,FOXM1;PPP1R12A;SSNA1;PAFAH1B1;DNM2;MAPRE1;AKAP9;ENSA;CSNK1D;FBXL17;CEP131;PPP1R12B;FBXL3;BRSK2;FBXL6;CEP63;FBXW11
gsea,positive regulation of protein kinase activity (GO:0045860),-0.35815808909944336,-1.3465315783721754,0.0784313725490196,0.15645600290221198,1.0,20/46,48.00%,CALM1;UNC119;CALM3;PDCD10;LAT;RHOA;CIB1;RAP1A;TGFBR2;AGAP2;ERBB3;STRADB;MAP2K1;CAB39;TOM1L1;PARP16;MAP2K2;DLG4;JTB;CACUL1
gsea,multivesicular body organization (GO:0036257),-0.40637903059039415,-1.3453685801414113,0.11316872427983539,0.15659070786229448,1.0,17/25,39.88%,CHMP2A;SNF8;VTA1;CHMP4B;CHMP5;CHMP2B;PDCD6IP;CHMP1B;MVB12A;VPS28;CHMP1A;VPS4A;CHMP6;VPS37A;VPS36;CHMP3;VPS25
gsea,multivesicular body assembly (GO:0036258),-0.40637903059039415,-1.3453685801414113,0.11316872427983539,0.15659070786229448,1.0,17/25,39.88%,CHMP2A;SNF8;VTA1;CHMP4B;CHMP5;CHMP2B;PDCD6IP;CHMP1B;MVB12A;VPS28;CHMP1A;VPS4A;CHMP6;VPS37A;VPS36;CHMP3;VPS25
gsea,regulation of MAP kinase activity (GO:0043405),0.42619128521618277,1.3424897124516035,0.1088560885608856,0.1850546029335644,1.0,7/22,12.87%,EZH2;STK38;PTPN1;TGFB1;PRKCD;SORL1;INPP5K
gsea,phosphate-containing compound metabolic process (GO:0006796),-0.32696403549071473,-1.3424662059683745,0.06378600823045268,0.15868197278226048,1.0,22/59,43.30%,CALM1;PPP1CA;PLAAT3;LPCAT4;NUDT3;INPP1;MINPP1;NT5C;IMPA1;IMPA2;ITPK1;THTPA;THNSL2;PLA2G15;PLCD4;EPHX2;LCAT;PLA2G4C;NUDT14;DUSP28;LIMD1;PLCB3
gsea,regulated exocytosis (GO:0045055),-0.35372027129248595,-1.3408586017271729,0.08764044943820225,0.1595164482844444,1.0,22/45,39.22%,CALM1;FERMT3;WDR1;TEX264;SRGN;RAB3A;APLP2;VAMP2;TLN1;TMX3;APOOL;VTI1B;RAB27B;STXBP2;LAMP2;SNAPIN;QSOX1;RAB26;HGF;STXBP1;TMEM79;RARRES2
gsea,cellular response to metal ion (GO:0071248),0.4175659151474097,1.3407457709132693,0.11895161290322581,0.18587012227160238,1.0,9/23,27.44%,CDKN1B;MAPK1;MCOLN1;CAPN3;CARF;BRAF;MAPK3;ANK3;MEF2A
gsea,cellular response to organic substance (GO:0071310),-0.3637230829594349,-1.3400824070111723,0.08836206896551724,0.15972897945166276,1.0,13/36,42.10%,HCLS1;TWF2;PTPN18;ARL6IP5;RHOA;CIB1;CTNNB1;TGFBR2;PTPN14;IL1RL2;BMPR2;CDK9;MME
gsea,regulation of reactive oxygen species metabolic process (GO:2000377),-0.4455750092127634,-1.3386153715023823,0.15306122448979592,0.16047193049999217,1.0,8/17,16.82%,ROMO1;RAC1;RAC2;GRB2;ARF4;MPV17;DHRS4;TGFBR2
gsea,positive regulation of protein phosphorylation (GO:0001934),-0.3075187082880922,-1.3385442458467878,0.06279069767441861,0.16006329789006504,1.0,38/86,48.55%,CALM1;CALM3;RAC1;HCLS1;PDCD10;LAT;ILK;ERP29;CIB1;CSNK2B;RAP1A;MAD2L2;AGAP2;FGF23;FNIP2;LEFTY1;AGER;CAB39;SDCBP;FXR1;NTRK1;TOM1L1;TNFRSF14;RPS6KA4;BMP8A;P2RY1;HGF;FGF20;BMPR2;SEMA4D;RARRES2;TREM2;RAPGEF3;CDK9;JTB;EGF;CACUL1;DDRGK1
gsea,positive regulation of protein localization to nucleus (GO:1900182),-0.4384075918914352,-1.3384937135935955,0.12804878048780488,0.15964650150407977,1.0,6/17,30.13%,HCLS1;NMD3;LAMTOR5;CDK5RAP3;PSEN1;TPR
gsea,cilium assembly (GO:0060271),-0.29305755411239565,-1.3376887303284408,0.05439330543933055,0.15985978584852367,1.0,52/108,41.47%,ACTR3;DYNLRB1;DYNLL1;IFT20;PPP2R1A;DCTN3;CETN2;ARF4;DCTN2;EHD1;UNC119B;IFT52;RAB1A;SNAP29;PRKACA;ARL3;GALNT11;RSPH1;ATP6V0D1;ARL6;BBOF1;TXNDC15;RAB8A;KIF17;TTC8;DNAAF3;BBS10;DISC1;TTC36;TTC30B;RAB8B;RILP;VANGL2;TMEM67;NPHP3;RILPL1;TTLL3;EXOC1;EXOC5;CCDC39;SSTR3;TCTN1;ARMC9;CCDC57;CFAP54;NINL;TTC26;CFAP43;NPHP1;RSPH4A;TMEM17;STK36
gsea,endocytic recycling (GO:0032456),0.3869893774617454,1.3355879223828886,0.12896825396825398,0.1900063721439332,1.0,8/28,15.74%,RAB11B;ACAP2;DENND1C;ARF6;DENND1A;RAB14;STX6;CCDC22
gsea,negative regulation of binding (GO:0051100),-0.393598682953764,-1.3339627417763364,0.10580912863070539,0.1624515258276462,1.0,9/25,23.55%,PPP1CA;TMBIM6;ITGB1BP1;SUMO1;LRPAP1;MITD1;PEX19;CTNNBIP1;DISC1
gsea,cellular response to organic cyclic compound (GO:0071407),-0.35757747228864517,-1.3312837536327224,0.12035010940919037,0.16418392194353398,1.0,13/38,26.33%,GNG2;GNB1;UBE2L3;ARL6IP5;CTNNB1;P2RY12;CASP6;RAP1B;PKD2;RAP1A;ADCY3;FAM210B;NR3C1
gsea,ribonucleoprotein complex assembly (GO:0022618),0.3756621474381079,1.3311598184289724,0.11485148514851486,0.19321390450437628,1.0,23/41,35.42%,RPS27;LUC7L2;SF1;YTHDC1;RBM5;PUF60;SF3B1;SRPK2;CPSF7;TRAF7;GEMIN7;NOP53;PRPF18;ISY1;ZRSR2;XAB2;RPS5;RPS14;TGS1;MRPS11;NUDT21;KHDC4;CRNKL1
gsea,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4592454698382937,1.327404002801788,0.13200723327305605,0.1961916207052689,1.0,6/19,9.08%,PTPRC;FYN;TGFB1;PAK2;PRKCD;SAMSN1
gsea,fatty acid biosynthetic process (GO:0006633),-0.4515837261822928,-1.326509041718149,0.1130952380952381,0.16761636316004985,1.0,9/15,42.62%,DEGS1;TECR;ELOVL1;EPHX2;ABHD3;ACOT7;GSTM4;LTA4H;ACSF3
gsea,amyloid fibril formation (GO:1990000),-0.4476645202633949,-1.3263821939074414,0.13226452905811623,0.16722231674720459,1.0,5/16,31.80%,ITM2B;B2M;FKBP1A;APH1B;MAPT
gsea,organelle assembly (GO:0070925),-0.27606604652502265,-1.3253161590816316,0.044715447154471545,0.16775408538051972,1.0,84/169,43.15%,ACTR3;DYNLL1;IFT20;LSM4;STX7;EMC6;CHMP2A;VMP1;DBNL;SNF8;VTA1;CHMP4B;CHMP5;MAP1LC3B;CHMP2B;BSCL2;ARF4;TMOD3;EHD1;UNC119B;IFT52;BECN1;PDCD6IP;UBXN2A;RAB1A;SNAP29;CHMP1B;ATG3;HPS1;ARL3;GALNT11;YTHDF2;ATP6V0D1;MVB12A;ARL6;TXNDC15;RAB8A;FITM2;RAB1B;VPS28;TTC8;CHMP1A;YTHDF3;STARD9;DISC1;TTC36;CSDE1;RAB8B;VPS4A;RILP;TMEM67;RPS23;NPHP3;MAPRE2;CHMP6;RILPL1;TTLL3;MAPT;EXOC1;EXOC5;VPS37A;RPS3;SSTR3;TCTN1;ARMC9;TRAPPC6A;CCDC57;VPS36;CFAP54;CHMP3;TTC26;PLA2G4C;GABARAPL2;CFAP43;UBQLN2;RAB19;VPS25;TMEM17;STK36;TMOD2;ATAT1;LIMD1;GABARAPL1;MAP1LC3A
gsea,protein modification by small protein conjugation (GO:0032446),-0.2897544956832035,-1.3248211234215739,0.06412825651302605,0.167750738982482,1.0,68/143,37.71%,ELOB;UFM1;NEDD8;RRAGA;RBX1;UBE2L3;UBE2G2;DCUN1D5;WDR61;UBE2E1;UFC1;UBE2F;SUMO1;UBE2J2;TRIM13;UBE2D1;ARRB2;UBE2R2;COMMD1;URM1;RNF14;OS9;UBA5;UBE2W;FBXO4;UBE2A;RNF20;ATG3;CDK5RAP3;RNF135;TRIM32;UBE2Q2;DERL1;PCNP;TRPM4;ZNRF3;RNF6;UBE2D3;AMFR;FBXO9;OTULIN;TSPAN17;TRIM47;TRIM11;VCPIP1;RNF187;ANAPC16;KLHL7;TRIM62;TRIM7;UBE2I;MOCS3;KLHL2;TPR;FBXO7;MSL2;FBXL5;CUL2;ASB5;CAND2;PEX12;KLHL8;FBXL2;CHFR;TRIM27;CUL9;TRIM69;RNF34
gsea,transcription initiation from RNA polymerase II promoter (GO:0006367),0.34281190248186805,1.3237661001364671,0.08905380333951762,0.19886719512341186,1.0,20/50,25.35%,NR4A1;NR4A3;NCOR1;NR2C2;GTF2A2;MAML1;NR1H2;RXRB;TAF4;TAF8;MED27;NR6A1;TAF11;RBPJ;MED26;NR1D2;ESR1;NRBP1;TAF7;NR4A2
gsea,positive regulation of proteasomal protein catabolic process (GO:1901800),0.36768116046646193,1.3199058802179484,0.11066398390342053,0.20169728673189707,1.0,19/35,34.83%,PIAS1;GABARAP;DDA1;GSK3B;TMEM259;GSK3A;HECTD1;RCHY1;NOP53;DVL1;BAG6;CSNK1D;ARIH2;DET1;RNF144A;RNF185;CEBPA;RNF144B;BBS7
gsea,positive regulation of cell migration (GO:0030335),0.3270731894012721,1.3190395513510482,0.07216494845360824,0.20159352967686753,1.0,28/64,29.87%,HIF1A;PTPRC;NIPBL;SPAG9;TGFB1;TGFBR1;RAB11A;MAPRE1;LEF1;STAT3;APC;AKT2;SEMA4F;ADAM10;CRKL;CAPN7;INSR;IGF1R;NUMB;INSL3;SMO;CARMIL1;SEMA6C;RREB1;ACVR1B;PTK2;PODXL;SRC
gsea,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.3950968860561322,-1.318977950672253,0.10429447852760736,0.17220452510744513,1.0,8/24,30.17%,PYCARD;ARL6IP5;PDCD10;MAP3K10;ANKRD6;AGER;SDCBP;RELL2
gsea,cellular response to nutrient levels (GO:0031669),-0.426014487199936,-1.31490940027437,0.12320328542094455,0.17514118246900517,1.0,10/20,43.15%,RRAGA;MAP1LC3B;STK26;RRAGC;LAMP2;STK24;BMPR2;KCNB1;SREBF1;MAP1LC3A
gsea,negative regulation of neuron apoptotic process (GO:0043524),0.42102582240188613,1.314236842124412,0.13982300884955753,0.20559545483734923,1.0,4/21,16.25%,HIF1A;SOD1;CNTF;MAG
gsea,positive regulation of protein modification process (GO:0031401),-0.3329781131781985,-1.3137043493645568,0.08126410835214447,0.17580484726040216,1.0,20/53,40.72%,CALM1;CALM3;RAC1;ILK;ERP29;CIB1;CAMTA1;GBA;PTPA;FGF23;AGER;FXR1;NTRK1;P2RY1;HGF;FGF20;SEMA4D;RARRES2;TREM2;RAPGEF3
gsea,positive regulation of cell-substrate adhesion (GO:0010811),-0.39943028459867436,-1.3081221962085317,0.12422360248447205,0.18018403543122133,1.0,8/22,30.90%,CDC42;RAC1;ILK;CIB1;RAC3;EPHA1;RELL2;CSPG5
gsea,negative regulation of supramolecular fiber organization (GO:1902904),-0.39722844285045233,-1.3079107580356275,0.1261061946902655,0.17992517785233042,1.0,11/23,41.13%,TWF2;PFDN1;CIB1;EML2;CHADL;PFDN2;SSH3;CAMSAP3;SPEF1;TREM2;TWF1
gsea,glycerophospholipid biosynthetic process (GO:0046474),0.327963779963975,1.3051473976979986,0.10721247563352826,0.21406659877758197,1.0,29/58,41.61%,ARF3;PLEKHA2;INPP4A;MBOAT7;CHKB;PIP4K2A;PTEN;SLC44A2;PITPNM1;RAB14;HDHD5;INPP5D;DGKZ;CSNK2A1;INPP5K;MTMR6;OCRL;CDS2;PIP5K1A;PCYT1B;PI4K2A;PIK3C3;MTMR9;PIP4K2C;RAB5A;LPCAT3;INPP5E;PNPLA3;MTM1
gsea,rRNA metabolic process (GO:0016072),-0.4818851003443122,-1.302720297750603,0.27479338842975204,0.18402143774678006,1.0,18/51,11.30%,RPS6;RPL28;RPL35;RPL27;RPL32;RPL37;RPL11;C1D;RPS19;RPL38;RPL6;RPL12;RPL24;IMP3;RPL36A;RPL26;RPL39;RPS7
gsea,vesicle organization (GO:0016050),-0.4431158773666224,-1.3025400055350589,0.14893617021276595,0.18366666136121068,1.0,5/16,14.12%,SAR1A;SAR1B;CHMP2B;SRGN;PLEKHJ1
gsea,bicellular tight junction assembly (GO:0070830),0.4430825411418861,1.3015163070987934,0.15412186379928317,0.21702356262747205,1.0,7/15,33.59%,PAK2;DLG1;APC;PARD6A;TBCD;PATJ;CLDN7
gsea,regulation of protein secretion (GO:0050708),-0.3694828992469553,-1.2992791421605325,0.1341991341991342,0.18632543452960143,1.0,13/29,40.72%,UQCC2;IER3IP1;ERP29;RAP1A;DNAJC1;SLC8B1;DPH3;EXOC1;PER2;ANG;TREM2;KCNB1;RAPGEF3
gsea,regulation of cellular response to stress (GO:0080135),0.40783221604240827,1.296082681799102,0.14859437751004015,0.22195643963238074,1.0,10/20,22.62%,MCL1;ING2;NUP50;GSK3B;MAPK1;EP300;SMG1;CAMK2B;ARMT1;MAPK3
gsea,axon guidance (GO:0007411),0.3464101924516314,1.2934404852621673,0.10951526032315978,0.22359194192048762,1.0,25/49,30.77%,FYN;PRKCQ;NPTN;LYPLA2;MAPK1;PTPRA;RANBP9;PLXNA3;SPTB;NTN1;SPTBN2;RHOG;SEMA4F;RHOH;EFNB1;GAB2;RAP1GAP;MAPK3;SMO;EPHB6;SEMA6C;PTK2;SPTBN4;SRC;PLXNB1
gsea,cellular calcium ion homeostasis (GO:0006874),-0.3751910192340837,-1.293275928003682,0.14541387024608501,0.19144424514423292,1.0,13/28,28.55%,ANXA6;SMDT1;SELENOK;MAIP1;TMEM165;FKBP1B;TMCO1;PRKACA;SLC8B1;VAPB;GCM2;FZD9;PSEN1
gsea,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3833275558012884,-1.2930778143855142,0.14473684210526316,0.19116891621993673,1.0,10/25,34.43%,NEDD8;CTSB;CTSC;CHMP4B;PDCD6IP;UBE2W;CTSO;CASP8;VPS4A;CHFR
gsea,response to insulin (GO:0032868),0.38892417874778873,1.2915702337156063,0.137291280148423,0.22466546712615165,1.0,16/25,36.95%,RAB10;GSK3A;FOXO1;AKT2;OGT;INPP5K;GCK;INSR;KHK;INSIG2;SORT1;RPS6KB1;GPLD1;CITED1;USF1;RAB31
gsea,membrane fusion (GO:0061025),-0.4452319730180325,-1.2893570781530466,0.1483739837398374,0.1940020446581319,1.0,9/15,26.10%,SNAP23;RABIF;UBXN2A;SNAP29;VAMP2;VTI1B;VAPA;RABEP1;NAPA
gsea,negative regulation of macromolecule metabolic process (GO:0010605),0.3312766639108064,1.2879800786976643,0.11070110701107011,0.22762128003566728,1.0,32/57,40.17%,HIF1A;CD28;FOXP1;TNRC6C;TNRC6B;TGFB1;WWP2;NDFIP1;PTPN22;ANKRD13B;SFMBT2;MECP2;ADAM10;CRKL;ATOH8;AP1AR;ANKRD13A;ANKRD13D;ESR1;SMO;TERT;CD3E;SLC24A3;AGO3;TTBK1;SNX12;FLCN;YY1;CD46;STOX1;VHL;BMPR1A
gsea,plasma membrane bounded cell projection assembly (GO:0120031),-0.2824332287107895,-1.2875792155276016,0.058823529411764705,0.19509242530667859,1.0,47/103,42.36%,ACTR3;DYNLL1;IFT20;RAC1;FXYD5;ARF4;STK26;EHD1;UNC119B;IFT52;RAB1A;SNAP29;P2RY12;RAP1B;ARL3;GALNT11;RAP1A;ATP6V0D1;ARL6;TXNDC15;RAB8A;ARHGEF6;TTC8;ARHGEF4;DISC1;TTC36;RAB8B;RILP;SDCBP;TMEM67;NPHP3;RILPL1;TTLL3;EXOC1;EXOC5;FGD6;SSTR3;TCTN1;ARMC9;CCDC57;CFAP54;TTC26;SPEF1;CFAP43;TMEM17;STK36;ATAT1
gsea,chromatin remodeling (GO:0006338),0.3798947024348661,1.2875588967689722,0.13043478260869565,0.22701667474480036,1.0,12/26,26.98%,SATB1;MYB;RSF1;INO80B;SMARCD1;HMGA2;SMARCD2;PADI4;ACTR8;ESR1;MYSM1;KDM4C
gsea,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.37462755593014196,-1.2853185803534704,0.11324376199616124,0.19664824265173267,1.0,12/30,51.18%,ELOB;RBX1;FBXO22;SUMO1;SGTA;BCAP31;RNF14;PSMD10;UBQLN2;CSNK1A1;DDRGK1;SIRT2
gsea,long-chain fatty acid metabolic process (GO:0001676),-0.40485839346638075,-1.2830758551988182,0.14107883817427386,0.1981958929766027,1.0,8/20,28.58%,GSTP1;ACOT2;SCP2;DAGLB;ACOT8;ELOVL1;HSD17B4;EPHX2
gsea,mitotic sister chromatid segregation (GO:0000070),0.37641984439307874,1.2814189964114437,0.18234165067178504,0.23310128089870372,1.0,10/26,27.95%,RAD21;NIPBL;EML4;RAB11A;AKAP8L;CSNK2A1;CHMP4C;CHMP7;VPS4B;POGZ
gsea,regulation of cellular component organization (GO:0051128),0.35280208858021483,1.2794925291586623,0.140625,0.23421754160318317,1.0,33/33,96.29%,PRKCQ;PTPN1;STK11;CDK11B;ITCH;LAMTOR1;CD22;SETD5;MARK4;ARFGAP1;SNX12;SGK3;RAB5A;ABL2;RAB33B;ALKBH4;LTBP4;OGFR;SLC2A10;SEMA4D;CAMSAP3;EGLN2;SNX17;BBS10;RAB4B;MAD2L2;RAP1A;RAP1B;AP2S1;ANKRA2;RAB5C;LAMTOR2;DCUN1D5
gsea,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.40399357858249685,-1.2793939673464148,0.24634655532359082,0.20100062601870386,1.0,40/89,38.98%,RPS6;RPL28;RPL35;RPL27;RPL32;RPL37;PPP2R1A;RPL11;RPS19;RPL38;EIF3E;RPL6;RPL12;RPL24;DCP2;POLR2G;RPL36A;RPL26;RPS13;POLR2D;RPL39;RPS11;RPS7;PPP2R2A;RPS10;RPL29;RPS29;CSDE1;RPS9;NBDY;RPS23;RPS4X;MTPAP;RPS28;RPS3;CNOT3;PDE12;PNLDC1;RPL23;CNOT7
gsea,transferrin transport (GO:0033572),0.413754113179655,1.277400834462036,0.16569200779727095,0.23542304134348538,1.0,8/20,28.35%,RAB11B;ATP6V1D;MCOLN1;DNM2;ATP6V1G1;ATP6V0C;STEAP3;ATP6V0A1
gsea,positive regulation of protein kinase B signaling (GO:0051897),0.3509198819369892,1.276559047355476,0.15900383141762453,0.23537785855662824,1.0,15/33,29.87%,FYN;CD28;LCK;TGFB1;IL18;TGFBR1;OSBPL8;AKT2;RHOG;INSR;IGF1R;GAB2;ESR1;PTK2;SRC
gsea,"mRNA splicing, via spliceosome (GO:0000398)",0.31131312814851414,1.2762523826100627,0.1431578947368421,0.23461395815249772,1.0,49/88,35.93%,PCBP2;DDX5;SF1;YTHDC1;RBM5;FRG1;PUF60;TRA2A;TRA2B;SMNDC1;CD2BP2;SF3B1;FIP1L1;SRPK2;CPSF7;U2AF1L4;GEMIN7;WDR33;ZMAT2;GPKOW;IK;ISY1;ESS2;PABPN1;SNRNP48;CDC5L;ZRSR2;SYF2;DNAJC8;WBP4;XAB2;PRPF40B;PQBP1;SNRNP27;SCNM1;SF3B5;SNIP1;SLU7;DCPS;PRCC;DDX17;RAVER2;TGS1;SRSF12;CDK13;NUDT21;RBM22;CRNKL1;USP49
gsea,regulation of anatomical structure morphogenesis (GO:0022603),0.3768601704708684,1.276127242024688,0.1600790513833992,0.23364652622411747,1.0,15/30,35.58%,ETS1;TGFB1;GSK3B;PAK2;CDK5;ZRANB1;LFNG;MARK2;ZMYM6;RC3H1;SP100;NEDD4L;BRSK2;LRRC4C;LZTS3
gsea,positive regulation of programmed cell death (GO:0043068),0.30018276288787676,1.2747132356259083,0.10074626865671642,0.23422833064780527,1.0,81/81,99.41%,HMGB1;GNA13;ARHGEF1;RBM5;STK4;BCL10;SUDS3;AKAP13;STK17B;DIABLO;SOD1;UBC;DNM2;FOXO1;ING3;APC;BMF;DAPK3;HMGA2;TNFRSF12A;SOX4;SLC27A4;TRIO;USP27X;UBE2Z;TRAF6;CRADD;NCSTN;PSENEN;FGD1;MOAP1;FGD4;MARK4;RASGRF2;ING4;FLCN;GPLD1;RPS6KA2;UBA52;TIAM2;PLEKHG5;ARHGEF7;APH1A;DNM1L;TNFRSF8;ARHGEF16;CALHM2;RNF122;CTNNBL1;PIP5KL1;SQSTM1;LAPTM5;NTRK1;MCF2L;RYBP;TRADD;PSEN1;FZD9;VAV1;APH1B;CASP9;ARHGEF4;BIN1;CASP8;BNIP3L;PTPA;ARHGEF6;CASP2;DUSP9;TFPT;MAP3K10;HTATIP2;CTNNB1;BAD;SAP18;ARL6IP5;PDCD2;MTCH1;PDCD5;PYCARD;RPS6
gsea,phosphatidylinositol metabolic process (GO:0046488),0.346320704238557,1.2737301072608593,0.1350293542074364,0.23428675856982978,1.0,18/38,30.36%,ARF3;PLEKHA2;INPP4A;MBOAT7;PIP4K2A;PTEN;PITPNM1;RAB14;INPP5D;INPP5K;MTMR6;PIP4P1;OCRL;PIP5K1A;PI4K2A;PIK3C3;MTMR11;MTMR9
gsea,positive regulation of organelle assembly (GO:1902117),0.4303731935040653,1.273524552924892,0.1949317738791423,0.2334412419949944,1.0,10/15,38.46%,CNOT6L;TAPT1;PIP4K2A;CROCC;CNOT2;CNOT6;MARK4;PIP4K2C;STX18;LRSAM1
gsea,cellular response to molecule of bacterial origin (GO:0071219),0.3763728993008165,1.2723468457673228,0.1723404255319149,0.23373700142895332,1.0,16/26,31.80%,HMGB2;HMGB1;BCL10;PAF1;TNFRSF1B;MAPK14;PABPN1;SHPK;NFKBIL1;TRAF6;RELA;FZD5;TIRAP;IRAK1;NR1D1;GIT1
gsea,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.3504930856524231,-1.2698676769893533,0.1396508728179551,0.2099137840207562,1.0,13/33,42.94%,GNAI2;GNAS;P2RY12;ADCY3;GNA12;GALR2;ADCY9;ADCY7;GNAL;GALR3;LGR5;PTGER3;PRKACB
gsea,negative regulation of intracellular signal transduction (GO:1902532),-0.3170866088795501,-1.269754903267651,0.09282700421940929,0.2094649518905138,1.0,26/63,53.37%,PYCARD;GSTP1;NDUFA13;PDCD6;SLA2;IFI35;NMI;CIB1;NDUFS3;ARRB2;PSMD10;MAGI2;PPM1N;CASP8;PRDM15;BCL2L2;OTUD3;EPM2A;MINAR1;RNF34;NLRX1;TREM2;LIMD1;ADIPOR1;PPP2R5B;WWC2
gsea,regulation of osteoblast differentiation (GO:0045667),0.3995396347379119,1.2683936590049365,0.1618181818181818,0.2371414079753808,1.0,11/21,42.76%,DDX5;SUCO;NBR1;PTK2;ACVR2A;CITED1;ACVR2B;SUFU;BMPR1A;ATP6AP1;RUNX2
gsea,neurotransmitter transport (GO:0006836),-0.40026120900965423,-1.2645940487271856,0.18565400843881857,0.21414057581134455,1.0,9/20,29.38%,TSPOAP1;RAB3A;VAMP2;SLC29A2;LIN7C;LIN7B;SLC29A4;STXBP2;SNAPIN
gsea,"DNA-templated transcription, initiation (GO:0006352)",0.31930361639013377,1.2645744558918695,0.12815533980582525,0.24050175801303228,1.0,26/57,33.57%,NR4A1;NR4A3;NCOR1;NR2C2;GTF2A2;MAML1;NR1H2;RSF1;RXRB;TAF4;TAF8;BRF1;MED27;NR6A1;TAF11;RBPJ;MED26;NR1D2;MAPK3;ESR1;NRBP1;TAF7;NR4A2;NR1D1;TAF1C;TEAD1
gsea,regulation of programmed cell death (GO:0043067),-0.3431129640657554,-1.2644413455289982,0.15625,0.21377718679926438,1.0,17/40,38.64%,PRDX2;IKZF3;CTSB;ASAH1;RTN4;STK26;HTATIP2;SRA1;CASP6;TRIAP1;CASP2;BNIP3L;NTRK1;BCL2L14;RPS3;HS1BP3;WFS1
gsea,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.32840410676343934,-1.264130147528409,0.1350293542074364,0.21352891251164538,1.0,19/49,43.10%,YWHAZ;PYCARD;GSTP1;ITGB1BP1;CIB1;LGALS9;DDT;ARRB2;RAP1A;RRAS;DUSP9;PTPRR;SYNJ2BP;AGER;MAP2K1;NTRK1;P2RY1;TREM2;NDRG4
gsea,"DNA-templated transcription, termination (GO:0006353)",-0.4224145986507611,-1.263185693708764,0.1814516129032258,0.21378855652990789,1.0,8/18,18.64%,SSU72;POLR2K;SNRPG;GTF2H5;LSM10;CLP1;PAPOLA;CCNH
gsea,negative regulation of cell population proliferation (GO:0008285),0.29257054397697013,1.2627928412923877,0.11347517730496454,0.2413945618570965,1.0,92/92,99.39%,BTG1;CDKN1B;RAF1;RBM5;ETS1;STK11;VGLL4;TGFB1;PPM1D;TES;PTEN;PTPN2;EMD;APC;ABI1;CDK10;SLC9A3R1;MORC3;OGN;SOX4;PPP2R5C;CTBP1;DLG3;ADORA3;NACC2;TMEM115;MCC;CEBPA;MYO16;ATP8A2;PLXNB1;ING4;TENM1;FLCN;IRF6;GPLD1;IL12A;PTGIR;AVPR2;ZBTB49;VHL;B4GALT7;TFAP2A;RPS6KA2;RNF41;INCA1;SIRT2;NOS3;ATRAID;ADARB1;COL18A1;TNFRSF8;RNF139;NDRG4;TGFB1I1;GATA2;TREM2;ANG;CNOT7;PTPRU;BMPR2;MINAR1;AQP11;IGFBP6;SSTR3;PER2;GNRH1;HPN;NTRK1;MAP2K1;MED25;CTNNBIP1;CDKN1C;TNS2;PTPN14;MAGI2;BTG3;PKD2;TRIM32;RUNX3;CSNK2B;CTNNB1;CD164;COPS8;CIB1;NMI;IFI35;B2M;ITGB1BP1;PDCD5;GSTP1;FTH1
gsea,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3407476121749646,1.2622643802626774,0.1488933601609658,0.24099324680460632,1.0,24/40,39.11%,PIAS1;GABARAP;DDA1;GSK3B;GSK3A;FHIT;HECTD1;WAC;UBXN1;RCHY1;NOP53;DVL1;BAG6;OGT;CSNK1D;ARIH2;DET1;RNF144A;ARAF;CEBPA;N4BP1;RNF144B;BBS7;PRICKLE1
gsea,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.38851607237627245,1.261495553271186,0.1848906560636183,0.24089875615628817,1.0,11/24,26.59%,CDKN1B;CCNI;PTEN;MAPRE3;APC;SERTAD1;CCNT1;CCNT2;CCNYL1;PKD1;CEBPA
gsea,IRE1-mediated unfolded protein response (GO:0036498),-0.3816190870279469,-1.2613425616524216,0.158004158004158,0.21512191190425148,1.0,11/23,25.84%,SSR1;TLN1;ATP6V0D1;DNAJC3;EXTL2;KLHDC3;DNAJB9;VAPB;ACADVL;TATDN2;YIF1A
gsea,RNA metabolic process (GO:0016070),-0.3362900762438845,-1.2589844258628073,0.15037593984962405,0.21694283860874208,1.0,16/39,35.87%,RBM3;POLR2K;POLR2G;POLR2J;HNRNPH2;POLR2D;ALKBH1;HNRNPL;RNASEH2C;CLP1;PAPOLA;POLR2I;RNASE4;LAGE3;RBM4;DDX24
gsea,positive regulation of T cell activation (GO:0050870),-0.4077801856016973,-1.2572275882446342,0.18664047151277013,0.21816203717054833,1.0,7/21,48.20%,THY1;PYCARD;PNP;LGALS9;NCKAP1L;IL7;CD6
gsea,regulation of mitochondrion organization (GO:0010821),0.4105592478721519,1.2572102476049587,0.1685823754789272,0.24479765511765614,1.0,8/20,22.94%,GSK3B;GSK3A;EP300;MFF;GOLPH3;PDE2A;RHOT1;FZD5
gsea,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.31085411413758823,1.2554839493029302,0.1729957805907173,0.24580976509079636,1.0,81/81,97.69%,PCBP2;DDX5;SF1;YTHDC1;RBM5;FRG1;PUF60;TRA2A;TRA2B;SMNDC1;CD2BP2;SF3B1;FIP1L1;CPSF7;U2AF1L4;GEMIN7;WDR33;ZMAT2;GPKOW;IK;ISY1;ESS2;PABPN1;SNRNP48;CDC5L;ZRSR2;SYF2;DNAJC8;WBP4;XAB2;PRPF40B;PQBP1;SNRNP27;SF3B5;SNIP1;SLU7;PRCC;RAVER2;SRSF12;NUDT21;RBM22;CRNKL1;USP49;SUGP1;AQR;RBM41;CTNNBL1;PDCD7;RBM4;WDR83;POLR2I;CDC40;SRSF5;SNW1;ZMAT5;BCAS2;PAPOLA;PRPF4B;CLP1;ELAVL1;RALY;PPIL3;HNRNPL;SNRPC;POLR2D;HNRNPH2;POLR2J;ZCRB1;RNPC3;SRSF11;POLR2G;SNRPG;CWC15;SNRPD2;POLR2K;LSM6;SNRPB2;SF3B6;LSM4;LSM5;UBL5
gsea,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4223344486606814,-1.2547942042025964,0.1812366737739872,0.22014159178066509,1.0,7/16,16.59%,RPS6KA1;CST7;DNAJB6;LAMTOR5;BEX3;LAMP3;TRIAP1
gsea,regulation of translation (GO:0006417),-0.3330942896804552,-1.2546570377125428,0.1593625498007968,0.2197566618211233,1.0,27/45,45.32%,RBM3;RPS6KA1;EIF4E2;MTPN;EIF3E;RPL26;ALKBH1;ELAVL1;CPEB3;EIF3H;YTHDF3;EIF4A2;CSDE1;FXR1;METTL18;EIF1B;RPS4X;MTRF1;RPS3;RBM4;MALSU1;PLD1;CNOT7;CTIF;RNF139;EEF2;CNOT8
gsea,intrinsic apoptotic signaling pathway (GO:0097193),0.3740744661674526,1.2530403050321457,0.17009345794392525,0.24762127226431618,1.0,13/26,31.06%,MCL1;DDX5;STK11;FHIT;DIABLO;TNFRSF1B;PRKCD;BAG6;PPP1R13B;TOPORS;BRSK2;ATP2A1;MOAP1
gsea,regulation of neuron death (GO:1901214),0.3880451799504622,1.2514379882462492,0.1606425702811245,0.2483507858160957,1.0,10/22,29.38%,FYN;GSK3B;CHP1;CDK5;TNFRSF1B;EGR1;SORL1;INPP5A;BTBD10;TBK1
gsea,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.37872787065032215,-1.2497716648299229,0.172,0.22413093474407333,1.0,11/28,38.98%,LSM5;WDR61;LSM4;LSM6;DCP2;POLR2D;NT5C3B;CNOT3;PDE12;PNLDC1;CNOT7
gsea,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.34773488494058713,1.2461667890128432,0.16766467065868262,0.2535022126825295,1.0,20/34,34.83%,PIAS1;GABARAP;DDA1;GSK3B;GSK3A;PTEN;HECTD1;RCHY1;NOP53;DVL1;CSNK1D;ARIH2;DET1;RNF144A;CCDC22;CEBPA;PTK2;SMURF1;RNF144B;BBS7
gsea,ERBB signaling pathway (GO:0038127),-0.4282999942374547,-1.2444478040812033,0.1953125,0.22919309684257963,1.0,8/15,32.03%,CDC37;PTPN18;GRB2;PTPRR;ERBB3;NRG4;NRG2;AAMP
gsea,positive regulation of interleukin-1 beta production (GO:0032731),-0.42602345166176925,-1.2443992665987256,0.2076271186440678,0.22865859166908045,1.0,8/15,33.70%,PYCARD;LGALS9;TRIM16;CASP8;MYD88;AGER;PANX1;GSDMD
gsea,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.4653880449162747,-1.244107368461892,0.3084886128364389,0.2283727788128784,1.0,22/63,14.66%,RPS6;RPL28;RPL35;RPL27;RPL32;RPL37;PPP2R1A;RPL11;RPS19;RPL38;EIF3E;RPL6;RPL12;RPL24;RPL36A;RPL26;RPS13;RPL39;RPS11;RPS7;PPP2R2A;RPS10
gsea,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3595879943172791,1.2431177184886946,0.17009345794392525,0.25599279429285027,1.0,17/32,30.77%,HCST;IL18;PIP4K2A;MAPK1;PTEN;PPP1R16B;NOP53;SLC9A3R1;INSR;IGF1R;PPP2R5C;PIP5K1A;MAPK3;WNT16;PTK2;SRC;PLXNB1
gsea,extracellular matrix organization (GO:0030198),-0.3149643094982877,-1.2420597775834177,0.166270783847981,0.23004201650459385,1.0,25/50,51.45%,PPIB;ITGB2;ITGAV;CAPNS1;MMP11;F11R;MMP28;KIF9;QSOX1;ITGB5;COL8A2;P3H4;ADAMTS10;NID2;ADAMTSL5;ICAM4;NOXO1;COL5A1;BMP1;COL18A1;LAMB2;COL23A1;WASHC1;ICAM5;COL9A3
gsea,positive regulation of tumor necrosis factor production (GO:0032760),-0.4041450781723467,-1.2416834313421772,0.193158953722334,0.2298137916768339,1.0,8/18,31.57%,CYBA;PYCARD;LGALS9;DDT;AGER;SETD4;PSEN1;LY96
gsea,lipid homeostasis (GO:0055088),-0.3984202096054515,-1.2388545752501379,0.189010989010989,0.2320126030278748,1.0,6/19,23.49%,PNPLA2;ORMDL1;ABHD5;ORMDL2;FITM2;ABHD8
gsea,positive regulation of protein binding (GO:0032092),-0.40224951128366737,-1.2385747922500108,0.20042194092827004,0.23171503229220178,1.0,7/17,28.55%,RPL11;B2M;FKBP1A;NMD3;DERL1;AMFR;PSEN1
gsea,cellular protein catabolic process (GO:0044257),-0.39623269060224786,-1.236901441155983,0.19301848049281314,0.23292330061671498,1.0,10/20,26.43%,UBE2G2;CTSB;CTSC;AP2S1;CTSO;RAB12;AP2M1;BNIP3L;CASP8;CLTA
gsea,regulation of protein localization (GO:0032880),0.4044225956751989,1.233827786568063,0.1900990099009901,0.2658338305353178,1.0,10/18,24.59%,RABGAP1L;DLG1;DVL1;RAB14;KDM1A;TRIM68;TESK1;STX6;TMEM231;DVL3
gsea,regulation of cytosolic calcium ion concentration (GO:0051480),-0.3575191873143676,-1.2336619719058104,0.17257683215130024,0.23581261141291493,1.0,12/27,35.38%,CD52;SELENOT;BCAP31;FKBP1B;FIS1;TAC4;PRKACA;TRPM4;SLC8B1;FZD9;XCR1;P2RY1
gsea,regulation of TORC1 signaling (GO:1903432),-0.41590746360397407,-1.2332941543521698,0.18329938900203666,0.23568449852683743,1.0,5/16,30.52%,RRAGA;LAMTOR5;RRAGC;KPTN;GPR137C
gsea,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.391864053672966,1.2288551191633237,0.19415807560137457,0.2707734851799646,1.0,11/24,34.40%,PTPRC;PTPN1;TGFB1;IL18;PAK2;STAT3;CNTF;DLG3;IL11;SRC;IL12A
gsea,generation of neurons (GO:0048699),0.32887143630423166,1.2286518421497687,0.15412186379928317,0.26980117340286836,1.0,22/44,42.76%,HMGB2;BHLHE40;IER2;PAFAH1B1;CDK5;DTNB;MARK2;CELSR1;LHX2;ATOH8;PEX13;FZD5;BRSK2;WNT16;NR4A2;LHX6;LRP12;NRBP2;ITM2C;MAP1B;HEY1;RUNX2
gsea,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.35619871233330985,-1.227025005625017,0.18661257606490872,0.24206780760498348,1.0,13/31,22.90%,NDFIP2;UBE2L3;DCUN1D5;NSMCE3;FKBP1A;UBE2D1;COMMD1;FBXO4;CDK5RAP3;DERL1;PSMD10;AMER1;UBE3A
gsea,JNK cascade (GO:0007254),0.37835398543411625,1.22576117838632,0.186219739292365,0.27227132305938845,1.0,10/21,30.67%,GPS2;UBC;MAP4K2;TAB2;MAP2K7;CRKL;TRAF6;IRAK2;MAP2K4;IRAK1
gsea,regulation of stress-activated MAPK cascade (GO:0032872),0.3847581076673112,1.2247695121132987,0.1816326530612245,0.27231333720423345,1.0,10/22,26.24%,FOXM1;MAPK1;FOXO1;MAPK8IP3;IGF1R;MAPK3;KLHDC10;STK25;TAOK3;NBR1
gsea,regulation of protein localization to plasma membrane (GO:1903076),0.3822646906283046,1.224485329544699,0.20743639921722112,0.27152602505696455,1.0,10/24,18.99%,TGFB1;ARF6;CDK5;TMEM59;DLG1;RHOG;LRP1;LDLRAP1;PRKCH;NUMB
gsea,cellular response to growth factor stimulus (GO:0071363),0.320974350124536,1.2219516959972958,0.18700787401574803,0.273687187196091,1.0,20/44,31.64%,NR4A1;ACAP2;MAP2K5;TGFB1;SOX5;TGFBR1;EMD;MAPK14;PDE8A;INPP5K;CRKL;PDE2A;SMAD4;LIMS1;RELA;DSTYK;ACVR1B;RPS6KB1;APPL1;ACVR2A
gsea,insulin receptor signaling pathway (GO:0008286),0.35200354756926583,1.2206438827188812,0.18217821782178217,0.27414813452215425,1.0,14/30,34.09%,GSK3B;ATP6V1D;GSK3A;FOXO1;PTPN2;APC;ATP6V1G1;AKT2;ATP6V0C;INSR;IGF1R;ATP6V0A1;APPL1;GPLD1
gsea,regulation of signal transduction (GO:0009966),0.2952502492515892,1.2198757786373926,0.13594040968342644,0.27399836098641916,1.0,37/73,39.34%,FYN;ANKRD54;GIT2;PTPN1;TGFB1;GRK6;UBASH3B;LFNG;SENP2;PTPN2;CBFB;CDC42SE2;OGT;CDKN2AIP;FBXL17;GNG7;RASGRP4;LLGL2;SHARPIN;ESR1;CASTOR2;SP100;RGS14;IRAK2;MGLL;CD3E;CRK;GRK3;SRC;IRAK1;GIT1;NCK1;INTU;ZDHHC17;BRAP;CD46;TSPEAR
gsea,ciliary basal body-plasma membrane docking (GO:0097711),-0.3655632706662966,-1.219641566167217,0.2200392927308448,0.24962857168233468,1.0,10/25,39.63%,DYNLL1;PPP2R1A;DCTN3;CETN2;DCTN2;PRKACA;TMEM67;TCTN1;NINL;NPHP1
gsea,phospholipid dephosphorylation (GO:0046839),0.40331655257517157,1.2176264719018812,0.19924812030075187,0.2756252856982634,1.0,9/17,31.67%,PTEN;PLPPR3;INPP5K;MTMR6;PIP4P1;OCRL;MTMR11;MTMR9;PLPPR2
gsea,proteolysis (GO:0006508),-0.2816833285954424,-1.216081730266071,0.1434878587196468,0.25284529069372524,1.0,30/75,36.43%,NEDD8;CTSB;CTSC;SPCS1;XPNPEP1;SVBP;FBXO6;CNDP2;SRGN;PM20D2;CASP6;CTSO;SPPL2A;CASP2;PGPEP1;CASP8;GGT1;APEH;UBE3A;CELA1;APH1B;PSEN1;MBTPS1;CAPN5;HPN;ASPRV1;CPA2;FBXL2;RNPEPL1;HGF
gsea,skeletal system development (GO:0001501),-0.3495092658850501,-1.2151340247205282,0.17439293598233996,0.2534653714671147,1.0,12/32,48.68%,PPIB;GNAS;PAPSS1;EBP;PKDCC;TRAPPC2;DEAF1;HYAL1;BMP1;DDRGK1;UFD1;FGFR3
gsea,positive regulation of cell motility (GO:2000147),-0.30612187538952274,-1.2138319432705729,0.17620137299771166,0.2543640603730471,1.0,23/50,51.32%,FERMT3;MIEN1;PDCD10;FAM89B;PHPT1;CIB1;SNAI1;TRIM32;SEMA6B;EPHA1;TRADD;SDCBP;FER;HGF;SEMA4D;CBLL1;CCDC25;EGF;MYLK;DDRGK1;RHOD;PIK3R3;WASHC1
gsea,tight junction assembly (GO:0120192),0.41319608935131347,1.2135733048102582,0.20964749536178107,0.279599595442546,1.0,7/16,33.59%,PAK2;DLG1;APC;PARD6A;TBCD;PATJ;CLDN7
gsea,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3042228648315549,-1.2135055012114495,0.1851106639839034,0.25411928268587247,1.0,21/50,34.45%,PYCARD;MTPN;UBE2V1;LAMTOR5;CIB1;LGALS9;TRIM13;CFLAR;TRIM32;TICAM1;IL1RAP;RIPK4;MYD88;AGER;TRIM62;TRADD;NTRK1;FER;RPS6KA4;RPS3;TRIM27
gsea,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.40800193014332325,1.2126378849341395,0.2250996015936255,0.27965420993701684,1.0,9/16,24.82%,PTPRC;PTPN1;PTEN;PTPN2;DLG1;RANBP9;SLC9A3R1;SMAD4;RGS14
gsea,regulation of exocytosis (GO:0017157),-0.40369023064533477,-1.2117595202869083,0.20901639344262296,0.2554385049064971,1.0,11/16,37.70%,UNC13D;RAB3A;VAMP2;RAB12;RAB8A;RAB27B;RAB8B;CHMP6;RAB26;RAB3B;CHMP3
gsea,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2884094228437176,1.2108940120094738,0.14864864864864866,0.28070656151306406,1.0,70/70,98.99%,ARID5B;PRKCQ;BCL10;IL18;ATF2;RNF31;TCF3;PTEN;EP300;UBC;RTKN2;CAPN3;STAT3;TAB2;KDM1A;TRIM68;CEBPG;AIM2;CRTC3;RBCK1;PRKCH;TRAF6;RELA;CRTC2;ESR1;SMO;RNF25;IRAK2;TIRAP;IRAK1;TSSK4;TRIM26;TLR6;TAF12;ABRA;NOD1;DVL2;NOD2;CRTC1;CARD9;UBA52;DDRGK1;ZBTB7A;TNFRSF11A;STK36;IKBKB;TRIM27;RPS3;RPS6KA4;FER;NTRK1;TRADD;TRIM62;AGER;MYD88;RIPK4;IL1RAP;TICAM1;TRIM32;CTNNB1;CFLAR;TRIM13;LGALS9;CIB1;LPAR5;LAMTOR5;UBE2V1;MTPN;HCLS1;PYCARD
gsea,positive regulation of developmental process (GO:0051094),0.31397301779481956,1.2108397109076634,0.17345132743362832,0.27964752292578904,1.0,20/46,42.95%,NR2C2;HMCES;TAPT1;SOX5;RALBP1;MFF;DVL1;SORL1;ANAPC2;CAMK2B;INSR;DVL3;RREB1;ACVR1B;SRC;MUL1;VHL;BMPR1A;MDK;DVL2
gsea,positive regulation of protein transport (GO:0051222),-0.3663276016201508,-1.2093628480950953,0.2138364779874214,0.25743206286923187,1.0,10/23,32.04%,OAZ1;IER3IP1;PDCD10;VAMP2;ZFAND1;VPS28;OAZ2;B3GAT3;TPR;EXOC1
gsea,cellular response to UV (GO:0034644),-0.36455827728553947,-1.2091878725517224,0.21336206896551724,0.256990640179513,1.0,11/24,42.10%,COPS9;NSMCE3;RPL26;TRIAP1;CASP9;ACTR5;HYAL1;OPN1SW;ERCC1;OPN3;MME
gsea,positive regulation of binding (GO:0051099),0.3543816863988077,1.2082710385082587,0.206,0.28173706739233734,1.0,13/26,28.97%,HMGB2;HMGB1;STK4;GSK3B;SPPL3;MARK3;CEBPG;CAPRIN2;LRP1;HMBOX1;TERT;PKD1;DACT1
gsea,positive regulation of epithelial cell migration (GO:0010634),0.3767223147182823,1.2080541513639056,0.20292504570383912,0.28087286883247786,1.0,11/23,34.09%,HIF1A;FOXP1;ETS1;ARF6;RAB11A;CAPN7;ATOH8;INSL3;RREB1;SRC;GPLD1
gsea,synapse organization (GO:0050808),-0.35730060870469926,-1.2061131940581162,0.2149122807017544,0.26000816536001553,1.0,8/26,31.80%,CDC42;DBNL;LRFN4;SNCB;OBSL1;CACNB4;PSEN1;MAPT
gsea,regulation of intracellular protein transport (GO:0033157),-0.4078374258797009,-1.2060843181463727,0.2240325865580448,0.25940879309120174,1.0,10/16,30.13%,OAZ1;PDCD10;UHMK1;VAMP2;ZFAND1;PTPN14;OAZ2;SIRT7;B3GAT3;TPR
gsea,kidney development (GO:0001822),0.4178189171227858,1.2057891116147599,0.22851919561243145,0.2825399558813065,1.0,8/17,29.30%,NIPBL;TGFBR1;BAG6;SOX4;PRKX;C1GALT1;PKD1;GREB1L
gsea,mRNA 3'-end processing (GO:0031124),0.3712999020061668,1.2048251110693688,0.20436507936507936,0.282566311995312,1.0,13/24,23.99%,CHTOP;FIP1L1;PAF1;CPSF7;U2AF1L4;POLDIP3;WDR33;RPRD2;PABPN1;TENT2;ZC3H11A;SLU7;PAPOLG
gsea,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.398301723519742,-1.2047924419808345,0.24390243902439024,0.26027205316612584,1.0,7/19,23.14%,POLR2K;POLR2G;GRB2;POLR2J;POLR2D;FGF23;POLR2I
gsea,defense response to virus (GO:0051607),0.4130545694781196,1.2041412160498497,0.22440087145969498,0.28231925849872197,1.0,8/15,29.53%,PTPRC;IRF2;NLRC5;IRF3;PQBP1;RELA;SERINC5;ZMYND11
gsea,cellular response to reactive oxygen species (GO:0034614),-0.4105551568280587,-1.2039087540645304,0.24586776859504134,0.26059971666648135,1.0,9/15,34.06%,ROMO1;PRDX5;MPV17;PKD2;MAPK9;PXN;FER;MAPT;RPS3
gsea,metal ion transport (GO:0030001),0.3658412187541756,1.203906129481958,0.21350364963503649,0.2814543277580723,1.0,13/28,30.34%,TPT1;FYN;TUSC3;NDFIP1;NIPAL1;SLC39A8;TRPM7;CACNG7;CACNA1D;SLC24A1;ATP2C1;NIPA1;ATP2A1
gsea,regulation of receptor internalization (GO:0002090),-0.4183714414701558,-1.2005764712364304,0.23554603854389722,0.2637085338136554,1.0,7/15,29.17%,ARF1;LRPAP1;ARRB2;MAGI2;ATAD1;RIN3;SDCBP
gsea,regulation of epithelial cell migration (GO:0010632),0.42355830009119266,1.2002272084944061,0.21516754850088182,0.28507454344660343,1.0,8/15,29.87%,HIF1A;RAB11A;CAPN7;INSL3;MCC;RREB1;PTK2;SRC
gsea,cellular amino acid catabolic process (GO:0009063),-0.3958857067348129,-1.1970604329414765,0.21739130434782608,0.2670296183966092,1.0,9/17,39.68%,KYAT1;ACAT1;AMDHD1;ECHS1;CARNS1;PRODH;DAO;HMGCL;QDPR
gsea,aminoglycan biosynthetic process (GO:0006023),0.3989319512297715,1.1963161235305357,0.22157996146435452,0.28872336239697616,1.0,6/18,27.38%,B3GNT2;EXT1;B3GNT8;AGRN;B3GALT2;B3GNT4
gsea,response to UV (GO:0009411),-0.3524093572029422,-1.1958453042682735,0.24267782426778242,0.26774726689943334,1.0,8/26,23.59%,COPS9;NSMCE3;CAT;RPL26;UBE2A;TRIM32;TRIAP1;CASP9
gsea,phosphatidylinositol biosynthetic process (GO:0006661),0.3116131137548863,1.1946783800850886,0.21042084168336672,0.289729061410375,1.0,28/46,37.90%,ARF3;PLEKHA2;IP6K1;INPP4A;MBOAT7;PIP4K2A;PTEN;PITPNM1;RAB14;INPP5D;SMG1;INPP5K;MTMR6;OCRL;MPPE1;ITPKC;PIP5K1A;PI4K2A;EFR3B;TMEM150A;PIK3C3;MTMR9;SOCS4;EFR3A;PIGO;PIP4K2C;ITPKA;RAB5A
gsea,regulation of interferon-gamma production (GO:0032649),0.41553351558428886,1.1930890259362101,0.25147347740667975,0.29046500172637163,1.0,7/15,22.94%,HMGB1;PDE4D;IL18;PTPN22;CEBPG;CD2;FZD5
gsea,organic substance transport (GO:0071702),-0.32874312540188644,-1.1928644829655295,0.20481927710843373,0.27040653456131103,1.0,19/33,40.43%,CD3G;ARL6IP5;CHMP2A;CHMP2B;VAMP2;CHMP1B;SNX4;PEX19;RD3;CHMP1A;TOM1;SPNS2;SLC29A4;RILP;SLC22A5;ARRDC2;CHMP3;AMN;SLC48A1
gsea,positive regulation of neuron projection development (GO:0010976),0.3518151011042278,1.1912009269453845,0.22469635627530365,0.2916548068028179,1.0,14/26,41.65%,TOX;NPTN;RETREG3;EP300;MARK2;SERPINI1;CAPRIN2;CAMK2B;CBFA2T2;DHX36;ATP1B2;ABL2;GPC2;MDK
gsea,cellular response to insulin stimulus (GO:0032869),0.3137702861173177,1.1910596437565422,0.19573643410852712,0.2907029840424845,1.0,23/45,38.62%,GSK3B;RAB10;ATP6V1D;GSK3A;FOXO1;PTPN2;APC;ATP6V1G1;AKT2;INPP5K;ATP6V0C;GCK;SLC27A4;INSR;IGF1R;INSIG2;ATP6V0A1;RPS6KB1;APPL1;GPLD1;USF1;RAB31;ATP6V1C1
gsea,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.34806326446716546,-1.1910348759750926,0.19957081545064378,0.27190496926389324,1.0,13/30,38.25%,RBM3;MTPN;EIF3E;NMD3;RPL26;ELAVL1;CPEB3;YTHDF3;PPP1R3E;FXR1;RPS4X;HGF;PLD1
gsea,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4071120845733789,1.188476777664696,0.23735408560311283,0.2927800798077607,1.0,12/15,37.40%,IP6K1;PIP4K2A;SMG1;ITPKC;PI4K2A;EFR3B;TMEM150A;PIK3C3;SOCS4;EFR3A;PIP4K2C;ITPKA
gsea,myeloid cell differentiation (GO:0030099),-0.3799129458659936,-1.1812072796217572,0.24539877300613497,0.2825426816718769,1.0,4/17,36.37%,HCLS1;RPS19;UBA5;KLF1
gsea,receptor-mediated endocytosis (GO:0006898),-0.34074285020091694,-1.1811443400065251,0.19517543859649122,0.2819442265781678,1.0,12/30,40.17%,ITGB2;AP1S1;GRB2;SCARB2;ARRB2;GPR107;AP2S1;AP2M1;STAB2;CLTA;TFR2;AMN
gsea,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3027437196016254,1.1805527033565326,0.19444444444444445,0.30149730099489264,1.0,26/47,30.67%,TAX1BP1;ID3;BHLHE40;SIK1;MAP2K5;NLRC5;CHP1;ITCH;WWP2;CYLD;KDM1A;CEBPG;RNF2;AIM2;RBCK1;PEX14;NFKBIL1;TBX6;ESR1;FOXJ1;SP100;ADORA3;IRAK2;PKD1;RWDD3;IRAK1
gsea,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.35399051897978523,1.1802328486739109,0.2463768115942029,0.3007669846377644,1.0,14/24,34.94%,TNRC6C;TNRC6B;PPM1D;PTEN;CBFB;LEF1;MECP2;MED31;MED27;RELA;MED26;AGO3;DHX36;MED6
gsea,nuclear export (GO:0051168),0.38637821833178054,1.1786643854375147,0.24652087475149106,0.30140344578197853,1.0,10/18,33.50%,TGFB1;CHP1;CHTOP;U2AF1L4;POLDIP3;ZC3H11A;SLU7;PKD1;SMURF1;NUP62CL
gsea,positive regulation of synaptic transmission (GO:0050806),0.4102260029389179,1.1783437163378596,0.2693726937269373,0.3006529394133464,1.0,7/15,24.82%,MPP2;NPTN;CACNG7;RIMS3;SLC24A1;NLGN3;RGS14
gsea,cell morphogenesis involved in neuron differentiation (GO:0048667),0.3867315182837141,1.1778334941090383,0.2606060606060606,0.30015346216278266,1.0,11/20,28.52%,RAB10;CDK5;DVL1;CELSR2;NTNG2;ANK3;BRSK2;TMEM106B;MEF2A;TBCD;SPTBN4
gsea,negative regulation of transport (GO:0051051),-0.37681478744550057,-1.172622390501555,0.24267782426778242,0.2914299999663308,1.0,6/19,27.85%,NDFIP2;ARL6IP5;ITGAV;PIP4P2;ERBB3;SNX3
gsea,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.3728185943692661,-1.1723568441446106,0.255859375,0.2910486237018394,1.0,8/19,31.57%,CYBA;PYCARD;LGALS9;DDT;AGER;SETD4;PSEN1;LY96
gsea,regulation of protein kinase B signaling (GO:0051896),-0.2991730807200133,-1.169955777948627,0.22792607802874743,0.29331979645895634,1.0,21/49,36.94%,RAC1;HCLS1;ITGB1BP1;RAC2;PDCD6;GRB2;RTN4;CIB1;ARRB2;P2RY12;RRAS;MAGI2;FGF23;VAV1;ERBB3;NRG4;NRG2;NTRK1;OTUD3;HGF;FGF20
gsea,actin cytoskeleton reorganization (GO:0031532),-0.3926510213975961,-1.1696002959089276,0.26652452025586354,0.2930615794825818,1.0,9/17,44.91%,PARVG;RHOA;GRB2;FER;INSRR;CDC42BPB;DTNBP1;CDC42BPG;SYDE1
gsea,regulation of proteolysis (GO:0030162),0.36179204691528594,1.1695278530243058,0.22574626865671643,0.309924325151454,1.0,12/22,32.25%,CYFIP2;TBC1D10A;ITCH;CDK5;SPOP;CAPN3;BAG6;OGT;IST1;CLN8;F2;FBXW11
gsea,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.3464967112707027,-1.1692889514722806,0.22119815668202766,0.292752031705154,1.0,9/24,35.38%,CD52;SELENOT;BCAP31;FIS1;TAC4;TRPM4;LPAR6;XCR1;P2RY1
gsea,cellular macromolecule catabolic process (GO:0044265),-0.3759773671013853,-1.1690543486922638,0.2535211267605634,0.2923449224162832,1.0,8/19,27.31%,UBE2G2;FBXO6;RNASEH2C;DFFB;FBXO17;RAB12;DNASE1;MANBA
gsea,protein localization to cilium (GO:0061512),-0.3775999311617694,-1.1676718525795087,0.24899598393574296,0.2932556881466549,1.0,7/19,37.76%,IFT20;EHD1;ARL3;ARL6;RABEP1;TCTN1;TTC26
gsea,import into nucleus (GO:0051170),0.38018306729153806,1.1657447961037888,0.2509727626459144,0.3139549820889404,1.0,9/19,39.11%,BACH2;NUP50;GEMIN7;STAT3;PTTG1IP;NXT2;APPL1;NUP62CL;PRICKLE1
gsea,calcium-mediated signaling (GO:0019722),-0.3810203221415311,-1.1655644244813812,0.24311926605504589,0.294941885839391,1.0,7/18,15.55%,LAT;BCAP31;FKBP1B;FIS1;P2RY12;PRKACA;TRPM4
gsea,regulation of axonogenesis (GO:0050770),-0.39010999655956463,-1.1627939369700675,0.2534883720930233,0.29753983275220974,1.0,17/17,96.90%,THY1;RHOA;RTN4;TIAM2;AMIGO1;CHN1;LRRC4C;PLXNB1;BRSK2;MAG;OMG;PLXNA3;MARK2;PTEN;PAK2;GDI1;GSK3B
gsea,regulation of response to external stimulus (GO:0032101),-0.3256497788893986,-1.162785098951544,0.22727272727272727,0.29686291199610043,1.0,12/30,45.39%,CALM1;P2RY12;RNF135;DAGLB;CASP8;GGT1;MYD88;GUCA1A;STK24;IL1RL2;TREM2;CNGA1
gsea,positive regulation of transferase activity (GO:0051347),0.328980304388077,1.1611080508641536,0.23861566484517305,0.31896028467921544,1.0,18/35,27.37%,PRKCQ;TGFB1;TNKS;MAPK1;GSK3A;SORL1;PABPN1;PNKP;MAP2K7;INSR;IGF1R;HMBOX1;DSTYK;MAPK3;TOPORS;EPHB6;DCUN1D4;SERINC5
gsea,establishment of protein localization to organelle (GO:0072594),0.37270503825298273,1.1591235726725202,0.2476007677543186,0.3205898434947677,1.0,10/20,39.11%,NEURL1B;NUP50;RAB11A;STAT3;PTTG1IP;NXT2;APPL1;NUP62CL;LRSAM1;PRICKLE1
gsea,glucose homeostasis (GO:0042593),-0.339998094776877,-1.1558695030403103,0.2569593147751606,0.3046715509510999,1.0,27/27,99.45%,RPS6;CYB5R4;SELENOT;BAD;SLC8B1;WFS1;KCNB1;ADIPOR1;ADIPOR2;MLXIPL;LRRC8A;FOXK1;USF1;NR1D1;CEBPA;CRTC2;IGF1R;INSR;GCK;SOX4;MBD5;INPP5K;STAT3;PTPN2;FOXO1;STK11;HIF1A
gsea,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3950642743603572,1.1532397025514662,0.26095617529880477,0.32727590787257765,1.0,5/15,21.21%,CDKN1B;CCNI;SERTAD1;CCNT1;CCNT2
gsea,neuron development (GO:0048666),0.3032367798326736,1.1482279331361058,0.258364312267658,0.3326706251478654,1.0,20/43,37.93%,HMGB1;FRYL;GSK3B;CDK5;RAB11A;TOR1A;B4GALT6;PQBP1;TENM4;SAMD14;TBCD;TBC1D24;ATP8A2;ZFYVE27;LRP12;TENM1;PLP1;LGI4;PPT1;BLOC1S6
gsea,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3856959666197137,1.147577342207844,0.2690166975881262,0.3322997156772052,1.0,12/18,34.22%,RAF1;STK4;TGFB1;AKAP9;CAPRIN2;ARAF;BRAF;IL11;TBK1;CREBL2;TENM1;MTCP1
gsea,negative regulation of metabolic process (GO:0009892),-0.36976217954324087,-1.1470611118585416,0.2786177105831533,0.31486523998615795,1.0,5/19,14.36%,GSTP1;ACOT13;PGAM5;FIS1;ZDHHC7
gsea,cilium organization (GO:0044782),-0.2611335603444895,-1.14438533998158,0.2128099173553719,0.31747977066147015,1.0,37/82,42.36%,ACTR3;DYNLL1;IFT20;ARF4;EHD1;UNC119B;IFT52;RAB1A;SNAP29;PKD2;ARL3;GALNT11;ATP6V0D1;ARL6;TXNDC15;RAB8A;TTC8;DISC1;TTC36;RAB8B;RILP;TMEM67;NPHP3;RILPL1;TTLL3;EXOC1;EXOC5;SSTR3;TCTN1;ARMC9;CCDC57;CFAP54;TTC26;CFAP43;TMEM17;STK36;ATAT1
gsea,protein import (GO:0017038),-0.33529845384493245,-1.1438427754704128,0.2515212981744422,0.31740097876481027,1.0,17/28,41.62%,SEC13;PEX16;TOMM22;FIS1;FAM53A;PEX19;PXMP4;ATAD1;RANBP17;LAMP2;RAB8B;TPR;PEX12;SPRN;IPO13;ACBD5;PEX26
gsea,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3902728800934152,1.143727273676068,0.26789366053169733,0.33619905439089953,1.0,8/15,30.67%,ITCH;UBC;CYLD;TAB2;TRAF6;RELA;IRAK2;IRAK1
gsea,positive regulation of apoptotic signaling pathway (GO:2001235),0.3678485456692137,1.14285768411595,0.2857142857142857,0.3362479165162542,1.0,11/20,25.05%,LCK;BCL10;PAK2;TGFBR1;TRAF7;CYLD;BMF;SLC9A3R1;TNFRSF12A;CRADD;DEDD2
gsea,autophagosome organization (GO:1905037),-0.3289781004874669,-1.1423885914521996,0.255278310940499,0.31856891648236085,1.0,15/31,48.51%,EMC6;VMP1;MAP1LC3B;BECN1;UBXN2A;RAB1A;ATG3;RAB1B;GABARAPL2;UBQLN2;RAB19;GABARAPL1;MAP1LC3A;ATG5;WDR45B
gsea,regulation of cilium assembly (GO:1902017),0.3429900850775181,1.140757604387009,0.2692307692307692,0.3378346907486593,1.0,14/26,37.58%,TAPT1;TBC1D10A;CROCC;TBC1D15;CYLD;CDK10;TESK1;TBC1D22A;TBC1D19;TBC1D24;MARK4;TBC1D17;TBC1D2B;TBC1D9B
gsea,potassium ion transmembrane transport (GO:0071805),-0.31307562084039825,-1.140458582100826,0.2518518518518518,0.32039173032193613,1.0,15/31,40.67%,KCNA4;PKD2;KCNK3;KCNK12;KCNK6;ATP1B3;SLC12A9;KCNA7;KCNC3;TMEM175;HPN;KCNIP2;KCNH1;KCNB1;KCNAB3
gsea,protein K48-linked ubiquitination (GO:0070936),-0.33047291948085156,-1.1351066172593391,0.2890625,0.3262719717845355,1.0,15/31,24.30%,RBX1;UBE2G2;UBE2E1;UBE2D1;UBE2R2;UBE2A;TRIM32;UBE2Q2;BFAR;RNF6;UBE2D3;AMFR;RNF146;UBE3A;RNF187
gsea,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.38698657845494316,-1.135051383245733,0.31262939958592134,0.3256187823597009,1.0,7/15,28.06%,NDUFA13;TMBIM6;ARMC10;NDUFS3;SNAI1;TRIM32;BCL2L2
gsea,protein catabolic process (GO:0030163),0.3551348130431281,1.1330886967739597,0.2803738317757009,0.3468932828825038,1.0,14/22,38.46%,USE1;NGLY1;CAPN3;BAG6;ATE1;CLN8;SIAH2;UBE2G1;NEU4;TPP1;NR1D1;PPT1;FBXO2;LRSAM1
gsea,innate immune response (GO:0045087),0.2887651484359026,1.1314891367438014,0.24535315985130113,0.3478750891737597,1.0,50/50,99.88%,HMGB1;FYN;LCK;BCL10;NLRC5;SRPK2;CYLD;CLEC4D;TRIM68;YES1;RELA;SP100;PTK2;SERINC5;TBK1;SRC;IRAK1;F12;CITED1;TRIM26;ZAP70;ADAM15;NOD2;MASP2;ALPK1;CARD9;CYBC1;TREM2;IKBKB;ANG;RARRES2;IRAK4;TRIM27;ZDHHC1;MSRB1;FER;TRIM62;AGER;MYD88;RNF187;TRIM11;OTULIN;TRIM32;RNF135;CAPZA1;RPL39;TRIM13;B2M;KLRD1;CYBA
gsea,lysosome localization (GO:0032418),0.3738341059982867,1.1296799441966283,0.2991967871485944,0.3490562065397849,1.0,9/17,33.73%,NR4A3;SPAG9;KXD1;LAMTOR1;ARL8B;PIP4P1;KLC2;TMEM106B;FLCN
gsea,regulation of cell-matrix adhesion (GO:0001952),0.3748800319118606,1.1265552319662078,0.30393996247654786,0.3520411845887063,1.0,8/18,27.27%,SKAP1;PLEKHA2;GSK3B;PTPRA;DAPK3;CASK;PTK2;CD3E
gsea,negative regulation of cellular component organization (GO:0051129),0.3591896585207434,1.1231303825552952,0.29887218045112784,0.3555129941751126,1.0,12/21,38.46%,RAF1;GSK3B;EP300;DNM2;NOP53;RIOK3;SORL1;CARMIL1;SCAMP5;SRC;SNX33;LRSAM1
gsea,positive regulation of catabolic process (GO:0009896),0.32876495188694155,1.1229223114099722,0.29672447013487474,0.35455544123378374,1.0,28/28,98.37%,CDKN1B;GSK3B;ITCH;GSK3A;WWP2;FOXO1;APC;SORL1;CSNK2A1;APC2;NEDD4L;NKD1;DACT1;SMURF1;RNF41;ACTN3;SMURF2;EGLN2;ASB5;RILP;OAZ2;VPS28;APOA2;TRIM32;SNF8;SEC22B;NDUFA13;OAZ1
gsea,regulation of protein ubiquitination (GO:0031396),0.29667145692327357,1.1154703245682334,0.26476190476190475,0.36402659788954983,1.0,45/45,96.41%,MYCBP2;BCL10;CHP1;GSK3A;SENP2;TGFBR1;NDFIP1;UBXN1;PTTG1IP;RCHY1;XIAP;OGT;SOX4;TRAF6;USP4;N4BP1;PRICKLE1;HDAC3;SPOPL;SASH1;WASHC1;CENPX;SQSTM1;WFS1;HDAC8;MINAR1;RPS3;PER2;LAPTM5;SIRT7;UBE3A;VPS28;AMER1;PSMD10;DERL1;CDK5RAP3;FBXO4;COMMD1;ARRB2;UBE2D1;FKBP1A;SVBP;NSMCE3;UBE2L3;NDFIP2
gsea,regulation of neurogenesis (GO:0050767),0.37408380947995684,1.1124936284194755,0.3234714003944773,0.3670029839082182,1.0,17/17,95.24%,HMGB2;BHLHE40;SORL1;NUMB;RGS14;NUMBL;HEY1;MME;PER2;HES7;SNW1;FAIM;YTHDF2;TRIM32;CTNNB1;HES6;B2M
gsea,positive regulation of cold-induced thermogenesis (GO:0120162),-0.36327176683600904,-1.1113717309330904,0.318,0.3565615280168245,1.0,8/18,38.08%,GNAS;BSCL2;UCP2;THRA;PEMT;PER2;CNOT3;ZBTB7B
gsea,glycoprotein biosynthetic process (GO:0009101),0.356106097525042,1.1106877255385526,0.32,0.3680864092975987,1.0,11/22,35.35%,B3GNT2;CANT1;CHST12;GOLPH3;LARGE1;B3GNT8;B3GALT2;B3GNT4;ST6GALNAC2;GAL3ST4;ALG1
gsea,cellular response to fibroblast growth factor stimulus (GO:0044344),0.34379504967508,1.1102354668621481,0.3192771084337349,0.3673934266392517,1.0,9/23,22.62%,NR4A1;TIAL1;MAPK1;FRS3;RAB14;FIBP;TIA1;DSTYK;MAPK3
gsea,response to interleukin-1 (GO:0070555),-0.35875717983931116,-1.1085238713775905,0.32842105263157895,0.35966414550031683,1.0,6/18,43.75%,PYCARD;LGALS9;MYD88;HYAL1;IGBP1;TNFRSF11A
gsea,protein localization to nucleus (GO:0034504),0.31910629695260473,1.1077443658782848,0.3215686274509804,0.3697303639219956,1.0,17/30,39.29%,NUP50;CNEP1R1;PAF1;STAT3;PTTG1IP;NOP53;TOR1A;DVL1;TAF8;MORC3;NXT2;TOPORS;APPL1;XPA;NUP62CL;PRICKLE1;TOR1AIP1
gsea,regulation of organelle assembly (GO:1902115),-0.31006325392131057,-1.1060661516822048,0.31958762886597936,0.36236734839563994,1.0,12/31,48.17%,IFT20;TBC1D10C;PDCD6IP;ATG3;TBC1D20;TBC1D16;RAB1B;KIF9;CDKL5;UBQLN2;DYNC2LI1;ATG5
gsea,positive regulation of proteolysis (GO:0045862),-0.3692091329141064,-1.105433520066475,0.32842105263157895,0.36246444460301025,1.0,7/16,21.19%,NDUFA13;CTSC;BAD;AURKAIP1;TRIM32;GBA;CASP8
gsea,histone deacetylation (GO:0016575),0.37451981743134877,1.1029131674338357,0.3528225806451613,0.37532675577846036,1.0,16/16,96.75%,SUDS3;RCOR1;MIER1;HDAC11;MTA3;MSL3;HDAC3;SIRT2;RCOR2;BRMS1;HDAC8;PER2;SIRT7;SMARCAD1;MORF4L1;SIN3B
gsea,negative regulation of cell differentiation (GO:0045596),-0.28781144837687084,-1.1024849044132101,0.2936170212765957,0.36585235462742544,1.0,23/42,46.57%,ID2;WDR61;ITGAV;CCDC85B;SRA1;CHADL;BBS12;YTHDF2;TRPM4;MAD2L2;FGF23;SDHAF2;JAG1;EID2B;NPHP3;HPN;LRP5;SEMA4D;NOTCH4;GATA2;LIMD1;COL5A1;NELFB
gsea,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3405621394052244,1.102281880284765,0.31007751937984496,0.3749770832839172,1.0,12/23,33.40%,MCL1;MAP2K5;GSK3B;TGFBR1;SIAH2;RELA;EYA1;TERT;ZMYND11;RFFL;SRC;PELI3
gsea,positive regulation of cellular component biogenesis (GO:0044089),-0.32805443804515494,-1.10200939831701,0.30831643002028397,0.36568411582050253,1.0,13/24,38.57%,CHMP2A;SNF8;SUMO1;PDCD6IP;SH3GLB1;BRK1;FNIP2;VPS4A;SDCBP;TPR;RPS3;HYAL1;ERCC1
gsea,negative regulation of proteasomal protein catabolic process (GO:1901799),0.37404386478444057,1.101744130499379,0.33587786259541985,0.374367785129799,1.0,17/17,97.04%,FHIT;WAC;UBXN1;NOP53;BAG6;OGT;N4BP1;USP25;DDRGK1;GABARAPL2;AQP11;RYBP;SDCBP;EIF3H;PSMF1;LAMP3;RPL11
gsea,iron ion transport (GO:0006826),-0.3369358712454317,-1.0993175979206626,0.3293172690763052,0.3685673388889179,1.0,12/23,39.11%,FTH1;ARHGAP1;ATP6V1F;ATP6V1A;ATP6V1G2;ATP6V1H;ATP6V0D1;IREB2;ATP6V1E1;ATP6V1B2;TFR2;ATP6V0B
gsea,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.32643098766414125,-1.0988103197877421,0.30426356589147285,0.3684272031747849,1.0,9/25,19.77%,PYCARD;G3BP2;COMMD7;COMMD6;ARRB2;COMMD1;CDK5RAP3;PSMD10;OTULIN
gsea,neuron projection morphogenesis (GO:0048812),-0.2900437827681894,-1.0980981239557017,0.2851153039832285,0.36858752058050964,1.0,13/41,36.11%,CDC42;DBNL;RAB3A;CTNNB1;DBN1;RAB8A;NCKAP1L;ATL1;WASL;PARD6B;MAP1S;NYAP1;DTNBP1
gsea,regulation of protein-containing complex assembly (GO:0043254),0.32217168836879023,1.0972196682934852,0.3265720081135903,0.37939438627658345,1.0,27/27,99.74%,RAF1;TGFB1;GSK3B;PREB;EP300;NOP53;RIOK3;SORL1;BMF;TIRAP;SRC;TPPP;LCMT1;STXBP1;RPS3;KIF9;NAPA;FNIP2;BBS10;GBA;BRK1;SH3GLB1;ANKRA2;SUMO1;SAR1B;SAR1A;CDC42
gsea,protein localization to membrane (GO:0072657),-0.26416895623406644,-1.0965415070487718,0.29436325678496866,0.36997150271271284,1.0,36/70,40.34%,THY1;ITGB2;ITGB1BP1;ARL5A;RAB3A;EHD1;ABHD17A;SH3GLB1;ARL3;RAP1A;RAB12;LIN7C;SLC9A3R2;RAB8A;MAGI2;ATP1B3;TSPAN17;LIN7B;KCNIP3;SYNJ2BP;TM9SF3;HPS6;RABEP1;PIGW;RAB40C;ZDHHC3;F11R;RAB8B;RAB3B;TM9SF2;P2RY1;STXBP1;LRRC4;ZDHHC23;IKBKB;KCNB1
gsea,regulation of cell motility (GO:2000145),0.2997625460907505,1.0958237732626164,0.30828516377649323,0.38012526461557045,1.0,39/39,98.01%,RAF1;PKN2;TGFB1;CFAP20;ARHGAP18;PLXNA3;AKT2;NTN1;DAPK3;PRKX;DOCK10;BEX4;CRK;PKN1;PLXNB1;SGK3;ABL2;CADM4;FRMD5;LDB1;MEAK7;TACSTD2;EGF;CCDC25;FGF20;CAMSAP3;PRAG1;NRG2;PARD6B;NRG4;ERBB3;FGF23;SPINT2;TRIM32;MGAT3;WAS;PHPT1;RHOA;RAC1
gsea,plasma membrane bounded cell projection organization (GO:0120036),0.29236233436284476,1.0925102129940953,0.3262135922330097,0.38375641772974917,1.0,22/43,37.93%,HMGB1;FRYL;GSK3B;CDK5;RAB11A;TOR1A;SLC9A3R1;FAM161B;PQBP1;SAMD14;ARMC2;CARMIL1;TBC1D24;WDPCP;MARK4;TTC17;ZFYVE27;LRP12;FAM161A;PLP1;ATP1B2;BLOC1S6
gsea,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.29297309633613955,1.0917346598669018,0.3134057971014493,0.3835640866160263,1.0,20/39,40.17%,DDX5;TGFB1;TGFBR1;UBC;RNF111;PARD6A;SMAD4;ZFYVE9;MAPK3;FNTA;ACVR1B;PTK2;SRC;APPL1;SMURF1;ACVR2A;CITED1;RGMA;ACVR2B;BMPR1A
gsea,cell-cell junction organization (GO:0045216),0.3622353975161614,1.0912668376280308,0.3291814946619217,0.38289691454750263,1.0,10/20,26.81%,TGFB1;CDH24;PARD6A;ARVCF;TLN2;CDH11;LIMS1;NECTIN1;TJP3;CXADR
gsea,regulation of innate immune response (GO:0045088),-0.3646019092815721,-1.0850580945571087,0.34782608695652173,0.38574408957486533,1.0,6/16,30.00%,CDC37;IFI35;NMI;RNF135;CASP8;TYRO3
gsea,regulation of protein catabolic process (GO:0042176),0.29695154105045896,1.0848942129221508,0.3378119001919386,0.3908822170789276,1.0,36/36,98.37%,CDKN1B;GSK3B;ITCH;GSK3A;WWP2;FOXO1;APC;SORL1;CSNK2A1;WDR91;APC2;NEDD4L;NKD1;DACT1;SMURF1;SNX12;AZIN2;RNF41;CTSA;SIRT2;SMURF2;RAB26;EGLN2;ASB5;CHMP6;RILP;SNX3;OAZ2;AGAP2;VPS28;MAD2L2;TRIM32;SNF8;SEC22B;NDUFA13;OAZ1
gsea,glycolipid metabolic process (GO:0006664),-0.35252981811976203,-1.0843370700454065,0.37058823529411766,0.3859865511557604,1.0,9/19,39.01%,ESYT1;ASAH1;UGCG;SUMF1;GBA;PIGW;GLB1;NEU3;SMPD2
gsea,positive regulation of kinase activity (GO:0033674),0.32485407218010504,1.083762252503635,0.35727109515260325,0.3914198011966282,1.0,10/28,27.21%,PTPRC;MAPRE3;TAB2;PRKAG1;F2;INSR;IGF1R;DSTYK;EPHB6;PTK2
gsea,positive regulation of type I interferon production (GO:0032481),-0.36943962135533553,-1.0830524254930198,0.36531365313653136,0.3868718711887391,1.0,6/16,24.74%,POLR2K;LRRFIP1;CTNNB1;CRCP;RNF135;MYD88
gsea,calcium ion transport (GO:0006816),0.31142778230300816,1.0791420097771727,0.351985559566787,0.39689639342738325,1.0,17/33,30.34%,TPT1;FYN;MCOLN1;STIM1;TRPM7;TRPM6;CACNG7;CACNA1D;SLC24A1;TRPC4AP;CRACR2B;CACNA1I;ATP2C1;PKD1;SLC24A3;MICU1;ATP2A1
gsea,organic anion transport (GO:0015711),-0.3347712483650248,-1.077358270248564,0.3355855855855856,0.39425805683503595,1.0,9/20,43.80%,CYB5R4;SLC25A4;MFSD10;SLC35A2;SLCO5A1;SLC4A11;SLC35B4;SLC2A10;CYB5RL
gsea,autophagosome assembly (GO:0000045),-0.30720149194160623,-1.0767302655416944,0.33268858800773693,0.39428029343280585,1.0,15/32,48.51%,EMC6;VMP1;MAP1LC3B;BECN1;UBXN2A;RAB1A;ATG3;RAB1B;GABARAPL2;UBQLN2;RAB19;GABARAPL1;MAP1LC3A;ATG5;WDR45B
gsea,negative regulation of neuron death (GO:1901215),0.3107404809776783,1.0741963988065533,0.3464419475655431,0.4029112344112437,1.0,14/30,42.27%,GSK3B;CDK5;SOD1;TNFRSF1B;SORL1;CNTF;INPP5A;MAG;BTBD10;CITED1;PPT1;NRBP2;MDK;POU4F1
gsea,mitotic nuclear division (GO:0140014),-0.3659196920105209,-1.0709389366506228,0.39344262295081966,0.40189962955455316,1.0,8/15,40.11%,CHMP2A;CHMP4B;RHOA;SPAST;KLHDC8B;ABRAXAS2;TUBG2;ARHGEF10
gsea,positive regulation of viral process (GO:0048524),0.3360294128775452,1.069217108409559,0.3531827515400411,0.4089881782939741,1.0,21/21,94.43%,CD28;PKN2;SRPK2;RSF1;STAU1;CCNT1;NELFA;ADARB1;NELFB;CDK9;CNOT7;PDE12;TYRO3;VPS4A;POLR2I;VAPB;TBC1D20;POLR2D;POLR2J;POLR2G;POLR2K
gsea,positive regulation of interleukin-8 production (GO:0032757),-0.37498452324153764,-1.0671874519895757,0.3696969696969697,0.4065342517803234,1.0,6/15,24.74%,PYCARD;LAMTOR5;LGALS9;RAB1A;APOA2;MYD88
gsea,cholesterol metabolic process (GO:0008203),-0.3485847677369973,-1.0668659650015964,0.3624031007751938,0.40612137069379567,1.0,10/18,36.20%,ACAA2;SOAT2;EBP;PLPP6;APOA2;GBA;GGPS1;SNX17;ARV1;LCAT
gsea,regulation of Notch signaling pathway (GO:0008593),0.30275741468282835,1.063891792089498,0.34879406307977734,0.4157258236675443,1.0,33/33,96.28%,LFNG;EP300;ARRDC1;WWP2;MAML1;TSPAN14;STAT3;LLGL2;RBPJ;HIF1AN;SRC;CD46;TSPEAR;HEY1;NOD2;NOS3;EGF;ZBTB7A;RFNG;BEND6;GATA2;NOTCH4;YJEFN3;PRAG1;JAG1;SYNJ2BP;TM2D3;SNW1;YTHDF2;GALNT11;MFNG;PDCD10;ITGB1BP1
gsea,regulation of fat cell differentiation (GO:0045598),-0.3370753873778332,-1.0638081854165156,0.35135135135135137,0.4096783532574775,1.0,8/20,41.51%,ID2;CCDC85B;CCDC71L;BBS12;TRPM4;LRP5;RARRES2;GATA2
gsea,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3443502427221603,1.0630991133277516,0.3689516129032258,0.41552388407152513,1.0,19/19,98.99%,TAX1BP1;GPS2;RNF31;PTPN2;CYLD;RBCK1;SHARPIN;RFFL;PELI3;UBE2K;IKBKB;LAPTM5;TRADD;CASP8;OTULIN;SPPL2A;CFLAR;GSTP1;PYCARD
gsea,mitochondrion disassembly (GO:0061726),0.337364304327362,1.0614923410527382,0.3700623700623701,0.41646819066702545,1.0,22/22,93.38%,GABARAP;WIPI2;MARK2;RB1CC1;WDR45;ATG9A;CISD2;ATG12;WIPI1;WDR45B;ATG5;MAP1LC3A;GABARAPL1;SQSTM1;GABARAPL2;FBXO7;FUNDC1;FUNDC2;ATG3;FIS1;BECN1;MAP1LC3B
gsea,negative regulation of cellular protein metabolic process (GO:0032269),0.3179701263495115,1.0533857704343845,0.3675889328063241,0.42713111772288737,1.0,26/26,98.40%,PCIF1;RPL13A;CDK5;SAMD4B;BAG6;RIC1;DAPK3;DDX6;CLN8;F2;DHX36;LSM14A;PAIP2;ATRAID;CNOT8;RNF139;CNOT7;MALSU1;RBM4;RPS3;FXR1;DNAJC1;CPEB3;CDK5RAP3;EIF4E2;CSTB
gsea,negative regulation of cell death (GO:0060548),0.30560087212971854,1.0533217028595894,0.376,0.42580660338493,1.0,14/27,33.56%,FYN;GSK3B;CDK5;TNFRSF1B;SORL1;PDE8A;INPP5A;SOX4;DCPS;WNT16;VPS4B;BTBD10;TXNDC12;NCK1
gsea,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.32493721219142746,1.0530446336795705,0.384180790960452,0.424834379917712,1.0,22/22,97.16%,POLD4;UBC;DCP1B;PNRC2;XRN2;EDC3;XPA;EXD2;DNASE1L1;UBA52;DNASE1L2;FAN1;TREX1;REXO4;ERCC1;PDE12;SETMAR;RNASE4;SPO11;DNASE1;GTF2H5;RBX1
gsea,peptidyl-lysine modification (GO:0018205),0.3077215218140132,1.0525083419542518,0.35714285714285715,0.4243009889266079,1.0,29/29,95.28%,PIAS1;NUP50;EP300;SENP2;KAT5;NSMCE2;SENP6;LOXL3;METTL21C;EYA1;TOPORS;STX1A;ATP7A;SIRT2;VIPAS39;P3H4;LIPT1;TPR;ESCO1;UBE2I;EEF1AKMT2;SIRT7;EEF1AKMT3;BLOC1S1;TRPM4;SUMO1;EEF1AKMT1;METTL21A;VCPKMT
gsea,positive regulation of metabolic process (GO:0009893),-0.3368680875406459,-1.0523006057417859,0.38589211618257263,0.4257759178413405,1.0,10/20,48.58%,GNAS;BSCL2;UCP2;THRA;PEMT;PER2;CNOT3;ZBTB7B;PRKAB1;ADIPOR1
gsea,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3518820923024718,-1.0498764909070715,0.3902439024390244,0.42841512865565684,1.0,8/17,38.71%,RPL11;PDCL3;SGTA;RPS7;EIF3H;SDCBP;RYBP;RPL23
gsea,toll-like receptor signaling pathway (GO:0002224),-0.3163345314793401,-1.0496582993797412,0.38144329896907214,0.42787229983578695,1.0,12/25,39.79%,ITGB2;CTSB;NMI;LGALS9;UBE2D1;TICAM1;UBE2D3;CASP8;MYD88;LY96;IRAK4;IKBKB
gsea,phospholipid transport (GO:0015914),0.3528763593107135,1.049283249463248,0.3984375,0.4276506969543638,1.0,17/17,95.80%,ATP9B;PITPNC1;ATP11B;OSBPL8;ABCA3;PITPNM1;ATP9A;ATP8A2;TMEM30B;MTTP;NPC2;TRIAP1;SCP2;APOA2;SCARB2;PITPNA;TMEM30A
gsea,neuron projection development (GO:0031175),0.2696797584519652,1.0489383321813919,0.38593155893536124,0.42677633421157934,1.0,56/56,99.74%,HMGB1;FRYL;GSK3B;CDK5;PTEN;RAB11A;DNM2;MARK2;WHRN;TOR1A;GAS7;OMG;MAPK8IP3;PQBP1;TRIO;SAMD14;SLC9A6;DOCK10;CNTNAP1;TAOK3;TBC1D24;MYO16;PLXNB1;ZFYVE27;LRP12;PLP1;BLOC1S6;POU4F1;ATP7A;CDK5R1;DLG4;NRTN;NBL1;STX3;DTNBP1;NYAP1;BLOC1S4;MAPT;MAP1S;SNAPIN;WASL;AGER;NCKAP1L;RAB35;VAPA;BLOC1S3;GBA;GPRIN2;BLOC1S1;DBN1;UHMK1;EHD1;ATXN10;DBNL;SVBP;CDC42
gsea,phagosome maturation (GO:0090382),0.3571081809262231,1.0457116216139495,0.3888888888888889,0.4302176549848159,1.0,9/17,38.62%,RAB43;ATP6V1D;MCOLN1;ATP6V1G1;RAB14;ATP6V0C;ATP6V0A1;RAB31;ATP6V1C1
gsea,establishment of protein localization to membrane (GO:0090150),0.3083394743486956,1.0453627561987873,0.3782178217821782,0.4293332499317101,1.0,27/27,99.47%,RAB11B;VPS37B;RAB10;RAB11A;OXA1L;BRAF;VPS37D;ZDHHC23;AQP11;ZDHHC9;ZDHHC1;NECTIN3;SEC63;VPS37A;RABGEF1;SDCBP;ZDHHC3;GORASP1;ZDHHC18;ZDHHC20;ZDHHC4;ARL6;ZDHHC7;ATG3;YIF1B;GOLGA7;NACA
gsea,negative regulation of immune response (GO:0050777),-0.2721502709987942,-1.0447853039853219,0.36519607843137253,0.43453460204098593,1.0,20/45,42.94%,CD3G;GNG2;GNB1;NMI;PDCD1;PRKACA;GPR150;GPR176;ADCY3;GGT1;GPR45;ADCY9;ADCY7;HTR6;TYRO3;FER;POMC;TRIM27;TREM2;PRKACB
gsea,positive regulation of secretion by cell (GO:1903532),-0.33339185276335315,-1.0440416686810465,0.39461883408071746,0.4346983615767441,1.0,10/19,40.34%,IER3IP1;UNC13D;RAB3A;NMB;RAB27B;EXOC1;DTNBP1;ANG;TREM2;KCNB1
gsea,protein maturation (GO:0051604),-0.30318245283717704,-1.043204556376422,0.37473684210526315,0.4350973568067585,1.0,12/29,36.60%,CIAO2A;NFU1;SRGN;CIAO2B;CASP2;BOLA2;TSPAN17;APH1B;PSEN1;ASPRV1;LIPT1;ISCA1
gsea,autophagy of mitochondrion (GO:0000422),0.32830100636640214,1.0421030339497925,0.391578947368421,0.43283768636098113,1.0,23/23,93.38%,GABARAP;WIPI2;MARK2;RB1CC1;WDR45;ATG9A;ATG13;CISD2;ATG12;WIPI1;WDR45B;ATG5;MAP1LC3A;GABARAPL1;SQSTM1;GABARAPL2;FBXO7;FUNDC1;FUNDC2;ATG3;FIS1;BECN1;MAP1LC3B
gsea,protein secretion (GO:0009306),-0.3295936893999321,-1.0387550992325714,0.40176600441501104,0.4410406964997429,1.0,7/19,33.42%,CYB5R4;SVBP;RAB3A;RAB12;RAB8A;RAB8B;RAB3B
gsea,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.32415814226800904,1.0382200566660587,0.4046692607003891,0.43728566717207934,1.0,9/22,31.08%,TGFB1;TGFBR1;UBC;CD109;LDLRAD4;IL17RD;DAND5;HTRA4;SMURF1
gsea,cholesterol homeostasis (GO:0042632),0.3460131105150233,1.0363880540347683,0.3824626865671642,0.4371436658582319,1.0,8/18,31.55%,IL18;TTC39B;LAMTOR1;NR1H2;LDLRAP1;CYP39A1;ABCA5;NR1D1
gsea,sterol homeostasis (GO:0055092),0.3460131105150233,1.0363880540347683,0.3824626865671642,0.4371436658582319,1.0,8/18,31.55%,IL18;TTC39B;LAMTOR1;NR1H2;LDLRAP1;CYP39A1;ABCA5;NR1D1
gsea,response to ionizing radiation (GO:0010212),0.3511218434530714,1.0298355711825535,0.41935483870967744,0.44581696954499916,1.0,12/17,28.81%,STK11;KAT5;BABAM1;BABAM2;MAPK14;NABP2;XRRA1;XRCC4;INIP;EYA1;USP28;UIMC1
gsea,regulation of protein targeting to membrane (GO:0090313),0.3569100662782527,1.0271552505195418,0.436399217221135,0.44849724640983907,1.0,7/15,22.64%,FYN;GDI1;CHP1;MFF;AKT2;INPP5K;ANK3
gsea,phospholipid metabolic process (GO:0006644),-0.3065065456483006,-1.0252620165768553,0.4170124481327801,0.4616658992257532,1.0,11/22,39.01%,PLAAT3;LPCAT4;APOA2;PLA2G15;AGPAT3;FITM2;GPAM;PLBD2;LCAT;PLA2G4C;SMPD2
gsea,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.33028993443545596,-1.024517757397135,0.4306418219461698,0.4618797624513327,1.0,11/19,42.76%,RPS6KA1;DNAJB6;LAMTOR5;BEX3;LAMP3;TRIAP1;BCL2L12;HGF;RNF34;NOL3;IGBP1
gsea,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.29806584464457275,1.020573367559849,0.42376237623762375,0.4571910170622661,1.0,15/30,43.66%,HMGB1;PTPRC;TGFB1;PTPN22;PDE8A;MAP2K7;CRKL;BRAF;DSTYK;MAPK3;PRXL2C;TIRAP;MAP3K12;ATP6AP1;NOD2
gsea,cytoplasmic microtubule organization (GO:0031122),0.3437356613612116,1.0191111750133934,0.4137254901960784,0.4579303217334914,1.0,17/17,93.23%,CHP1;RAB11A;SLAIN2;DLG1;CEP126;VPS4B;TPPP;LIMK2;KATNAL2;KATNA1;CAMSAP3;CRIPT;MAPT;KATNAL1;SPAST;CIB1;RHOA
gsea,protein import into nucleus (GO:0006606),0.3444948404572027,1.018174292389533,0.44106463878326996,0.45791921402786184,1.0,9/16,39.11%,NUP50;STAT3;PTTG1IP;KPNA4;KPNA1;NXT2;APPL1;NUP62CL;PRICKLE1
gsea,intracellular pH reduction (GO:0051452),-0.3560091622120837,-1.0172168133266362,0.41106719367588934,0.47244160811953956,1.0,9/15,41.77%,ATP6V1F;ATP6V1A;ATP6V1G2;ATP6V1H;ATP6V0D1;ATP6V1E1;ATP6V1B2;ATP6V0B;CLCN3
gsea,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.3395559118295577,-1.0149992575150033,0.42083333333333334,0.47488122569216396,1.0,6/16,29.49%,PYCARD;CUEDC2;TICAM1;MYD88;PLD3;ADCY7
gsea,negative regulation of response to stimulus (GO:0048585),0.35104650143201266,1.0137977695206928,0.44145873320537427,0.46341828702056503,1.0,9/17,25.16%,PTPN1;MAP2K5;UBASH3B;AKT3;NR1H2;HMGA2;GGT7;CASK;TERT
gsea,water-soluble vitamin metabolic process (GO:0006767),0.3403593680747957,1.0122947915935394,0.42003853564547206,0.4642694999992241,1.0,16/16,92.67%,PANK2;CYB5R3;MMAA;TPK1;LMBRD1;GSTO2;ABCD4;AMN;PCCB;SLC46A1;MTHFS;RFK;SLC5A6;THTPA;CYB5A;FLAD1
gsea,glycosphingolipid metabolic process (GO:0006687),-0.3345340997792181,-1.0083885674359814,0.4714285714285714,0.48422473399894456,1.0,8/18,39.01%,ESYT1;ASAH1;UGCG;SUMF1;GBA;GLB1;NEU3;SMPD2
gsea,negative regulation of translation (GO:0017148),0.30371979113894737,1.0018406811733538,0.4547325102880658,0.4790937855934035,1.0,27/27,97.63%,PCIF1;RPL13A;SAMD4B;EIF4EBP3;EIF4EBP2;DAPK3;DDX6;YTHDF1;MEX3D;DHX36;LSM14A;PAIP2;CNOT8;CPEB4;RNF139;PUM1;CNOT7;MALSU1;RBM4;RPS3;TPR;FXR1;YTHDF3;YTHDF2;CPEB3;EIF3E;EIF4E2
gsea,myeloid leukocyte differentiation (GO:0002573),-0.3096735041243956,-1.0004598731906091,0.43736730360934184,0.4962786282125871,1.0,12/20,43.75%,CDC42;LGALS9;GLO1;TGFBR2;CASP8;OSTM1;BATF;PDE1B;PIR;TREM2;EFNA2;TNFRSF11A
gsea,fatty acid metabolic process (GO:0006631),-0.29453504975279043,-0.9972267619707249,0.4577319587628866,0.5004477344411341,1.0,14/26,42.62%,ACOT2;ACOT8;PLA2G15;LPIN3;GGT1;GPAM;PON2;CROT;ACOT6;CPT1B;PER2;ACOT7;ACBD5;ACSF3
gsea,apical junction assembly (GO:0043297),-0.3158942933277629,-0.9948130913663319,0.43776824034334766,0.5032604450400159,1.0,9/19,47.58%,WDR1;RHOA;PDCD6IP;F11R;PARD6B;OCLN;CLDN23;CRB3;GRHL2
gsea,phosphatidylcholine metabolic process (GO:0046470),-0.2974987580253104,-0.9786026781320661,0.4874476987447699,0.5292811825814494,1.0,12/23,38.31%,PLAAT3;LPCAT4;CSNK2B;APOA2;PLA2G15;LPIN3;PHOSPHO1;ABHD3;PEMT;CEPT1;LCAT;PLA2G4C
gsea,regulation of translational initiation (GO:0006446),-0.2891503690312911,-0.9781701745050646,0.4752475247524752,0.5288104148201119,1.0,16/28,34.58%,EIF3E;POLR2G;POLR2D;ALKBH1;UHMK1;YTHDF2;DNAJC3;KHDRBS1;EIF3H;YTHDF3;EIF4A2;CSDE1;TPR;PPP1R15B;EIF1B;RBM4
gsea,protein localization to plasma membrane (GO:0072659),0.25696910737849343,0.9751124271649269,0.5075187969924813,0.5207064961284338,1.0,46/46,96.28%,RAPGEF6;RAB10;RAB11A;TSPAN14;DLG1;TMEM88;ASB3;FCHO2;SLC9A3R1;INPP5K;PPIL2;SCN3B;PIP5K1A;ANK3;EFR3B;TMEM150A;SPTBN4;SMURF1;ZFYVE27;EFR3A;PRAM1;PDZK1;CRB3;KCNB1;IKBKB;ZDHHC23;STXBP1;P2RY1;NECTIN3;RAB3B;RAB8B;F11R;ZDHHC3;RAB40C;PIGW;GORASP1;KCNIP3;TSPAN17;ATP1B3;RAB8A;SLC9A3R2;RAB12;RAP1A;EHD1;RAB3A;ITGB1BP1
gsea,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.27215062758740544,0.974546616310851,0.4826923076923077,0.5200319689218857,1.0,17/34,42.37%,TGFB1;TGFBR1;UBC;SORL1;CD109;LEMD2;SMAD4;LDLRAD4;IL17RD;DAND5;HTRA4;SMURF1;ACVR2A;FSTL3;ACVR2B;BMPR1A;PPM1A
gsea,regulation of cell death (GO:0010941),0.2860266782575818,0.9709983969742292,0.490272373540856,0.524240868360985,1.0,13/28,36.91%,CDKN1B;CHP1;TNFRSF1B;APC;PDE8A;LRP1;SOX4;WNT16;VPS4B;TBK1;TXNDC12;NCK1;RAB29
gsea,positive regulation of Ras protein signal transduction (GO:0046579),-0.33592012997646825,-0.9686370709779275,0.4854771784232365,0.5438108800399206,1.0,8/15,33.27%,RAC1;GRB2;LPAR6;VAV1;F11R;NTRK1;MAPRE2;PRAG1
gsea,sodium ion transport (GO:0006814),-0.3234205701412761,-0.9685311528294573,0.5258426966292135,0.5428553179793182,1.0,5/16,26.73%,NDUFA9;PKD2;SLC5A6;ATP1B3;SLC4A11
gsea,receptor metabolic process (GO:0043112),-0.3008603321624066,-0.9677270867033678,0.49256900212314225,0.5431558040166592,1.0,9/21,37.64%,ITGB2;GRB2;ARRB2;BECN1;SH3GLB1;PLEKHJ1;MVB12A;AP2M1;PHETA2
gsea,Golgi to plasma membrane transport (GO:0006893),-0.28901106363901025,-0.9652414248745946,0.47413793103448276,0.5463722218039568,1.0,15/27,45.22%,GOLGA7;COMMD1;VAMP2;BLZF1;ARL3;VAMP4;GOPC;CCDC93;RABEP1;EXOC1;EXOC5;RAB26;AMN;EXOC6;BBS1
gsea,cation transport (GO:0006812),-0.2574076020988693,-0.9612587147519573,0.5249406175771971,0.5520302173622708,1.0,18/36,41.49%,NDFIP2;NDUFA9;KCNA4;TRPM4;SLC5A6;KCNK3;SLC8B1;KCNK6;SLC36A1;SLC29A4;SLC4A11;PKD1L3;KCNIP2;PANX1;SLC36A3;KCNH1;KCNAB3;CHRNB1
gsea,monocarboxylic acid metabolic process (GO:0032787),-0.27530839670326107,-0.9612399522547308,0.4875,0.5509077675827381,1.0,16/28,38.55%,ACOT2;GLO1;SCP2;SLC5A6;HAGH;GGT1;GPAM;CROT;ACOT6;MTHFS;CPT1B;PDHB;PER2;GAMT;PCCB;ACOT7
gsea,regulation of Wnt signaling pathway (GO:0030111),-0.2668432373870418,-0.9591384661524986,0.5331858407079646,0.5534170911796691,1.0,12/33,28.55%,PPP1CA;PPP2R1A;CTNNB1;GSKIP;CCNY;AMER1;OTULIN;TCF7L1;CTNNBIP1;DISC1;SNX3;PSEN1
gsea,positive regulation of catalytic activity (GO:0043085),-0.316158198252005,-0.9539243922886169,0.5220883534136547,0.5613494749559117,1.0,7/18,53.31%,SSBP1;CIB1;PSEN1;B3GAT3;YWHAB;APH1A;ATP7A
gsea,cell-cell junction assembly (GO:0007043),-0.28923247329511353,-0.9446926076785198,0.5223214285714286,0.5758567409507125,1.0,8/22,28.50%,WDR1;RHOA;CTNNB1;TLN1;GJA5;CLDN12;GJD3;PARD6B
gsea,ribosomal small subunit biogenesis (GO:0042274),-0.37110243068721993,-0.9398209106229651,0.5060483870967742,0.5832718927196451,1.0,6/15,32.30%,RPS6;RPS19;LSM6;RPS7;RIOK1;RPS28
gsea,cognition (GO:0050890),0.32230363819193075,0.9396145264798211,0.5502958579881657,0.5744952609293738,1.0,15/15,93.29%,NIPBL;TUSC3;METTL23;DGCR2;JAKMIP1;SETD5;CTNS;SOBP;CHRNB2;GPR155;TTC8;RP9;LINS1;MGAT3;CHMP2B
gsea,positive regulation of JNK cascade (GO:0046330),-0.31389709124429555,-0.9365958268926085,0.5501066098081023,0.5876071846316403,1.0,7/17,42.79%,PYCARD;MAP3K10;ANKRD6;AGER;SDCBP;TPD52L1;MBIP
gsea,positive regulation of macroautophagy (GO:0016239),-0.32683465154324526,-0.9363255303016713,0.5240963855421686,0.586867932165139,1.0,6/15,36.56%,SLC25A4;TRIM13;SH3GLB1;BNIP3L;PAFAH1B2;EPM2A
gsea,lipid transport (GO:0006869),0.2905823783481824,0.935311273772452,0.5752895752895753,0.5797680841706506,1.0,12/23,40.43%,GLTP;PITPNC1;OSBPL8;ABCA3;PITPNM1;CLN8;SLC27A4;SLC10A1;ABCA5;SLC51A;MFSD2B;SLC10A3
gsea,external encapsulating structure organization (GO:0045229),-0.25494961582321585,-0.9348647040811718,0.5626535626535627,0.5881334806670024,1.0,17/36,51.45%,ITGB2;ITGAV;MMP11;F11R;MMP28;ITGB5;COL8A2;ADAMTS10;NID2;ADAMTSL5;ICAM4;COL5A1;COL18A1;LAMB2;COL23A1;ICAM5;COL9A3
gsea,RNA transport (GO:0050658),-0.30424517053133654,-0.9236566215032862,0.5527950310559007,0.6067167985228018,1.0,7/16,30.13%,RTRAF;SRSF11;THOC7;TGFBR2;SRSF5;CDC40;TPR
gsea,glycerophospholipid metabolic process (GO:0006650),-0.2750985538345466,-0.923247855464204,0.5615550755939525,0.6062302693899122,1.0,13/25,43.30%,PIGP;PRDX6;DPM2;SERINC1;PLA2G15;GDPD1;PIGM;PIGW;ABHD3;PIGX;LCAT;PLA2G4C;PLCB3
gsea,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.25371865500292523,-0.9231013392010083,0.5641025641025641,0.6052869538346599,1.0,13/32,44.50%,PDCD5;FKBP1A;RHOA;ARRB2;TGFBR2;ZYX;LEFTY1;NR3C1;F11R;PXN;ITGB5;TGFBR3L;SMAD2
gsea,negative regulation of protein ubiquitination (GO:0031397),0.306887494122696,0.9194769556144553,0.5524752475247525,0.6050610016436035,1.0,7/17,28.54%,CHP1;SENP2;UBXN1;OGT;SOX4;USP4;N4BP1
gsea,positive regulation of protein secretion (GO:0050714),0.3212672710441834,0.9194084037552903,0.5551470588235294,0.6033381659574901,1.0,7/16,40.12%,TGFB1;ARF6;GOLPH3;SOX4;GCK;GOLPH3L;LRRC8A
gsea,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.31089587403046737,0.9166645856875106,0.5666041275797373,0.6062132209449508,1.0,8/18,30.77%,HCST;IL18;INSR;IGF1R;WNT16;PTK2;SRC;PLXNB1
gsea,cytosolic transport (GO:0016482),0.2375836199736726,0.9109989966428873,0.6048387096774194,0.6139010216609843,1.0,24/48,44.11%,SPAG9;VPS13A;TBC1D10A;ARFRP1;RAB14;MON2;RIC1;VTI1A;STX6;GGA1;GOSR1;VPS54;WDR91;PHETA1;SNX32;SORT1;PIK3C3;TBC1D17;VAMP3;RAB29;RAB5A;MYO1D;TMEM87B;RAB6A
gsea,response to cytokine (GO:0034097),-0.2442085436106422,-0.9087930558317334,0.6145833333333334,0.6297557163992972,1.0,15/38,43.75%,HCLS1;PTPN18;RHOA;LGALS9;TRIM32;LAMP3;PTPN14;CASP8;GGT1;MYD88;IL1RL2;CDK9;MME;IGBP1;TNFRSF11A
gsea,intra-Golgi vesicle-mediated transport (GO:0006891),-0.2934985939822294,-0.9073139586394655,0.5843881856540084,0.6309800999721197,1.0,11/20,41.90%,COPE;TRAPPC3;COPB1;VTI1B;NAPA;COPZ1;TRAPPC3L;COG1;GABARAPL2;NAPG;COG8
gsea,protein-containing complex disassembly (GO:0032984),-0.26026132724746026,-0.9072385005623549,0.625,0.6298440433684471,1.0,16/29,46.78%,PPP1CA;MAP1LC3B;CTNNB1;SNAP29;AMER1;VTI1B;LAMP2;VPS4A;RUBCNL;CHMP3;GABARAPL2;RPL23;VIPAS39;GABARAPL1;MAP1LC3A;CSNK1A1
gsea,negative regulation of cellular amide metabolic process (GO:0034249),-0.27388527263302387,-0.9070479865585939,0.594,0.6289438562446225,1.0,14/24,45.32%,EIF4E2;RTN4;ORMDL1;CPEB3;ORMDL2;BIN1;FXR1;RPS3;RBM4;MALSU1;RTN2;CNOT7;RNF139;CNOT8
gsea,glycoprotein metabolic process (GO:0009100),-0.30060719502873945,-0.9051352791476822,0.5895833333333333,0.6312163563576125,1.0,7/18,34.12%,ERP44;FBXO6;MAN2B1;FBXO17;MAN1A2;MANBA;ENGASE
gsea,sterol metabolic process (GO:0016125),-0.29962103513620525,-0.9027330670732016,0.5551257253384912,0.6342109781924332,1.0,8/16,41.61%,SOAT2;LIPA;EBP;APOA2;GBA;ARV1;LCAT;OSBPL1A
gsea,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3059189470515211,-0.8906697051297803,0.6170212765957447,0.6539004727651901,1.0,8/16,48.55%,UFM1;RNF14;UBA5;KCTD6;RNF6;GPAM;DNAAF4;DDRGK1
gsea,Golgi to plasma membrane protein transport (GO:0043001),-0.2891503922336662,-0.8850204608904493,0.6394849785407726,0.6625047375035374,1.0,18/18,96.71%,GOLGA7;VAMP2;BLZF1;VAMP4;RAB26;AMN;BBS1;SYS1;KRT18;GOLPH3L;RAB31;ANK3;KIF13A;BBS2;GGA1;GOLPH3;ARFRP1;RAB10
gsea,regulation of neuron apoptotic process (GO:0043523),0.25238292671199203,0.8791233544363297,0.6428571428571429,0.666841117404936,1.0,31/31,90.78%,CDK5;SRPK2;SOD1;CNTF;MAG;BACE1;CITED1;PPT1;NRBP2;MDK;TFAP2A;POU4F1;NSMF;CDK5R1;CRLF1;CPEB4;KCNB1;TREM2;WFS1;UNC5B;SNX6;FGF20;SIX1;EGLN2;TYRO3;NTRK1;FZD9;ERBB3;AGAP2;TRIM2;CTNNB1
gsea,purine ribonucleotide biosynthetic process (GO:0009152),-0.2960372524412154,-0.8769209135724227,0.63125,0.6751322100025341,1.0,9/16,38.55%,NUDT2;PAPSS1;SLC35B3;ACAT1;ADCY3;PPCDC;ADCY9;ADCY7;ACOT7
gsea,histone H3 acetylation (GO:0043966),0.2988349624743079,0.8719465674085778,0.6329365079365079,0.6767793375101423,1.0,15/15,97.89%,MEAF6;BRD1;LEF1;PHF14;NAA60;ING4;TAF12;TAF5L;LDB1;MBIP;SUPT7L;DR1;TADA1;TRIM16;TAF10
gsea,regulation of calcium ion transport (GO:0051924),0.3013499350470415,0.8713661024513293,0.6428571428571429,0.6757287211672152,1.0,15/15,98.53%,ATP2B1;SARAF;STIM1;INPP5K;CAMK2B;CACNA1D;CD84;MYLK;EGF;HOMER3;WFS1;SLC8B1;PKD2;CTNNB1;SRI
gsea,regulation of secretion by cell (GO:1903530),-0.2970760013955602,-0.870144760985689,0.6376518218623481,0.685699794580225,1.0,8/15,33.42%,RAB3A;VAMP2;DNAJC1;RAB12;RAB8A;RAB8B;RAB26;RAB3B
gsea,establishment of protein localization to extracellular region (GO:0035592),0.28917457687929005,0.8696210229244473,0.6616541353383458,0.6767463472504411,1.0,17/17,94.68%,RAB10;PREB;GOLPH3;STEAP3;TVP23A;OLFM2;SEL1L;MON1A;TANGO2;NECAB3;MTTP;RAB3B;RAB8B;RAB8A;RAB12;RAB3A;SVBP
gsea,ion transport (GO:0006811),-0.25127654054153625,-0.8693028617113686,0.649890590809628,0.6857923965655108,1.0,10/25,41.49%,TSPO;LASP1;SLC8B1;SLC25A26;SLC36A1;PKD1L3;PANX1;CHRNB2;AQP11;CHRNB1
gsea,regulation of BMP signaling pathway (GO:0030510),0.2830225100693763,0.8646070309860353,0.6380368098159509,0.6832242014075964,1.0,12/19,40.17%,SORL1;XIAP;LEMD2;SMAD4;DAND5;RBPJ;SMURF1;ACVR2A;FSTL3;RNF165;ACVR2B;BMPR1A
gsea,protein localization to cell periphery (GO:1990778),-0.21611311976751174,-0.8481802198756965,0.7510729613733905,0.7205542391762476,1.0,26/49,43.88%,ITGB1BP1;RAB3A;EHD1;ARL3;RAP1A;RAB12;LIN7C;SLC9A3R2;RAB8A;ATP1B3;TSPAN17;LIN7B;KCNIP3;RABEP1;PIGW;RAB40C;ZDHHC3;F11R;RAB8B;RAB3B;P2RY1;STXBP1;ZDHHC23;IKBKB;KCNB1;CRB3
gsea,extracellular structure organization (GO:0043062),-0.22655120641227483,-0.841270329587359,0.7529976019184652,0.7306412503018527,1.0,18/37,53.31%,ITGB2;ITGAV;MMP11;F11R;MMP28;ITGB5;COL8A2;ADAMTS10;NID2;ADAMTSL5;ICAM4;COL5A1;COL18A1;LAMB2;COL23A1;ICAM5;COL9A3;ATP7A
gsea,protein O-linked glycosylation (GO:0006493),-0.2542770794919374,-0.8394725550362115,0.7218543046357616,0.7321285960040869,1.0,11/23,45.15%,POFUT2;DPM1;DPM2;C1GALT1C1;GALNT11;GALNT4;GALNT12;LARGE2;DPM3;MUC4;TMTC3
gsea,potassium ion transport (GO:0006813),-0.23820624116058464,-0.8307453422702037,0.73,0.7448443331126664,1.0,14/28,40.67%,KCNA4;PKD2;KCNK3;KCNK12;KCNK6;ATP1B3;KCNA7;KCNC3;TMEM175;HPN;KCNIP2;KCNH1;KCNB1;KCNAB3
gsea,positive regulation of neurogenesis (GO:0050769),-0.25399246172869056,-0.8258872064844497,0.6986301369863014,0.7512842009335359,1.0,10/22,42.10%,RHOA;CTNNB1;TRIM32;FAIM;SNW1;OBSL1;DISC1;SMARCD3;CDKL5;MME
gsea,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.2680559455608352,0.8204528645000023,0.7430683918669131,0.7532280297077976,1.0,12/19,41.06%,PTPN1;SORL1;LEMD2;SMAD4;CASK;DAND5;SMURF1;ACVR2A;FSTL3;ACVR2B;BMPR1A;CADM4
gsea,anion transmembrane transport (GO:0098656),-0.2523487048013492,-0.8162604857290492,0.7563025210084033,0.7650544973549122,1.0,19/19,99.05%,ARL6IP5;SLC25A4;SLC35A2;SLC5A6;PRAF2;SLC35B4;MFSD12;LRRC8A;SLC6A8;SLC25A38;SLC1A1;LRRC8E;SLC25A29;SLC25A11;SLC25A12;SLC39A8;LRRC8C;SLC25A42;SFXN3
gsea,endosome organization (GO:0007032),0.2731554038708972,0.7993764091365877,0.7504761904761905,0.7834877641995204,1.0,15/15,93.29%,RNF26;LAMTOR1;TMCC1;PI4K2A;PHETA1;SNX33;USP50;CLCN3;SQSTM1;RAB22A;PHETA2;RILP;SNX3;PLEKHJ1;CHMP2B
gsea,chemical homeostasis (GO:0048878),-0.25970406049111916,-0.7986558663564327,0.7556053811659192,0.7908295605261935,1.0,7/18,40.31%,PNPLA2;ABHD5;FITM2;ABHD8;SLC4A11;AQP11;TREM2
gsea,axon development (GO:0061564),-0.24541775797974041,-0.7954658905214012,0.765625,0.7941351962477949,1.0,10/23,49.96%,SVBP;RTN4;RAB3A;RAB8A;ATL1;PARD6B;MAP1S;MAPT;RTN4RL1;CDK5R1
gsea,establishment of protein localization to plasma membrane (GO:0061951),-0.25211180551781165,-0.795015292110768,0.7473002159827213,0.7932966097014129,1.0,10/20,45.22%,GOLGA7;VAMP2;BLZF1;VAMP4;GORASP1;RILPL1;RAB26;NECTIN3;AMN;BBS1
gsea,regulation of endocytosis (GO:0030100),-0.2387336184905748,-0.7801821450242998,0.7948164146868251,0.8132651722993943,1.0,10/22,46.18%,RAB5C;LRPAP1;AP2S1;RAB4B;SNX17;CALY;TFR2;RUBCN;CBLL1;MTMR2
gsea,transforming growth factor beta receptor signaling pathway (GO:0007179),0.22732074400796246,0.7728089322720513,0.8014705882352942,0.820239256485194,1.0,26/26,94.56%,TGFB1;TGFBR1;UBC;PARD6A;SMAD4;ZFYVE9;FNTA;PTK2;SRC;APPL1;SMURF1;CITED1;BMPR1A;TGFBRAP1;UBA52;SMAD2;TGFBR3L;ITGB5;PXN;F11R;LEFTY1;ZYX;TGFBR2;ARRB2;RHOA;FKBP1A
gsea,regulation of cellular localization (GO:0060341),-0.25038508778046187,-0.7465409002537777,0.8251599147121536,0.8572175280276196,1.0,7/16,46.30%,REEP5;UNC13D;STXBP2;PARD6B;FER;LRP5;STXBP4
gsea,epithelium development (GO:0060429),-0.22992413304139644,-0.7388591284316115,0.8509719222462203,0.8650650644389205,1.0,8/21,47.58%,CTSB;CASP6;PKD2;ACADVL;RIPK4;SIX1;NDRG4;GRHL2
gsea,determination of left/right symmetry (GO:0007368),-0.24872955009418632,-0.724178249112274,0.8565310492505354,0.8811368104983238,1.0,8/15,41.55%,PKD2;GALNT11;ARL6;LEFTY1;DNAH11;NPHP3;CCDC39;DNAAF4
gsea,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.2009549632684351,-0.7235545321836006,0.9172932330827067,0.8801193698470209,1.0,15/33,54.03%,ITGB2;CD164;LRFN4;TGFBR2;OBSL1;CLDN12;CDH15;CLDN23;NECTIN3;LRRC4;FAT4;CD6;AMIGO3;PCDHGB4;AMIGO1
gsea,sulfur compound catabolic process (GO:0044273),-0.23872047543233493,-0.714563752813725,0.8273684210526315,0.8882387654486775,1.0,7/16,35.22%,NUDT7;ACAT1;FITM2;GGT1;GLB1;CSPG5;HYAL1
gsea,sodium ion transmembrane transport (GO:0035725),0.23491778118416956,0.6830283600589713,0.8697183098591549,0.9218165160463958,1.0,11/17,36.33%,SLC6A19;SLC9A7;SCN3B;SLC9A6;SLC24A1;SLC5A2;SLC24A3;ATP4A;SLC9A5;ATP1B2;SLC6A8
gsea,organic acid transport (GO:0015849),-0.20452385137329093,-0.6373050678677351,0.9521739130434783,0.9527977319365868,1.0,8/19,51.81%,SLC5A6;SLC7A4;SLC36A1;SLC7A7;SLC46A1;ABCC3;PPARD;SLC43A1
gsea,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.2033818539703877,-0.6264382431610275,0.9371069182389937,0.9573935301871892,1.0,8/18,45.10%,DBNL;DBN1;SNX2;NCKAP1L;MAP1S;NYAP1;DTNBP1;NBL1
gsea,inorganic cation import across plasma membrane (GO:0098659),-0.2020931883243824,-0.5945650217027273,0.9620853080568721,0.9714664552555982,1.0,15/15,87.33%,TRPM4;ATP1B3;SLC12A9;KCNJ13;HCN2;KCNH2;SLC12A8;ATP1B2;SLC9A5;ATP4A;SLC5A2;SLC24A1;SLC9A6;SLC39A8;SLC9A7
gsea,inositol lipid-mediated signaling (GO:0048017),-0.20348907454892728,-0.5904651763246967,0.9727272727272728,0.9712397310745265,1.0,7/15,43.30%,RHOA;PLCD4;NTRK1;EXOC1;PIK3C2B;KCNH1;PLCB3
gsea,vascular transport (GO:0010232),0.1902110328269392,0.5453597249626805,0.9812382739212008,0.9906896427600941,1.0,16/16,86.87%,SLC9A3R1;LRP1;SLC27A4;INSR;SLC28A2;SLC24A3;SLC1A1;ATP1B2;SLC4A3;SLC2A10;SLC22A5;ABCC3;AGER;SLC29A4;SLC5A6;SLC29A2
gsea,transport across blood-brain barrier (GO:0150104),0.1902110328269392,0.5453597249626805,0.9812382739212008,0.9906896427600941,1.0,16/16,86.87%,SLC9A3R1;LRP1;SLC27A4;INSR;SLC28A2;SLC24A3;SLC1A1;ATP1B2;SLC4A3;SLC2A10;SLC22A5;ABCC3;AGER;SLC29A4;SLC5A6;SLC29A2
gsea,glycosaminoglycan metabolic process (GO:0030203),0.15868653261970192,0.49511520174389445,0.997946611909651,0.9965772018010121,1.0,18/18,84.17%,EXT1;AGRN;IDS;B3GAT2;HS3ST3B1;XYLT2;SGSH;B4GALT7;GPC2;IDUA;FUCA1;NDST1;HS3ST6;NDST2;UGDH;B3GAT3;GLB1;EXT2
gsea,phosphatidylinositol-mediated signaling (GO:0048015),0.14958592584410885,0.4708369351567884,0.9981515711645101,0.9962485768163382,1.0,22/22,93.23%,PTEN;OGT;IGF1R;GAB2;PLCL2;PIK3C3;RPS6KB1;MYO16;PLCD1;FGFR1;SIRT2;PLCB3;LTK;KCNH1;NYAP1;PIK3C2B;EXOC1;TYRO3;NTRK1;ERBB3;PLCD4;RHOA
gsea,regulation of smoothened signaling pathway (GO:0008589),-0.16391028697996207,-0.4700195774505981,1.0,0.9959718962852727,1.0,7/15,41.47%,KCTD6;TXNDC15;ARMC9;MOSMO;KIF7;GLIS2;STK36
